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Abstract 
Human noroviruses of the Caliciviridae family are the major cause of acute gastroenteritis in the 
developed world, but little is known about their molecular mechanisms of translation and replication. 
Since human noroviruses are not cultivatable in vitro, most molecular studies have therefore been based 
on the cultivatable murine norovirus (MNV) or feline calicivirus from the Vesivirus genera. Calicivirus 
translation is dependent on the viral VPg protein covalently linked to the 5’ end of viral RNA and 
removal of the VPg from calicivirus RNA results in loss of infectivity. VPg functions as a ‘cap substitute’ 
by interacting with eIF4E to recruit translation initiation factors (eIFs). Given that VPg plays a critical role 
in the virus life cycle, it is potentially a good anti-viral target. As an initial attempt to identify ways of 
targeting VPg as an anti-norovirus therapy, we used phage display to identify peptides with an affinity 
for VPg. Despite repeated attempts however, we failed to generate a peptide that had clear specificity 
for the calicivirus VPg. 
Since VPg has ability to bind the cap binding protein eIF4E, m7-GTP Sepharose affinity chromatography 
was used to isolate eIF4E and the associated VPg. Similar to the analysis of the MNV VPg-translation 
initiation factor complex, this method successfully isolated not only the human norovirus VPg, but also 
isolated the entire eIF4F complex and PABP from a cell based-norovirus replicon system. Human 
norovirus and MNV VPg proteins share 54% amino acid identity and MNV has been proposed as a good 
model for human norovirus. To begin structural and functional analysis of the human norovirus VPg in 
the context of an authentic viral life cycle, we introduced the human norovirus VPg into an infectious 
clone of MNV, to generate a chimera containing all the MNV non-structural and structural proteins but 
with the human norovirus VPg.  Whilst the insertion of the human norovirus VPg into the MNV genome 
did not affect polyprotein processing, we were unable to recover infectious viral particles.  
Since the requirement for other cellular factors in the VPg-dependent translation is not fully understood, 
we used “tandem affinity purification” to further define the components of the initiation factor complex 
associated with VPg. Our data demonstrated that VPg associates with both canonical initiation factors 
and possibly non-canonical initiation factors. Further investigation suggested that the scaffold protein 
eIF4G, which bridges the interaction between PABP and eIF4E, binds directly to VPg via its central 
domain. To determine the function of eIF4G in the norovirus life cycle, we have silenced eIF4G isoforms 
in 293T cells using specific siRNAs and transfected them with infectious VPg-linked viral RNA. The siRNA-
mediated knockdown of either eIF4G isoform resulted in a 9 fold reduction in virus titre, as well as 
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reduction of viral RNA and protein synthesis, confirming that eIF4G has a functional role in norovirus life 
cycle. Furthermore, it is not known if the eIF4G-eIF4E interaction is not limiting for MNV translation. 
Thus, we altered the availability of eIF4E to bind eIF4G by overexpressing wild type or non-
phosphorylatable mutant forms of the eIF4E binding protein 1 (4E-BP1) in cells. Overexpression of either 
the wild type 4E-BP1 or the non-phosphorylatable 4E-BP1 mutant in MNV infected cells showed no 
significant change in viral RNA, virus titre or protein expression suggesting that the eIF4G-eIF4E 
interaction in a VPg-translation initiation complex is not limiting for MNV translation.  
In addition to studying the interaction between VPg and the eIFs, we also examined the effect of 
mutations in VPg on virus viability and ability to bind the eIF4F complex. A number of mutants were 
generated in MNV infectious clone to identify residues that play a role in calicivirus translation. The 
mutational analysis of MNV VPg indicated the C-terminus of VPg is essential for the association of VPg 
with the components of eIF4F complex and virus viability. This work provides new insights on the 
interaction between noroviruses and the host cell, as well as the novel mechanisms that viruses use to 
synthesis their proteins. 
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1.1 The significance of caliciviruses in humans and animals 
Caliciviruses are responsible for various important diseases in both humans and animals. Human 
caliciviruses (HuCV) from the Norovirus and Sapovirus genera are the major cause of non-bacterial 
gastroenteritis (Fankhauser et al., 1998) and contribute to 3.5 to 5 million deaths annually (Atmar and 
Estes, 2001). They are most commonly associated with outbreaks of illness in crowded locations, such as 
hospitals, restaurants, cruise ships and military camps (Halperin et al., 2005; Riddle and Tribble, 2008; 
Said et al., 2008; Siebenga et al., 2009). Outbreaks in hospitals alone are estimated to cost the National 
Health Service approximately £115m each year due to decontamination of the affected settings, ward 
closures and lost working days of infected healthcare workers, making noroviruses not only a health 
burden for patients and staff, but also an economic burden with potential service disruption (Lopman et 
al., 2004b). Although HuCVs have a significant economic impact and cause substantial morbidity, very 
little is known about how they replicate and translate because of the lack of an efficient tissue culture 
system (Duizer et al., 2004). Caliciviruses cause a broad spectrum of disease in a wide range of animals, 
such as enteric, respiratory and haemorrhagic diseases. For example, feline calicivirus (FCV) of the 
vesivirus genus causes an upper respiratory tract infection in domestic and wild cats (Hurley and Sykes, 
2003). Rabbit haemorrhagic disease virus (RHDV) of the Lagovirus genus, causes a highly lethal and 
contagious disease in rabbits resulting in up to 95% mortality in infected animals (McIntosh et al., 2007). 
In addition to human noroviruses, there are also noroviruses that infect swine, cattle, lion and mice 
(Karst et al., 2003; Martella et al., 2007; Pringle, 1998; Wobus et al., 2006). 
1.2 Taxonomy 
The Caliciviridae currently has five recognised genera and an additional putative genus (figure 1.1). The 
classification is largely based on phylogenetic analysis of the capsid and polymerase genes. Of the 
recognised genera, the Vesivirus genus includes for example FCV and vesicular exanthema virus, the 
Sapovirus genus includes Manchester virus, and the Lagovirus genus includes RHDV (Green et al., 2000; 
Pringle, 1998). The Beco/Nabovirus genus includes the bovine calicivirus Newbury-1, which causes 
diarrhoea and intestinal disease in calves (Oliver et al., 2006). The genus Norovirus has been further 
divided into 5 genogroups (GI- GV) that infects different hosts, and the genus is sub-divided into multiple 
genotypes on the basis of the amino acid sequences of the capsid and polymerase (Bailey and Goodfellow, 
2009; Scipioni et al., 2008). Only genogroups GI, GII and GIV noroviruses infect humans and these can 
differ by up to 50% of the nucleotide sequence (Bailey and Goodfellow, 2009; Zheng et al., 2006). GII and 
GIV also infect other animals, such as pigs and domestic and wild cats. Genogroup V contains murine 
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norovirus (MNV) (Karst et al., 2003; Wobus et al., 2006), whereas GIII comprises bovine and ovine 
noroviruses (Bailey and Goodfellow, 2009; Zheng et al., 2006). Both noroviruses and sapoviruses have also 
been detected in animals. In addition to these established genera, Recovirus genus is the proposed genus. 
It includes the Tulane virus that infects rhesus macaques (Farkas et al., 2008).  
 
1.3 Calicivirus and disease 
1.3.1 Human norovirus 
While lagoviruses and vesiviruses mostly infect animals and are responsible for a range of different 
diseases, noroviruses and sapoviruses are the only caliciviruses that can infect humans and are 
responsible for 90% of non-bacterial gastroenteritis (Fankhauser et al., 1998). In particular, noroviruses 
are the dominant cause of sporadic and epidemic human gastroenteritis in the world, infecting all age 
groups. Human norovirus infection is also known as ‘winter vomiting disease’ because the outbreak 
follows a pattern of winter seasonality and the clinical symptoms associated with acute gastroenteritis, 
including vomiting and diarrhoea (Mounts et al., 2000). The infection is often referred to as ‘stomach flu’ 
Figure 0.1 Classification of CalicivirIdae. The Caliciviridae has five recognised genera: norovirus, 
vesivirus, sapovirus, lagovirus and beco/nabo-virus, and a proposed genera, recovirus. Examples 
are named for each genus. The genus Norovirus is further sub-divided into five genogroups 
infecting a variable host range. 
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or ‘gastric flu’ (Siebenga et al., 2009). The earliest documented outbreak of ‘winter vomiting disease’ 
originated at an elementary school in Norwalk, Ohio, in 1968 (Kapikian et al., 1972). The causative agent 
was not found until 1972, when Albert Kapikian detected viral particles from the stool samples of 
volunteers who were experimentally given stool filtrate from a patient infected during the Norwalk 
outbreak. The viral particles elicited immune response in the volunteers and naturally infected people 
could be detected using electron microscopy (Kapikian et al., 1972).  
Noroviruses have been estimated to cause 23 million infections in the US every year (CDC, 2006) and 3.5 
to 5 million deaths every year in developing countries (Bailey and Goodfellow, 2009). Several features of 
noroviruses contribute to their success in the human population, such as their low infectious dose, their 
high stability in all environments, highly infectious, short-lived protective immunity, high antigenic and 
genetic diversity, a high level of shedding and prolonged asymptomatic shedding after recovery (Atmar 
et al., 2008; Bailey and Goodfellow, 2009; Chen et al., 2006; Rockx et al., 2002; Siebenga et al., 2009). 
The transmission of noroviruses is primarily via the faecal-oral route; however, airborne transmission via 
the aerosolisation of vomit and transmission via direct contact are possible (Caul, 1994; Gallimore et al., 
2006; Marks et al., 2000). The multiple routes of transmission combined with the collective 
characteristics of noroviruses give them the ability to cause repeated infection and vulnerability to fast-
spreading epidemics in closed settings, such as care facilities, cruise ships, hospitals, restaurants and 
military camps. The financial loss is associated with ward closures, sick leave, and the expense of 
disinfectants (Lopman et al., 2002; Lopman et al., 2004a; Lopman et al., 2004b; Riddle and Tribble, 2008; 
Said et al., 2008). 
The symptoms of norovirus infections are usually mild and self-limiting in developed countries, typically 
lasting for 1-3 days, although symptoms can occur for longer periods in the young, the elderly and the 
immunocompromised (Estes et al., 2006; Gallimore et al., 2006). These include nausea, vomiting, 
abdominal cramps and diarrhoea. While diarrhoea is the most common symptom, followed by vomiting 
(Rockx et al., 2002), other more serious complications have been reported, including infantile seizures 
(Chen et al., 2009) and necrotising enterocolitis in neonates (Turcios-Ruiz et al., 2008). Although the 
illness caused by noroviruses is generally mild, they have been responsible for an estimated 200,000 
deaths of children under 5 annually. The illness can be fatal among elderly and immunocompromised 
patients due to severe dehydration (Patel et al., 2008). Despite the significant impact of norovirus 
outbreaks, to date, there is no licensed anti-viral drug or vaccine available. 
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1.3.2 Murine norovirus 
Murine norovirus (MNV) was first isolated in 2003 from immunocompromised mice (Karst et al., 2003). 
It is one of the most prevalent enteric pathogens in laboratory mouse with up to 64.3% of mice being 
recorded as positive for MNV (Karst et al., 2003; Muller et al., 2007). This finding could have an impact in 
other mice model research studies especially those involving intestinal pathogens. For example, a recent 
study has indicated that disease progression in the mouse model of inflammatory bowel disease caused 
by bacteria infection is affected by MNV infection (Lencioni et al., 2008). MNV belongs to the Norovirus 
genogroup GV (Karst et al., 2003), which shares a significant genetic similarity with human norovirus, 
and hence, their mechanism of viral translation and replication are likely to be conserved. Unlike human 
norovirus, MNV can replicate effectively in cell culture, with a cellular tropism for macrophages (e.g. 
RAW264.7 and BV-2 cells) and dendritic cells (Wobus et al., 2004). It is also easily manipulated by 
reverse genetics (Chaudhry et al., 2007; Ward et al., 2007), which makes it a good model system to 
study the molecular mechanism of the human norovirus lifecycle and aspects of viral pathogenesis. Two 
reverse genetics systems were established based on the first isolated strain of MNV, MNV-1 (CW1). The 
system generated by Ward et al is based on a polymerase II driven system to recover MNV (Ward et al., 
2007). An alternative system presented by Chaudhry et al, relies on fowlpox virus (FPV) expressing T7 
RNA polymerase in order to drive the expression of MNV cDNA clones under the control of a T7 
promoter (Chaudhry et al., 2007).  
MNV-1 strain is lethal for immnocompromised mice lacking the signal transducer and activation of 
transcription 1 (STAT-1) and recombination activation gene 2 (RAG-2) genes. STAT-1 knockout mice 
(STAT-1-/-) or mice lacking type I and II interferon receptors succumbed to a fatal systemic disease when 
challenged with MNV-1. In RAG2 knockout mice (RAG2-/-), MNV-1 infection is not lethal, but leads to a 
persistent infection with continuous virus shedding (Karst et al., 2003; Mumphrey et al., 2007; Wobus et 
al., 2006). These observations indicate that innate immunity is required for infection control, while the 
adaptive immune system is important for viral clearance (Karst et al., 2003). Of interest, mice lacking 
either type I or type II interferon receptors did not succumb to fatal disease, whereas those lacking both 
types of receptors did, demonstrating the importance of IFN in clearing MNV-1 infection (Karst et al., 
2003). This provides evidence that the type I and type II interferon receptors are functionally 
interchangeable. The symptoms of infected immnocompromised mice include encephalitis, vasculitis, 
pneumonia, meningitis, and hepatitis (Karst et al., 2003). However, MNV-1 can be cleared after a sub-
clinical infection in immunocompetent mice. In contrast, most other MNV strains can persistently infect 
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immunocompetent mice (Karst et al., 2003). These other strains share approximately about 86% to 91% 
nucleotide identity to MNV-1 (Hsu et al., 2006). Despite their genetic similarity, it is interesting to note 
the phenotypic variability during infection between MNV-1 and these other strains (Hsu et al., 2006).  
The characteristic features of MNV such as the rapid course of an MNV infection, a low infectious dose 
and transmission via the faecal-oral route are similar to human norovirus (Liu et al., 2009; Perdue et al., 
2007) However, as with all model systems, some differences exist between MNV and human 
noroviruses. For instance, mice lack an emetic reflex and therefore cannot vomit. Mice also do not 
routinely develop diarrhoea after MNV infection. In immunocompetent mice, prolonged faecal shedding 
and viral persistence is typically associated with MNV infection, whereas in humans, persistent norovirus 
infections are usually associated with immunocompromised individuals (Estes et al., 2006; Gallimore et 
al., 2004; Gallimore et al., 2006; Murata et al., 2007). Despite the difference, MNV is likely to share a 
similar molecular mechanism of translation and replication and continues to be a good model for 
accelerating the knowledge of the human norovirus lifecycle and for identifying potential antiviral 
strategies to eliminate human norovirus infection.  
1.3.3 Feline calicivirus 
FCV belongs to the Vesivirus genus, and is a common pathogen of cats. It is responsible for a range of 
diseases from mild oral upper respiratory tract infection to systemic disease (Hurley and Sykes, 2003). 
The upper respiratory tract infection is often referred to as ‘cat flu’ due to it having similar clinical signs 
as human flu. It is usually accompanied by conjunctivitis, an ocular and nasal discharge, and is also 
associated with stomatitis and arthritis in cats (Radford et al., 2007). A highly virulent strain of FCV, 
which induces virulent systemic disease with a hemorrhagic fever, has recently emerged, causing a high 
rate of mortality. FCV infects cats via a nasal, oral or conjunctival route and can be transmitted to the 
foetus of infected pregnant individuals (Radford et al., 2007). FCV can cause persistent infections and is 
shed for approximately 30 days post-infection. This, together with its high stability in the environment, 
shapes the success of FCV in the cat population, similar to norovirus (Radford et al., 2007).  
Since FCV was the first calicivirus to be discovered that replicated efficiently in culture and has reverse 
genetics, it was the most common model system for studying human caliciviruses, although it does not 
cause gastroenteritis (Hurley and Sykes, 2003). Despite the clear differences between human 
noroviruses and FCV, studies using FCV lead to the identification of functional interactions between viral 
and host factors, with comparable interactions also later observed in noroviruses. For example, an 
interaction between polypyrimidine tract binding protein and viral genomic RNA is required for FCV 
                                                             P a g e  | 24 
 
replication (Karakasiliotis et al., 2006), which has also been demonstrated in human noroviruses 
(Gutierrez-Escolano et al., 2003). Unlike for noroviruses, an FCV vaccine is available in live attenuated 
and inactivated antigen forms to control and prevent FCV infection. Although the vaccine is considerably 
safe and effective at preventing or reducing FCV-induced diseases, it does not prevent productive 
infection or virulent systemic disease. Furthermore, it does not provide cross reactivity to all FCV strains 
(Radford et al., 2007). This underlines the urgency to discover an improved FCV vaccine for full 
protective coverage against a wide range of FCV isolates. 
1.4 The study of Caliciviruses 
Despite considerable efforts, there has been limited success in developing an animal model and cell 
culture to elucidate the molecular mechanism of the human nororvirus lifecycle. However, a recent 
finding demonstrated that VPg-linked RNA of Norwalk virus (NV) is infectious in mammalian hepatoma 
(Huh-7) cells, but only enables a single cycle of replication, indicating the synthesised viruses cannot 
infect other cells (Guix et al., 2007). This finding supports the hypothesis that the major barrier of virus 
being cultivated in tissue culture is at the level of virus entry into the cell, either through receptor 
specificities or restrictions in uncoating (Guix et al., 2007). Recently, a study has demonstrated that 
human norovirus is able to grow in gnotobiotic pigs and the fact that infection occurred was shown by 
diarrhoea, virus shedding and seroconversion (Cheetham et al., 2006). In spite of the potential for 
gnotobiotic pigs as a good model, it is extremely costly and labour intensive. Another report has shown 
that human norovirus can be replicated in human small intestine epithelium 3D differentiated cells 
(Straub et al., 2007). However, this system is very costly and difficult to establish. It requires special 
equipment, and the findings remain to be duplicated by another independent laboratory. With the 
limited possibilities of virus cultivation, MNV and FCV are the best currently available systems to 
accelerate the knowledge of the immunity, pathogenesis and basic molecular mechanisms of 
caliciviruses. An alternative approach to studying the molecular biology of norovirus is by a cell-based 
replicon system, whereby a self-replicating Norwalk virus (NV) RNA is stably maintained in BHK cells 
(Chang et al., 2006). This NV replicon system should provide the first tool to unravel viral replication and 
translation, such as the identification of cellular and viral proteins which promote translation or 
replication and potentially provide useful information about the efficient development of vaccines and 
antivirals. 
                                                             P a g e  | 25 
 
1.5 Morphology and genome organisation 
The name Caliciviridae comes from the Latin word calyx, meaning ‘cup’ or goblet, since the virion 
particle displays a total of 32 cup-shaped depressions on its surface (figure 1.2). The virions of 
caliciviruses are non-enveloped capsids, which were first visualised by immune-electron microscopy in 
1972. The norovirus capsid exhibits a T=3 icosahedral symmetry, is 27-39nm in diameter (Venkataram 
Prasad et al., 2000). It is made of 180 copies of the major protein VP1, organised as 90 dimers. VP1 
contains two domains:  the shell (S) and the protruding (P) domain, with the P2 domain being itself 
subdivided into P1 and P2 subdomains (see section 1.6.6). In addition to VP1, capsids also consists of 
one or two copies of the minor capsid VP2(Bertolotti-Ciarlet et al., 2002; Chen et al., 2006; Prasad et al., 
1999). The viral capsid is resistant to environmental changes i.e. high temperature, high concentration 
of chlorine, acidity, ethanol and quaternary ammoniums, which make them difficult to disinfect. These 
physiochemical properties contribute to the highly contagious nature of the caliciviruses, which causes 
problems in terms of controlling the outbreak of gastroenteritis (Bailey and Goodfellow, 2009; Estes et 
al., 2006). 
 
The calicivirus genome is a single-stranded positive-sense RNA, typically of about 7.5 kb in size. The 
genome is polyadenylated at the 3’ end and has a viral protein (VPg) covalently linked to the 5’ end.  The 
genome organisation of caliciviruses is relatively similar, with the non-structural proteins being encoded 
towards the 5’ end of the genome, while the structural proteins are encoded towards the 3’ end (Atmar 
and Estes, 2001; Bailey and Goodfellow, 2009).  
Figure 0.2 Morphology of the caliciviruses. Cup-shaped depressions are shown on the surface of 
virions. A) An electron microscopy image of RHDV (microbes.otago.ac.nz). B) An electron 
microscopy image of Norwalk viruses from the Norovirus genus (bar = 50nm) (www.epa.gov). C) A 
reconstruction of recombinant Norwalk virus capsid by cryo-EM (Prasad et al, 1999).  
A B C
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Typically, caliciviruses have two or three ORFs, which are flanked by two short untranslated regions 
(UTRs), and the length of each ORF varies as highlighted in figure 1.3. Based on the organisation of the 
VP1-encoding open reading frame (ORF), there are two major groups of genome organisation. One is 
that VP1 is encoded in a separated ORF as is the case for norovirus and vesivirus genomes; the second is 
that the VP1 encoding sequence is fused to the 3’ end of ORF1 as is the case for sapoviruses, lagoviruses 
and naboviruses (Atmar and Estes, 2001; Clarke and Lambden, 1997; Oliver et al., 2006). ORF1 encodes 
the non-structural proteins and is followed by ORF2 and ORF3, which encode the major and minor 
 
Figure 0.3 Genome organisation of the caliciviruses. (Adapted from Atmar & Estes, 2001). The 
genome organization is based on the organization of VP1-encoded ORF, and has divided into two 
major groups. In the case of sapovirus and lagovirus genomes, the sequence encoding VP1 is fused 
to the 3’end of ORF1, while VP1 is encoded in a separated ORF in the example of norovirus and 
vesivirus genomes. The open reading frame one, ORF1, depicted in white encodes non-structural 
(NS) proteins; ORF2 that encodes a major capsid is highlighted in pale grey, and ORF3 encoded a 
minor capsid VP2 is shaded in dark grey. The Manchester virus from the Sapovirus genus has an 
additional ORF, which are highlighted in dotted boxes. A fourth alternative ORF (ORF4) that is found 
in MNV, but not in other noroviruses, is indicated by an asterisk. Note: The nabovirus genome is 
not shown here, but the genome organisation is typical to that seen of lagoviruses and sapoviruses. 
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capsid proteins VP1 and VP2 respectively. Interestingly, the Manchester virus within the Sapovirus genus 
has an additional ORF (Clarke and Lambden, 2000). Recently, murine norovirus (MNV) has also been 
shown to possess an internal ORF4 within ORF2 i.e. overlapping with VP1 in a +1 frameshift, but this 
ORF4 is not found in other noroviruses (figure 1.3). Studies have demonstrated that ORF4 is not 
essential for virus replication in cell culture, yet plays a role in infection in vivo and virulence by 
antagonising the innate immune response (McFadden et al., 2011).  
1.6 Structural and non-structural proteins 
Although caliciviruses are genetically diverse, they share a similar strategy of protein expression and 
maturation. The translation of ORF1 initiates at the first AUG codon, resulting in the synthesis of a large 
polyprotein. The polyprotein is subsequently autocatalytically-processed by the viral protease to 
generate precursor and mature forms of non-structural proteins (figure 1.4). In the case of sapoviruses, 
naboviruses and lagoviruses, the capsid protein is contiguous with ORF1, therefore translation generates 
an ORF1-VP1 fusion protein (Clarke and Lambden, 2000; Sosnovtsev et al., 2006; Sosnovtsev et al., 
2002).  
The viral proteins have alternative nomenclature based on their genome position and their size; the 
nomenclature of NS1- NS7 is used to highlight the mature non-structural (NS) proteins made from the 
processing of the MNV ORF1 polyprotein, while the nomenclature of FCV NS proteins is based on their 
size. In FCV, the translational processing of polyprotein generates six NS proteins (p5.6, p32, p39, p13, 
p30 and p76) and numerous precursor proteins (Sosnovtsev et al., 2002). In infected cells, the FCV 
protease and polymerase functions as a fusion protein called p76 (Pro/Pol), while this protein must be 
separated into NS6 and NS7, in order to be functionally active in MNV infected cells (Sosnovtsev et al., 
2006; Ward et al., 2007). In addition, the capsid of FCV is produced as an immature protein, which 
requires proteolytic removal of the leader capsid sequence (Sosnovtsev et al., 2002). In MNV infected 
cells, the ORF1 polyprotein is cleaved into six mature viral proteins. The first two non-structural proteins 
(NS1/2) are found as a fusion, unlike the FCV equivalent proteins p32 and p39 (Sosnovtsev et al., 2006; 
Sosnovtsev et al., 2002). The proteolytic processing of MNV NS proteins in an in vitro system closely 
correlates to the products observed in infected RAW264.7 cells (Sosnovtsev et al., 2006). In general, 
vesivirus and norovirus ORF1 has 5 cleavage sites which correspond to the 6 mature NS proteins being 
made.   
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1.6.1 NS1/2 
The first NS protein encoded in MNV is NS1/2, which is potentially equivalent to the FCV p5.6 and p32 
proteins that are found as two separate proteins. NS1/2 shows no similarity to any established 
functional motif based on its protein sequence alignment despite containing a putative H box and NC 
 
Figure 0.4 Diagrammatic representations of MNV and FCV genome organization. Proteolytic 
cleavage map of the MNV and FCV genome highlighting the previously identified three ORFs, 
depicted as black boxes (adapted from Sosnovtsev at al., 2006). An additional ORF, ORF4, found in 
MNV only is highlighted in dark grey. Both genomic and subgenomic RNAs have a VPg protein linked 
to the 5’ end and a poly(A) tail at the 3’end. The translation of genomic and subgenomic RNA is 
facilitated by VPg represented as a black circle. Translation of ORF1 produces a large polyprotein 
which is subsequently cleaved by the viral encoded protease (Pro) to release mature NS proteins. 
The viral proteins have alternative nomenclature based on their genome position and their size; the 
nomenclature of NS1- NS7 is used to highlight the mature nonstructural proteins made from the 
processing of the ORF1 polyprotein, while the nomenclature of FCV NS proteins is based on their 
size. In addition, the NS proteins of picornaviruses that have functional similarity to those of MNV 
and FCV are displayed below the viral genome in italics. ORF2 is thought to be translated 
conventionally from the subgenomic RNA, while ORF3 is thought to be translated by a termination-
reinitiation mechanism. MNV ORF4 may be translated by leaky scanning and read-through of the 
ORF2 start codon. Note: N-terminal peptide is indicated by N-term; leader capsid is indicated by LC; 
protease is indicated by Pro and polymerase is indicated by RdRp.  
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motif, which suggests it may function in the regulation of cell proliferation (Baker et al., 2012). However, 
NS1/2 is predicted to have a similar function as the 2B protein of picornaviruses, which is believed to be  
involved in intracellular change during replication (Agirre et al., 2002) and membrane rearrangement 
through the hydrophobic spanning domain (Ettayebi and Hardy, 2003). In MNV infected cells, NS1/2 
associates with replication complexes, like the FCV equivalent p32 (Green et al., 2002; Hyde et al., 2009). 
In addition, evidence from NV analogue p48 suggests that the protein co-localises in the Golgi apparatus 
(Ettayebi and Hardy, 2003). NS1/2 has also been reported to bind vesicle-associated membrane protein-
associated protein A (VAP-A) implying that it has a role in membrane vesicle fusion and endoplasmic 
reticulum (ER)/Golgi transport and affects cellular secretion (Ettayebi and Hardy, 2003). However, the 
exact role of NS1/2 interaction with the membrane during the virus lifecycle remains to be examined. 
As a distinct protein expressed from the genome of vesiviruses, NS2 has been found in virus replication 
complexes, suggesting that it may be involved in membrane vesicle recruitment during the assembly of 
virus replication complexes (Kaiser et al., 2006). A yeast two-hybrid analysis of FCV shows that NS2 
interacts with NS3, NS4, NS6/7 suggesting NS2 is possibly involved in protein scaffolding during 
replication (Ettayebi and Hardy, 2003; Kaiser et al., 2006). 
1.6.2 NS3 
The MNV NS3 and FCV equivalent protein p39 exhibit sequences similar to the 2C NTPase of 
picornaviruses. Evidence from a 2C-like protein of RHDV and Southampton virus (GII human norovirus) 
shows that they have NTPase activity that functions to hydrolyse nucleoside triphosphates in vitro 
(Marin et al., 2000; Pfister and Wimmer, 2001). The expression of NS3 could promote membranous 
vesicle formation and facilitate the structural change of intracellular membranes in vitro. Further 
analysis indicates that the N-terminal hydrophobic region of NS3 is responsible for mediating its 
membrane association (Hyde et al., 2009; Sosnovtsev et al., 2002). In addition, NS3 is thought to interact 
with NS2. In MNV and FCV infected cells, NS3 has been shown to co-localise with viral replication 
complexes (Bailey et al., 2010b; Hyde et al., 2009). Considering the ability of NS3 to anchor membranes 
and its ability to bind NS2, it is possible that NS3 plays a role in establishing membrane-associated 
replication complexes during RNA synthesis.  
1.6.3 NS4 
The fourth NS protein is one of the least characterised calicivirus proteins. The MNV NS4 and FCV 
equivalent protein p30 have a functional similarity to the picornavirus 3A protein due to the presence of 
the predicted amphipathic helix, which has membrane association properties and have been implicated 
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in the inhibition of cellular protein transport. Since NS4 can exist as precursor form (NS4-NS5), it is 
thought to deliver VPg (NS5) to the replicative complexes and assist in VPg-mediated RNA synthesis 
(Green et al., 2002; Hyde et al., 2009; Sosnovtsev et al., 2006; Sosnovtsev et al., 2002). NS4 and its 
precursor have been found to be membrane-associated components of the FCV replication complexes, 
and NS4 has been identified to bind NS2 (Green et al., 2002; Kaiser et al., 2006). Recent work has 
demonstrated that NS4 is associated with the endosome and it has been proposed that NS2 and NS4 
may possibly be recruited to host membranes at the site of replicative complex (Hyde et al., 2009).  
Furthermore, mutations in MNV NS4 are thought to play a role in tissue culture adaptation of MNV, 
since serial passaged MNV-1 yielded attenuated viruses with sequence changes in NS4 (Bailey et al., 
2008).  
1.6.4 NS5 (VPg) 
The MNV NS5 or FCV p13 proteins are usually referred to as VPg. This is covalently linked to the 5’ end 
of the viral genomic and subgenomic RNA (Burroughs and Brown, 1978; Herbert et al., 1997). The 
linkage of VPg to the calicivirus RNA is essential for viral infectivity, since the removal of VPg from the 
calicivirus RNA using proteinase K abolishes viral translation, leading to the loss of viral infectivity 
(Burroughs and Brown, 1978; Herbert et al., 1997). In vitro transcribed capped FCV RNAs were infectious 
when transfected into cells (Sosnovtsev and Green, 1995). The VPg protein is also present in 
picornaviruses and some plant viruses. Although picornaviruses represent the best characterised 
member of positive strand RNA viruses, their VPg does not share a significant sequence similarity to that 
of the caliciviruses. In addition, the size of the picornavirus VPg is typically 22 amino acids, whereas the 
VPg from the caliciviruses is approximately 13-15kDa in size making it closer relative of plant VPg. Apart 
from the size and sequence diversity of the VPg between picornaviruses and caliciviruses, the VPg linked 
to the picornavirus RNA genome is not crucial to viral infectivity (Flanegan et al., 1977a; Nomoto et al., 
1977). In fact, picornaviruses exhibit an alternative translation initiation strategy, relying on the use of 
an internal ribosomal entry site (IRES) located in the 5’ UTR (e.g 650-1300 nucleotides) (Belsham et al., 
2008; Fitzgerald and Semler, 2009). With the extremely short 5’ UTR found in caliciviruses (e.g. 10 
nucleotides in MNV and 19 nucleotides in FCV) (Daughenbaugh et al., 2006; Sosnovtsev et al., 2006), it is 
likely that IRES-dependent translation does not occur.  
Evidence from the yeast two-hybrid system and various affinity chromatography assays have 
demonstrated that calicivirus VPg could be associated with the ribosomal protein S6 (Daughenbaugh et 
al., 2006) and numerous eukaryotic translation initiation factors (eIF(s)) including eIF4E (Chaudhry et al., 
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2006; Goodfellow et al., 2005), eIF3 complex (Daughenbaugh et al., 2003; Daughenbaugh et al., 2006), 
eIF4GI and eIF2a (Daughenbaugh et al., 2006). Interestingly, the VPg from plant viruses such as potyvirus 
and rice yellow mottle virus from the Sobemovirus genus appears to have a similar function to the VPg 
from the animal caliciviruses, both of which can recruit eIF4E and eIF4G to initiate viral translation 
(German-Retana et al., 2008; Hebrard et al., 2010; Nicaise et al., 2007). Given that these plant viruses 
use the viral encoded VPg protein to sequester translation initiation factors to the 5’ end of viral RNA, 
caliciviruses are likely to share a similar mechanism of translation initiation. These collective data have 
concluded that VPg functions as a ‘cap substitute’ to recruit canonical translation initiation factors and 
the 40S ribosomal subunit to the 5’ end of viral RNA, which due to its positive-sense polarity acts as an 
mRNA. This novel mechanism of translation initiation mediated by calicivirus VPg is discussed further in 
section 1.9.2.  
Since VPg from picornaviruses and caliciviruses is linked to the genomic and subgenomic RNA, the 
linkage of VPg is believed to serve as an RNA primer for template-dependent synthesis of viral RNA 
(Herbert et al., 1997; Rohayem et al., 2006; Steil and Barton, 2009). This linkage of VPg occurs via 
nucleotidylation mediated by the viral RNA dependent RNA polymerase (RdRp). Since the 5’ end of the 
picornavirus genome begins with the sequence UU, while all caliciviruses genomes begin with GU, thus 
the reaction for the nucleotide linkage in VPg is often referred to as uridylylation in the case of 
picornaviruses, and guanylation in the case of caliciviruses. Nevertheless, both picornavirus and 
calicivirus VPg acts as a primer to initiate RNA synthesis (Paul et al., 2000). In the case of picornaviruses, 
the nucleotide linkage in VPg has been identified at tyrosine 3 (Paul et al., 2000), while the site of 
nucleotide linkage in the VPg from different caliciviruses varies. For example, RHDV VPg can be 
uridylylated at a tyrosine residue located at position 21 (Machin et al., 2001), while the linkage of FCV 
VPg and the human norovirus VPg can occur at corresponding conserved tyrosines at positions 24 and 
27 respectively (Belliot et al., 2008; Mitra et al., 2004). Furthermore, the mutation of the corresponding 
tyrosine residue involved in the linkage of FCV VPg to viral RNA has been demonstrated to be lethal to 
the viruses (Mitra et al., 2004) 
VPg has been found in a mature form and 4 different precursor forms (NS4/NS5, NS4/NS5/NS6, 
NS5/NS6/NS7 and NS4/NS5/NS6/NS7 forms). Interestingly, these precursors also bind preferentially to 
the cap-binding protein, eIF4E in the cap-sepharose pull-down assay (Chaudhry et al., 2006; Goodfellow 
et al., 2005). Although the exact role of these precursors has not been defined, one might predict that 
they can participate in host shutoff, since they have the ability to bind eIF4E, which is required for cap-
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dependent translation in cells. However, one cannot exclude the possibility that these precursors may 
sequester cellular proteins and translation initiation proteins to the site of viral membrane-associated 
replication complexes or sites of viral translation (Goodfellow et al., 2005). Considering that the 
precursors of picornavirus VPg play an important role in the virus lifecycle and are involved in viral 
genomic RNA synthesis (Cameron et al., 2010; Pathak et al., 2008), precursors of the calicivirus VPg may 
also have similar functions.  
Other than the genome RNA priming and translational function, VPg is predicted to be involved in 
encapsidation, since the direct interaction of FCV VPg with capsid protein, as well as RNA polymerase 
NS6/7, as determined by yeast two-hybrid analysis (Kaiser et al., 2006). One might predict that VPg-
linked RNA, together with the VPg precursors, are specifically incorporated at the site of the replication 
complex, thus allowing viruses to be readily released once they have been encapcidated. It is worth 
noting that foot and mouth disease virus (FMDV) VPg has been shown to mediate virus release (Arias et 
al., 2010), leading to the question of whether or not calicivirus VPg plays a role in virus release. Although 
plant virus VPg has been identified as participating in cell-to cell spread (Rantalainen et al., 2011), it 
remains to be determined whether calicivirus VPg exhibits such a function. Of interest, potyvirus VPg 
has the ability to interact with RNA (Rantalainen et al., 2011), which it is also shared by FCV and MNV 
VPg. However, whether or not this RNA binding ability plays a role in the virus lifecycles remains to be 
elucidated.  
1.6.5 NS6 and NS7  
The FCV p76 (NS6/NS7) has two different functional domains; one with trypsin-like serine protease 
activity (equivalent to MNV NS6) and the other with RdRp activity (equivalent to MNV NS7) (Sosnovtsev 
et al., 2006; Wei et al., 2001). FCV p76 appears to have functional similarity to the picornavirus 3C 
protein and represents a mature and stable enzyme with no sign of further processing during infection. 
In contrast, the viral protease and polymerase (NS6/NS7) from MNV (Blakeney et al., 2003; Sosnovtsev 
et al., 2006) and RHDV (Martin Alonso et al., 1996) are further cleaved into two separate proteins, NS6 
and NS7. The protease domain p76 or NS6 is a single chymotrypsin-like protease. It is autocatalytically 
released from the protein precursor and is responsible for the proteolytic processing of polyprotein 
(Sosnovtsev et al., 2006; Sosnovtseva et al., 1999). In addition, the norovirus and FCV NS6 protein may 
also play a role in the inhibition of cellular translation (i.e. cap-dependent translation) via the cleavage of 
critical translation initiation factors, such as PABP and eIF4G (see section 1.10), although the precise role 
of the cleavage remains to be determined (Kuyumcu-Martinez et al., 2004a; Willcocks et al., 2004).  
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The FCV p76 or MNV NS7 proteins show sequence homology to the picornavirus 3CD protein RdRp, 
which suggests they have a similar function in replication. RdRp is a key enzyme involved in viral 
replication.  As previously mentioned, full length FCV p76 is an active RdRp (Wei et al., 2001), whereas 
the norovirus and RHDV RdRp are only active when separated from the protease domain (Blakeney et 
al., 2003; Martin Alonso et al., 1996; Sosnovtsev et al., 2006). The calicivirus RdRp has been suggested to 
mediate the nucleotidylation of VPg in a template-independent manner at a conserved tyrosine residue 
for RNA synthesis, which is initiated de novo at the 3’ end of the RNA (Belliot et al., 2008; Rohayem et 
al., 2006).  
1.6.6 VP1 and VP2 
In the genome of sapoviruses, naboviruses and lagoviruses, the sequence encoding VP1 (ORF2) is fused 
to the 3’ end of ORF1, producing a polyprotein which gives rise to the non-structural proteins and VP1 
(Clarke and Lambden, 1997). In contrast, the ORF2 and ORF3 of noroviruses encode the structural 
proteins VP1 and VP2 which are 58.9 kDa and 22.1 kDa in size, and therefore similar to vesiviruses. Both 
proteins are expressed from the viral VPg-linked subgenomic RNA that is 3’ co-terminal with the 
genomic RNA (Clarke and Lambden, 2000). Interestingly, translation of FCV ORF2 produces capsid 
protein with a leader peptide attached at the N- terminus, and this leader is subsequently removed by 
the viral protease to produce a mature form of capsid, whereas the leader sequence is absent in other 
caliciviruses, i.e. MNV (Green et al., 2002; Prasad et al., 1999).  
The expression of VP1, with or without co-expression of VP2 enables dimer formation, which can be 
further assembled to produce VLPs in the absence of an RNA genome (Green et al., 1997; Jiang et al., 
1992; Prasad et al., 1999). Given that human caliciviruses cannot be cultivated, VLPs have been used to 
study virus-host interactions as they are morphologically and antigenically indistinguishable from real 
virus particles (Estes et al., 2006). As previously described, VP1 is the major capsid which has two 
domains, namely, the P and the S domain, separated by a flexible hinge. The P domain protrudes from 
the surface to form a cup-like depression on the virion’s surface when dimerised, while the S domain 
forms an internal icosahedral capsid shell when dimerised (Bertolotti-Ciarlet et al., 2002; Prasad et al., 
1999). The S domain is important for initiating the assembly of virus-like particles (VLPs), while the P 
domain is responsible for the long-term stability of VLPs and correcting the capsid structure (Bertolotti-
Ciarlet et al., 2002; Prasad et al., 1999). The P domain is believed to contain immune and cellular 
recognition sites and can be subdivided into P1 and P2. P1 is responsible for linking the S domain via the 
flexible hinge, while P2 has been implicated in mediating viral-host interactions, which suggests it may 
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be the main immune recognition domain (Bertolotti-Ciarlet et al., 2002; Prasad et al., 1999; Tan et al., 
2004). P2 is highly variable and is believed to contain histo-blood group antigen (HBGA) binding pockets 
at its outermost end, which enables the virus to attach itself onto the mucosal lining in the case of 
human norovirus infection (Chen et al., 2006; Tan et al., 2004). It has recently been shown that the 
binding site for HBGA is constantly undergoing antigenic drift, allowing viruses to bind the heterogenic 
population of HBGAs (Chen et al., 2006; Choi et al., 2008; Tan and Jiang, 2005). This constantly mutating 
HBGA binding pocket within the capsid has been suggested to contribute to the ‘short’ lasting immunity 
and the antigenic drift of the norovirus, which has complicated the strategies for designing a vaccine 
(Chen et al., 2006; Lindesmith et al., 2008). VP2 has been determined to stabilise NV VLPs when VP1 and 
VP2 are co-expressed in a baculovirus expression system, and VP2 also prevents VLPs from proteolytic 
degradation (Bertolotti-Ciarlet et al., 2003). Studies of FCV have shown that VP2 is important for the 
production of infectious particles and for virus replication (Sosnovtsev et al., 2005). 
1.7 Virus lifecycle 
1.7.1 Attachment and entry 
Caliciviruses establish a successful infection by attaching to their specific cellular receptors, like all other 
viruses. In FCV infection, feline junctional adhesion molecule 1 (fJAM-1) is the key determinant of FCV 
host specificity and is essential for infection (Makino et al., 2006). Beside the requirement of fJAM-1, 
glycoprotein-bound α2,6-linked sialic acid is required to establish an efficient infection as a second 
cellular receptor (Stuart and Brown, 2007). After virus attachment, the virus enters the host cells 
through the plasma membrane by a clathrin-mediated endocytosis, which is followed by acidification of 
endosomes to facilitate virus uncoating and genome release into the cytoplasm (Bhella et al., 2008; 
Stuart and Brown, 2006).  
In humans, the susceptibility to the norovirus infection is determined by the expression of HBGA, the 
secretor status of HBGAs and Lewis antigen in individuals (Huang et al., 2003; Hutson et al., 2004). The 
HBGAs are present on the surface of mucosal epithelial cells and are the most probable norovirus 
receptors, although co-receptors may also be involved (Hutson et al., 2004). It is known that the 
secretion of these HBGAs is dependent on the presence of FUT2 protein. Individuals with FUT2 protein 
(i.e. secretor HBGAs) are more susceptible to the norovirus infection compared to those with a defective 
or mutated FUT2 (Hutson et al., 2005). Some human noroviruses have been identified to bind a 
polysaccharide heparan sulphate found on the cell surface (Tamura et al., 2004). It is worth noting that 
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different human noroviruses exhibit a different specificity for HBGA or heparan sulphate and so far, 
there is no evidence to verify that binding to HBGA can mediate cell entry (Shirato et al., 2008; Tamura 
et al., 2004). Other studies have also found that terminal sialic acid moieties present on gangliosides can 
act as a receptor for MNV (Taube et al., 2009). In general, HBGAs and heparan sulphate are the 
determinants of susceptibility to human norovirus infection. Although little is known in regard to the 
viral entry and uncoating, the process has been identified to be pH-dependent and requires host 
cholesterol and dynamin II, as shown in a recent study using MNV as a model system (Perry et al., 2009).  
1.7.2 Translation of viral proteins 
Following virus entry, the viral genome is released into the cytoplasm where it promptly begins protein 
synthesis, as the single-stranded positive-sense viral RNA genome can serve directly as a mRNA 
(Sosnovtsev et al., 2006; Sosnovtsev et al., 2002). Unlike most of the host mRNAs which possess a 5’ cap 
structure to initiate translation, caliciviruses have a viral encoded VPg protein covalently attached at the 
5’ end of the RNA (Herbert et al., 1997). Calicivirus VPg serves as a ‘cap’ substitute to recruit ribosome 
by interacting with the translation initiation factors in order to initiate the synthesis of viral protein from 
the positive strand genomic RNA (Chaudhry et al., 2006; Daughenbaugh et al., 2003; Daughenbaugh et 
al., 2006; Goodfellow et al., 2005). This novel mechanism of translation initiation used by caliciviruses 
enables a preferential translation of their mRNA over the host mRNA. The large polyprotein is then post-
translationally cleaved by a virus-encoded protease in cis-acting manner and generates mature forms of 
NS proteins in trans (Sosnovtsev et al., 2006; Sosnovtsev et al., 2002).  
1.7.3 Genome replication, translation of structural proteins and virus assembly and 
release 
Once the translation of NS proteins have begun, the NS proteins facilitate the rearrangement of the 
cellular intracellular membrane, e.g. the endoplasmic reticulum and the loss of Golgi apparatus leading 
to the formation of vesicles, where the replication complex is formed, similar to the observations found 
during poliovirus infection (figure 1.5) (Fernandez-Vega et al., 2004; Green et al., 2002). It is believed 
that viral replication occurs in or on the surface of these replication complexes to produce new positive 
strand RNAs (Green et al., 2002). Essentially, these replication complexes contain the viral RNA (single 
and double stranded intermediates), the viral proteins (NS proteins, precursors and structural proteins) 
and host cell factors (Green et al., 2002). 
The synthesis of the positive sense RNA genome is produced via a negative sense RNA intermediate, 
which is facilitated by the viral encoded polymerase, RdRp. The polymerase can bind to a specific 
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promoter sequence at the 3’ end of the positive 
strand genomic RNA and then generates a negative 
stand RNA intermediate (Fukushi et al., 2004). This 
negative strand RNA is then used as a template for 
synthesising a large number of genomic and 
subgenomic RNA copies. As previously described, 
the virus genomes are transcribed to produce 2.2-
2.4kb long subgenomic RNAs via the negative 
strand RNA. This subgenomic RNA has VPg linked 
to its 5’ end and shares the same 3’ UTR as the 
genomic RNA (Meyers et al., 1991; Perry et al., 
2009). Currently there are two proposed models 
for subgenomic RNA synthesis. The first one is 
based on the internal initiation mechanism 
whereby NS7 binds at a promoter sequence in the 
negative strand RNA (i.e. upstream of the start 
codon of ORF2 in the case of the MNV genomic 
strand) and subsequently initiates synthesis of 
subgenomic RNA (Morales et al., 2004). The second model proposes that premature termination occurs 
at a specific sequence located at 3’ end of the negative strand subgenomic RNA, thereby the negative 
strand subgenomic RNA serves as a template for production of positive strand subgenomic RNA 
(Morales et al., 2004). 
In support of the first theory is that 50 bases upstream of the start of subgenomic RNA sequence is 
required for RHDV polymerase to produce RNA with the same size as the subgenomic RNA highlighting 
that subgenomic RNA is produced via a negative strand subgenomic RNA initiated from the cis-acting 
RNA promoter (Morales et al., 2004). Furthermore, some RNA secondary structures were predicted to 
be more stable in the negative-sense template than the positive, supporting that internal initiation 
mechanism is used for subgenomic RNA synthesis (Simmonds et al., 2008). 
After replication of the subgenomic RNA, its VPg mediated translation follows. In the case of vesiviruses 
and noroviruses, ORF2 and ORF3 are thought to be translated from the subgenomic RNA template 
producing the structural proteins, VP1 and VP2. The translation of VP2 occurs via a termination-
 
Figure 0.5  Diagram depicting the formation of 
vesicles via re-arranging the intracellular 
membrane. During the replication of FCV in 
CRFK cells, viruses mediate the formation of 
vesicles as indicated by a large arrow (Green et 
al., 2002).  
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reinitiation mechanism of translation at the 3’ end of ORF2, since the stop codon of ORF2/VP1 is 
required to initiate the translation of ORF3 (Luttermann and Meyers, 2007; Meyers, 2003; Meyers, 
2007). After the ribosomes terminate on the stop codon of VP1, translation is reinitiated on the start 
codon of VP2, which relies on a bipartite RNA sequence upstream of the VP1 termination codon 
overlapping with the VP2 initiation codon. This motif is referred to as TURBS (termination upstream 
binding site) (Luttermann and Meyers, 2007; Meyers, 2003). Two models have currently been proposed. 
One suggests that TURBS is complementary to part of the 18S ribosomal RNA, which may prevent 
ribosome disassembly and subsequently permit ribosomes to reinitiate at the start codon of VP2 
(Meyers, 2003; Poyry et al., 2007). Another model suggests that the interaction between the TURBS 
sequence and eIF3 may be important for preventing the disassembly of ribosomes and allowing 
reinitiation to translate ORF3, since a study has shown that purified eIF3 stimulates translational re-
initiation (Poyry et al., 2007).  
In addition to ORF2 and ORF3, there is another ORF, namely ORF4, which is only found in MNV 
overlapping with the VP1 coding region (McFadden et al., 2011). It encodes the virulence factor 1 
protein (VF1), which play a role in infection and virulence in vivo. Infection of STAT1-/- mice with a 
mutant virus lacking ORF4 resulted in a delayed onset of clinical signs compared with mice infected with 
wild type virus. Furthermore, VF1 functions as a classical viral accessory protein which is not required for 
replication in tissue culture (McFadden et al., 2011). In the final stage of the virus lifecycle, the viral RNA 
progeny is packaged into viral particles (Alonso et al., 1998; Bok et al., 2009; Furman et al., 2009; 
Roberts et al., 2003), and further studies are required to address the precise mechanism. Furthermore, 
the mechanism of viral release is not well characterised. Given that many calicivirus infections induce 
apoptosis, the release of virus particles may be the result of apoptosis-induced membrane collapse 
(Alonso et al., 1998; Bok et al., 2009).  
1.8 Conventional cellular translation 
The majority of cellular mRNAs have a 7’ methyl-guanosine cap structure at the 5’ end and a 3’ poly(A) 
tail with variable length. In a canonical mechanism of translation, the cap structure is essential for 
protein synthesis, the mechanism of translation of which is referred to as cap-dependent translation. 
This cap structure has the ability to bind directly to the eukaryotic initiation factors 4E (eIF4E), which in 
turn, recruits other translation initiation factors and ribosomes to initiate translation (Pestova et al., 
2001; Pestova et al., 2007). Translation is a complex mechanism and it is mainly controlled by regulating 
the initiation phase. The process of translation initiation begins with the formation of a ternary complex 
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consisting of eIF2, a molecule of GTP and a tRNA initiator (eIF2/GTP/Met-tRNAi) (Pestova et al., 2001; 
Pestova et al., 2007). This ternary complex, together with eIF5, eIF1, eIF1A and eIF3, associates with the 
40S ribosomal subunit, leading to the formation of the 43S preinitiation complex (figure 1.6). 
Subsequently, the resulting 43S preinitiation complex attaches to the capped 5’ end of the mRNA, the 
interaction of which requires the eIF4F complex, eIF4B and ATP as a source of energy (Pestova et al., 
2001).   
The eIF4F complex is a heterotrimeric complex containing three subunits: firstly, eIF4E is the cap-binding 
protein, secondly, eIF4A which is an RNA helicase with ATPase activity and thirdly eIF4G, a 
multifunctional scaffold protein, which bridges the linkage of the mRNA to the 40S ribosome via 
interacting with eIF3. eIF4B functions to stimulate translation by enhancing the RNA helicase activity of 
eIF4A (Gallie, 1998; Goodfellow and Roberts, 2008). As a multifunctional scaffold protein, eIF4G not only 
interacts directly with eIF4E, but also binds directly to the polyadenylated binding protein (PABP), which 
in turn binds to the 3’ poly(A) tail (Gallie, 1998; Goodfellow and Roberts, 2008; Keiper et al., 1999; 
Pestova et al., 2007). The cooperative interaction of the eIF4E/eIF4G/PABP complex brings the 3’ end of 
the mRNA into close proximity with the 5’ end leading to the formation of a ‘closed loop’ structure. This 
‘closed loop’ structure has been determined to contribute to the enhancement of translation and 
ribosome recycling (Gallie, 1998; Mangus et al., 2003; Prevot et al., 2003).  
After the 43S preinitiation complex and the eIF4F complex are assembled on the capped 5’ mRNA, the 
entire complex scans along the mRNA in the 5’ to 3’ direction assisted by eIF1 and eIF1A, until it reaches 
a start codon (AUG), where the 48S preinitiation complex forms (Pestova et al., 2001). Next, eIF5 
triggers the hydrolysis of GTP-bound eIF2, which results in the release of all the eIFs from the 40S 
ribosomal subunit. Finally, the 60S ribosomal subunit joins the 48S preinitiation complex to form a 
competent 80S ribosome ready for translation elongation (Pestova et al., 2007).  
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Figure 0.6 Schematic of cap dependent translation initiation in eukaryotes. The eIF4F complex 
formation enables 40S ribosomal protein to be bound to the capped mRNA facilitating formation of 
the 43S pre-initiation complex. The cooperative interaction of the eIF4E-eIF4G-PABP complex brings 
the 3’ end of the mRNA into close proximity with the 5’ end of the mRNA, which results in the 
formation of a ‘closed loop’ structure. The 43S pre-initiation complex then scans along the mRNA 
until it reaches a start codon (AUG), where a 48S pre-initiation complex forms. Next, eIF5 triggers the 
hydrolysis of GTP-bound eIF2, which results in the release of all the eIFs from the 40S ribosomal 
subunit. Finally, a 60S ribosomal subunit joins the 48S pre-initiation complex and forms a competent 
80S ribosome for translation elongation.  
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1.8.1 Components of the eIF4F complex 
The eIF4F complex is made up of three translation initiation factors, namely, eIF4E, eIF4A and eIF4G. The 
eIF4F complex formation is essential for efficient cap-dependent translation (Gingras et al., 1999b), and 
is thought to be the rate-limiting step to determine the fidelity of the translation initiation. The function 
of eIF4F is to promote the 40S ribosomal subunit binding to the 5’ capped mRNA and assist ribosomal 
scanning, therefore, the activity of eIF4F is commonly regulated to control gene expression (Gingras et 
al., 1999b; Sonenberg and Hinnebusch, 2009).  
1.8.1.1 eIF4G 
eIF4G is a large scaffold protein within the eIF4F complex. There are two isoforms in humans, eIF4GI and 
eIF4GII, which share 46% of the homology in their amino acid sequence (Gradi et al., 1998a). These 
homologues generally exhibit similar biochemical activities and are functionally interchangeable (figure 
1.7), although they are expressed at different levels in various tissues (Gradi et al., 1998a). eIF4GI was 
formerly referred to as p220, since it runs at around 220kDa by SDS PAGE. In addition to these 
homologues, another protein which exhibits sequence similarity to the C-terminal region of eIF4GI is 
p97, which is sometimes referred to as NAT1 or DAP5. DAP5 displays 28% homology with eIF4GI and is 
abundantly expressed in normal tissues and cell lines. Given that DAP5 lacks the N-terminal region of 
eIF4GI, it does not have eIF4E- and PABP-binding sites; instead it consists of the binding domain of eIF3 
and eIF4A (Yamanaka et al., 2000). DAP5 has been identified as supporting the translation of IRES-
containing mRNAs, such as HIAP2, XIAP and DAP5 itself (Henis-Korenblit et al., 2002).  
eIF4G is one of the most versatile translation initiation factors and associates with many cellular proteins 
to facilitate translation initiation efficiently. In general, eIF4G forms part of the heterotrimeric eIF4F 
complex, with eIF4A and eIF4E facilitating the 43S preinitiation complex attachment to the capped RNA 
by interacting with eIF3 (Goyer et al., 1993; Korneeva et al., 2000; Pause et al., 1994b). eIF4G interacts 
with PABP which binds the poly(A) tail of the 3’ end of mRNA and enables the formation of a closed loop 
structure necessary for efficient translation (Gallie, 1991; Gallie, 1998). eIF4G also has other binding 
capacities for cellular proteins, such as the nuclear cap-binding protein 80 and mitogen-activated 
protein kinase-integrating kinase (Mnk) and serine/threonine-protein kinase (Pak2) and TNF receptor 
associated factor (TRAF2) (Kim et al., 2005; Ling et al., 2005; Pyronnet et al., 1999). Other than protein 
binding activities, eIF4G is capable of binding RNA through its RNA-recognition motif (RRM) - like RNA 
binding portion within its centrally located HEAT domain. A total of five HEAT repeats have been found 
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in the middle domain of eIF4GII. It has been suggested that the HEAT domain found in proteins 
participate in assembling large multiprotein complexes (Marcotrigiano et al., 2001).  
 
eIF4G consists of three domains which are based on the cleaved fragments generated by cysteine 
aspartic acid proteases (caspase 3). The N-terminal region consists of eIF4E and PABP binding sites; the 
middle domain consists of eIF3 and eIF4A binding sites, and the C-terminal domain contains eIF4A and 
Mnk1 binding sites (figure 1.7) (Gradi et al., 1998a). The C-terminal domains appear to modulate 
translation. The middle core domain has five HEAT repeats arranged in five repeating pairs of anti-
parallel alpha helices, which are involved in the assembly of the translation machinery (Marcotrigiano et 
al., 2001). While these repeats together with eIF4A are sufficient to mediate the formation of the 48S 
preinitiation complex with a picornaviral IRES (type I and type II) (Lamphear et al., 1995; Ohlmann et al., 
1996), expression of the middle domain of eIF4G and the eIF4E recognition domain is, in fact, able to 
facilitate cap-dependent translation in vitro (Marcotrigiano et al., 2001; Pestova et al., 1996). In 
addition, this core domain of eIF4G is evolutionarily conserved and contains three serum-stimulated 
phosphorylation sites which regulate various aspects of its activity through phosphorylation via an 
mTOR signalling pathway. The role of eIF4G phosphorylation in mRNA translation and how protein 
mediates phosphorylation is currently not well understood (Raught et al., 2000). Nevertheless, this 
Figure 0.7 Schematic representation of eIF4G homologues and their domain structure. (Adapted 
from Marcotrigiano et al., 2001). The binding domain for translation factors within the eIF4GI 
molecule is schematically represented. The domain of the interaction between eIF4G and eIF4A 
(shown in bright blue), eIF3 (shown in light grey), eIF4E (shown in black), PABP (shown in dark grey) 
and Mnk1 (shown in dark blue) is indicated. The amino acid position of each individual domain is 
shown below the eIF4G molecule. Putative corresponding domains on eIF4GII and DAP-5 are shown 
below the eIF4GI molecule. The percentage identity is shown to highlight homologies between 
eIF4GII and DAP-5 with eIF4GI. It should be noted that the diagram is not drawn to scale.  
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collective structural data verifies the important role of eIF4GI in coordinating the various essential 
translation initiation factors for the assembly of the preinitiation complex onto mRNA. 
1.8.1.2 eIF4E 
eIF4E is a cap-binding protein that is 24kDa in size. The protein is evolutionarily conserved and is 
indispensable for cap-dependent translation (Matsuo et al., 1997). Depletion of eIF4E results in a drastic 
reduction in the translation of capped mRNA in cell-free extracts, whilst addition of recombinant eIF4E 
can restore translation (Svitkin et al., 1996). This highlights the importance of eIF4E as an essential 
protein for translation initiation. eIF4E is regulated through phosphorylation mediated by either Mnk 
kinase (Waskiewicz et al., 1999) or is regulated by binding to the eIF4E-binding protein (4E-BP) (Pause et 
al., 1994a). Hence, regulation of the eIF4E activity is the key targets for translational control by viruses. 
4E-BP is a translation repressor regulating the formation of the eIF4F complex (Gingras et al., 1999a; 
Gingras et al., 2001; Pause et al., 1994a). There are three isoforms expressed in mice and in humans, 
namely 4E-BP1, 4E-BP2 and 4E-BP3. 4E-BP1 is predominantly expressed in adipose tissue, while 4E-BP2 
is primarily found in the brain. 4E-BP1 knock-out mice exhibit a difference in metabolic rate and adipose 
tissue content compared to healthy mice, whereas mice lacking 4E-BP2 display impaired long-term 
memory formation (Tsukiyama-Kohara et al., 1996). 4E-BP3 is largely found in the colon, liver and kidney 
(Poulin et al., 1998; Tsukiyama-Kohara et al., 1996). 4E-BP regulates eIF4E activity by competing with 
eIF4G for the same binding sites on eIF4E. This eIF4E-binding site has a conserved amino acid motif with 
the sequence YxxxLφ, whereby φ denotes any hydrophobic amino acid and x signifies any amino acid 
(Mader et al., 1995). When 4E-BP binds to eIF4E, eIF4E is sequestered away from eIF4G leading an 
impairment of eIF4F complex formation. In fact, 4E-BP activity is also tightly controlled by 
P13K/AKT/mTOR pathway through phosphorylation (Gingras et al., 2001; Pause et al., 1994a). There are 
5 phosphorylation sites at the residues Thr37, Thr46, S65, Thr70 and S83. When 4E-BP is at the 
hypophosphorylated state, it binds tightly to eIF4E, thereby impairing the eIF4F complex formation, 
which results in the inhibition of the cap-dependent translation (Gingras et al., 1999a; Gingras et al., 
2001; Gingras et al., 1996).  
eIF4E functions to assemble the eIF4F complex formation and its activity is modulated by Mnk. Mnk can 
bind eIF4G, bringing it in close proximity to the target, eIF4E (Pyronnet et al., 1999). Upon Mnk 
phosphorylation, it in turn phosphorylates eIF4G-bound eIF4E on serine 209 (S209) to stimulate 
translation in general. In contrast, dephosphorylated eIF4E correlates to the impairment of the cap-
dependent translation (Pyronnet et al., 1999; Waskiewicz et al., 1997; Waskiewicz et al., 1999). It has 
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been demonstrated that overexpression of eIF4E leads to the development of malignancies when eIF4E 
is phosphorylated at S209 (Topisirovic et al., 2004). Drosophila expressing eIF4E phosphorylation 
mutants display slow developmental growth and reduced cell and organism size in adults, suggesting 
that eIF4E phosphorylation stimulates cap-dependent translation (Lachance et al., 2002). However, the 
role of eIF4E phosphorylation in translation initiation is somewhat controversial to date. It has been 
demonstrated that overexpression of Mnk causes a reduction in translation or growth rate in 
mammalian cells and drosophila as a result of eIF4E hyperphosphorylation (Knauf et al., 2001). In 
contrast, there is no overall change in translation and development in Mnk-depleted mice (Ueda et al., 
2004). Taken together, the biological significance of eIF4E phosphorylation is not yet clear and further 
experiments are required to determine its role in translation initiation (Scheper and Proud, 2002; 
Scheper et al., 2002). 
1.8.1.3 eIF4A 
eIF4A is a 46kDa protein belonging to the DEAD-box protein family. It has an RNA-dependent ATPase, 
bidirectional RNA helicase and RNA binding activities (Pause et al., 1993). As a component of the eIF4F 
complex, eIF4A functions to unwind structured capped mRNA at the 5’ end to promote ribosomal 
binding and mRNA scanning for the start codon (Pause et al., 1994b). Within the eIF4F complex, eIF4A 
requires cofactors such as eIF4B, which stimulate its helicase activity (Fleming et al., 2003). The eIF4A 
family has three members, namely, eIF4AI, eIF4AII and eIF4AIII. eIF4AI and eIF4AII are homologues and 
are functionally interchangeable, with  the only difference being that they are expressed differentially in 
certain tissues (Li et al., 2001; Yoder-Hill et al., 1993). In contrast, eIF4AIII is functionally dissimilar to 
eIF4AI eIF4AII and cannot complement eIF4AI in a ribosomal binding assay (Li et al., 1999). It functions in 
non-sense mediated decay (NMD) to degrade premature mRNAs, such as mRNAs with a premature stop 
codon, thus preventing the synthesis of retarded proteins (Shibuya et al., 2004).  
1.9 Viral translation initiation strategies 
Positive-sense RNA viruses have evolved a variety of mechanisms to hijack the cellular translation 
machinery. In addition, many positive sense RNA viruses face the common translational challenges, 
since their genome serves as a template for RNA replication as well as protein synthesis. During 
translation, ribosomes scan from a 5’ to 3’ direction, whereas RNA polymerase is recruited to the 3’ end 
of the template and transcribes in a 3’ to 5’ direction. Hence these two processes cannot take place 
simultaneously and must be tightly co-ordinated. Furthermore, there is no known virus which encodes 
its own entire translation system; hence viruses must rely on the cellular machinery. Viral mRNA can 
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coexist and translate efficiently together with host mRNA, or it can compete with host mRNA for cellular 
translation initiation factors and translation machinery. Some viruses often hamper cap-dependent 
translation and opt for alternative and unconventional translation systems, i.e. IRES-mediated 
translation and VPg-dependent translation (Mohr et al., 2007; Thompson and Sarnow, 2000). Cellular 
defence mechanisms, such as apoptosis and the interferon system, can be elicited during viral infection, 
which often affects both cellular and viral translation (Thompson and Sarnow, 2000). For these reasons, 
it is not surprising that viruses have evolved diverse mechanisms to regulate and modify critical 
translation initiation factors in order to control the cellular translation system and regulate their own 
gene expression. In the next section, the mechanism of cellular translation initiation and various 
strategies of translation initiation adopted by viruses to regulate and control cellular translation for their 
own benefit are described.  
1.9.1 Internal ribosome entry sequence (IRES)-mediated translation  
Viruses, such as members of Picornaviridae have no cap structure at the 5’ end of mRNA; instead they 
rely on IRES within the 5’ UTR to initiate translation (Jackson et al., 1994; Jang, 2006). IRES elements 
consist of large RNA secondary structures at the 5’ end of cellular and viral mRNAs. IRESs function to 
recruit ribosomes at the initiation codon to initiate translation. The recruitment of the ribosome to the 
IRES is accomplished by some canonical translation initiation factors and often requires IRES trans-acting 
factors (ITAFs). Different IRESs differ in their requirement for translation initiation factors and ITAFs 
(Junemann et al., 2007). 
The best understood models for IRES-mediated translation are picornaviruses and hepatitis C virus (a 
member of the Flaviviridae). The IRES elements of picornaviruses are classified into four types (Jackson 
et al., 1994).  Type I IRES elements can be found in enteroviruses (e.g. poliovirus, PV or coxsackie B virus, 
CBV and human rhinoviruses, HRV), while type II IRES elements can be found in cardioviruses (e.g. 
encephalomyocarditis virus, EMCV) and the apthoviruses (e.g. the foot and mouth disease virus, FMDV) 
(Jackson et al., 1994). Whilst hepatitis A virus (HAV) has a type III IRES (Brown et al., 1991), the newly 
discovered porcine teschovirus (PTV) from the Picornaviridae has a type IV IRES, similar to the HCV IRES 
(Jang, 2006; Pisarev et al., 2004). Types I, II and III share common features and structures. Firstly, they all 
share a characteristic conserved and stable tRNA-like structure which constitutes the core of the IRES. 
Downstream of this core, there are secondary stem loop (SL) structures which have been determined to 
bind canonical translation initiation factors, whilst further downstream, the translation initiation factor 
binding domain has a conserved oligopyrimidine (py) tract sequence residing approximately 15-20 
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nucleotides upstream of an AUG codon (py-tact/AUG motif) (Jang, 2006; Pilipenko et al., 1994). The 
initiation factor binding domain, together with the py-tact/AUG motif, facilitate the placement of the 
ribosome to the internal region of the viral RNA , thus allowing the ribosome to either directly initiate 
translation or scan for the next start codon (Niepmann, 2009). In type I IRESs, such as the PV IRES, the 
start translation codon is not within the py-tact/AUG motif and is, in fact, located 156 nucleotides 
downstream. The mechanism of how the ribosome reaches the authentic start codon has not yet been 
determined but presumably it is by progressive or discontinuous scanning (Hellen et al., 1994; 
Niepmann, 2009). In contrast to type I IRES elements, the ribosome can directly initiate translation from 
the AUG upstream of the py-tact in the case of the type II IRES element (although FMDV can also begin 
translation in the second downstream start codon) (Belsham, 1992; Niepmann, 2009).  
Both type I IRES of PV and type II IRES of EMCV and FMDV have been identified to bind eIF4G (de Breyne 
et al., 2009; Ochs et al., 2003; Saleh et al., 2001). eIF4G and its interaction with eIF4A enhances the 
affinity of eIF4G for the IRES, while the general ability of eIF4G to bind eIF3 enables the ribosome to be 
recruited onto a viral mRNA, stimulating translation (de Breyne et al., 2009; Lomakin et al., 2000). In 
most cases, IRES-mediated translation bypasses the requirement for several canonical initiation factors 
and the requirement varies among IRES elements. In type I and II IRESs, eIF4E is dispensable for 
translation, in contrast to the type III IRES of HAV where eIF4E is required for eIF4G binding in order to 
establish translation (Ali et al., 2001). In fact, HAV IRES requires an intact eIF4F for its function. In 
contrast to HAV, some viruses (e.g. EMCV) bypass the requirement of canonical factors to impair cap-
dependent translation by reducing the availability of eIF4E through dephosphorylation of the 4E-BPs, 
which ultimately results in host shutoff when necessary (Gingras et al., 1996).  
The IRES of HCV is structurally and functionally different from those of the classical picornaviruses. It can 
bind tightly to the 40S ribosomal subunit and eIF3 in the absence of the entire eIF4F complex and even 
eIF2 (Terenin et al., 2008), and is still capable of assembling the preinitiation complex at the start codon. 
Interestingly, the PTV type IV IRES resembles a HCV-like IRES, by genome organisation and sequence, 
and does not require an intact eIF4F complex to initiate translation (Belsham, 2009; Pisarev et al., 
2004).The IRES of Cricket paralysis virus is by far the most independent viral IRES. It can fold into a tRNA-
like tertiary structure and bind to the ribosome without the presence of any other canonical factors 
including an entire eIF4F, eIF3 and the ternary complex. In fact, the ternary complex consisting of 
initiator methioyl-tRNA/eIF2-GTP is not even required for 80S assembly after 60S is recruited (figure 1.8) 
(Spahn et al., 2004).  
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Essentially, the IRES of the Cricket paralysis virus can bind to the P site of the ribosome and initiate 
methionine-independent translation (Schuler et al., 2006). Using IRES as a mechanism of translation can 
Figure 0.8  Variable canonical translation initiation factors required for each type of IRES element. 
IRES-driven translation bypasses the requirement for some canonical translation initiation factors 
and the factors required varies among IRES elements. A reduced requirement for canonical factors 
correlates with an increasingly tight and stably folded RNA structure within the IRES element 
(Adapted from Kieft, 2008). 
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bypass competition with the capped mRNA in host cells and establish host shutoff. It has been 
suggested that the reduced requirement for canonical factors correlates with an increasingly tight and 
stably folded RNA structure within the IRES element (figure 1.8) (Kieft, 2008; Martinez-Salas et al., 
2008). 
In addition to the canonical initiation factors, all IRES-mediated translation in picornaviruses can be 
stimulated by ITAFs such as the polypyrimidine tract-binding protein (PTB), human La autoantigen (La), 
poly(C)-binding protein (PCBP) and upstream of N-ras (UNR) (Boussadia et al., 2003; Costa-Mattioli et al., 
2004; Gamarnik and Andino, 2000). ITAFs are RNA-binding proteins which are involved in the post-
transcriptional control of mRNA translation and mRNA stability. They bind to stem loops within the IRES 
which stabilise the IRES to enable an efficient translation initiation. For example, the activity of the type I 
IRES such as poliovirus IRES is influenced by PCBP, La and UNR (Boussadia et al., 2003; Costa-Mattioli et 
al., 2004; Gamarnik and Andino, 2000), which in turn stimulates the IRES’s function, while the 
interaction of PTB with the type II IRES from FMDV can stimulate IRES-driven translation (Niepmann et 
al., 1997). It is worth noting that the requirement for ITAFs varies among different IRESs (Junemann et 
al., 2007) and the mechanism of these protein-RNA interactions and their stimulatory role in the virus 
life cycle remains to be determined. Furthermore, ITAFs have been implicated in the transition from 
translation to replication in positive-strand RNA viruses such as PV (Walter et al., 2002).  
1.9.2 VPg-dependent translation 
VPg-dependent translation initiation is a novel mechanism found in plant potyviruses and animal 
caliciviruses. As previously described, VPg is a ‘cap substitute’ to recruit translation initiation factors via 
its interaction with eIF4E in order to initiate translation. Evidence from cap-sepharose chromatography 
have indicated that VPg can associate with the eIF4E in a complex from infected cells, highlighting that 
the interaction of eIF4E with VPg does not prevent eIF4E from binding to the cap structure on cellular 
mRNAs (Chaudhry et al., 2006; Goodfellow et al., 2005). In other words, calicivirus VPg can bind to eIF4E 
at a site which is different from the binding sites for the cap structure. In contrast to the calicivirus VPg, 
the VPg of plant viruses such as potyviruses compete with the cap structure for binding to plant eIF4E 
(Leonard et al., 2000). 
A capture ELISA assay identified the direct interaction of calicivirus VPg (MNV and FCV VPg) with eIF4E 
(Chaudhry et al., 2006).  In terms of the functional role of the VPg-eIF4E interaction in translation, eIF4E 
is indispensable for FCV mRNA translation. Evidence from in vitro translation reveals that FCV mRNA 
translation is inhibited when eIF4E is depleted, or when the eIF4E-eIF4G interaction is disrupted by the 
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addition of 4E-BP1 (Chaudhry et al., 2006). However, this inhibition can be restored with the addition of 
the recombinant eIF4E (Chaudhry et al., 2006). In contrast to FCV mRNA translation, the eIF4E 
requirement for MNV mRNA translation is less clear. Based on in vitro studies using the rabbit 
reticulocyte lysate system, the translation of MNV mRNA appears to be insensitive to eIF4E depletion or 
the impairment of the eIF4E-eIF4G interaction. The fact that the MNV translation in vitro is not affected 
could possibly be because the high supply of other translation factors in the lysate compensates or 
complements the requirement for eIF4E (Chaudhry et al., 2006). One might not exclude the possibility 
that eIF4E may not be essential for efficient MNV mRNA translation leading to the question of whether 
or not the eIF4E-VPg interaction plays a role in the translation of viral mRNA. 
The functional role of the remaining eIF4F component, eIF4G was addressed by performing in vitro 
cleavage of eIF4G. Cleavage of eIF4G, mediated by FMDV Lb protease in vitro, separates the eIF4E-
binding domain of eIF4G from the C- terminal domain containing the eIF4A and eIF3 binding sites, 
resulting in the inhibition of a cap-dependent translation (Kirchweger et al., 1994). The effect of in vitro 
eIF4G cleavage on MNV and FCV translation was differential. FCV translation was sensitive to eIF4G 
cleavage mediated by FMDV Lb protease, whereas the MNV translation was stimulated. The stimulation 
of MNV translation in the presence of Lb protease implies that either the C-terminal fragment is 
sufficient for translation, or the eIF4E-eIF4G interaction may not be required for MNV translation 
(Chaudhry et al., 2006). Hence, further investigation is required to understand whether or not eIF4G 
plays a functional role in MNV translation and to determine which domain of eIF4G is crucial for MNV 
translation. In contrast, FCV translation requires an intact eIF4G to mediate efficient translation 
(Chaudhry et al., 2006).  
Both FCV and MNV translations have been identified to require eIF4A, since in vitro translation of both 
RNAs is sensitive to the addition of a dominant negative form of eIF4A with defects in the ATPase and 
helicase activity (Chaudhry et al., 2006). Furthermore, the eIF4A inhibitor hippuristanol inhibits FCV and 
MNV RNA translation to various degrees, whereas translation from the PTV-IRES is not affected. 
Hippuristanol binds to the C-terminal domain of eIF4A, thus inhibiting RNA binding, ATPase and helicase 
activity of eIF4A. Interestingly, the complete inhibition of MNV translation can be achieved using a 5-fold 
lower concentration of inhibitor compared to that used for the complete inhibition of FCV mRNA 
translation (Chaudhry et al., 2006). This highlights the fact that MNV RNA translation appears to have a 
greater requirement for eIF4A than FCV RNA translation. Although one might predict that a higher level 
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of secondary RNA structures may be present at the 5’ end of MNV RNA compared to FCV RNA, this 
hypothesis is not consistent with a computational analysis of their RNA structure (Chaudhry et al., 2006).  
FCV and MNV VPg are evolutionarily conserved proteins, although they have a degree of variability in 
the amino acid sequence. Even though FCV and MNV have evolved to share the eIF4A requirement for 
VPg-dependent translation initiation, they appear to have a different requirement for eIF4E and eIF4G 
(Chaudhry et al., 2006) (figure 1.9). In fact, FCV and MNV VPg have a size difference of approximately 
2kDa and their structure varies slightly. Although both MNV and FCV VPg have a stable helical structural 
core domain with two flexible termini, MNV VPg has two alpha helices within its core structure, whereas 
FCV VPg has three (Eoin Leen, personal communication). While the third helical region of FCV VPg does 
not appear to be similar to the corresponding region of MNV VPg, the first helix of MNV VPg is similar to 
that of FCV VPg (unpublished data). To date, it is unclear whether the general difference in the structure 
and functionality of FCV and MNV VPg influences the specificity for canonical factors. Current data 
indicates that caliciviruses differ in their functional requirement for the eIF4F complex (figure 1.9) 
(Chaudhry et al., 2006), similar to the observations from picornaviruses IRESs. 
Based on yeast-two hybrid analysis and in vitro binding assays, norovirus VPg can directly bind to the 
eIF3d subunit of  eIF3 complex, and its interaction with eIF4G is likely to bring the ribosomal protein in 
close proximity to the 5’ end of the viral genome (Daughenbaugh et al., 2003). Further in vitro studies 
demonstrated that eIF4G was present in a complex that can be purified from cells using GST-VPg 
(Daughenbaugh et al., 2006), but it is not known if a direct interaction occurs in these cases. 
Interestingly, VPg has been identified to exhibit sequence homology to eIF1a, which is required for the 
formation of the ternary complex and mRNA binding and scanning, suggesting that VPg may compete 
with host cell factors for ribosomal binding (Sosnovtseva et al., 1999). Based on these observation, it is 
apparent that calicivirus VPg binds various canonical translation initiation factors which may be 
responsible for translation, therefore, it is important to elucidate which other cellular factors are 
involved in VPg dependent translation in order to determine the functionality of calicivirus VPg proteins. 
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1.10 Regulation of host translational machinery during virus infection 
While some viruses have evolved other mechanisms to maximise their coding capacity within a confined 
genome, some have also developed strategies to arrest gene expression in the host by hijacking cellular 
machinery, thereby accelerating their replication or translation, referred to as ‘host cell shutoff’. Most 
often, viruses regulate and modify translation initiation factors, such as eIF4G, eIF4E and PABP (Kleijn et 
al., 1996; Prevot et al., 2003; Smith and Gray, 2010), since they are the prime factors required to form 
the eIF4F complex or mediate the 5’ to 3’ linkage of mRNA. Consequently, viruses have adapted 
strategies to supersede cellular translation by regulating and modifying these translation initiation 
factors at different levels, although the mechanisms of these modifications are not well understood in 
most cases.  
Figure 0.9 Cartoon model of the calicivirus VPg-associated translation initiation complex. The 
predicted model of MNV VPg- or FCV VPg-associated translation initiation complex is based on 
published data (Chaudhry et al, 2006; Daughenbaugh et al., 2003). The VPg protein that is attached 
to the 5’ end of viral RNA is highlighted in blue. Translation initiation factors that bind directly to VPg 
and have a functional role in virus translation are indicated by a solid red line, while factors binding 
directly to VPg whose functions remain to be elucidated are indicated by a dashed solid line. Factors 
that have not yet been identified to bind VPg, but are indispensable for calicivirus translation 
initiation are shaded in black. 
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1.10.1 eIF4G cleavage 
As a multi-functional protein, eIF4G is the prime target for virus-mediated ‘host shutoff’, since it 
mediates three important linkage functions during cap-dependent translation initiation. Firstly, eIF4G 
associates with eIF4E and eIF4A to form an active eIF4F complex located at the capped RNA (Gingras et 
al., 1999b; Korneeva et al., 2000). Secondly, eIF4G bridges eIF4E and eIF3, thus providing the linkage of 
mRNA to the ribosomal subunit (Goyer et al., 1993; Gradi et al., 1998a). Thirdly, eIF4G also mediates the 
linkage of PABP with eIF4E, which is essential for bringing the 5’ and 3’ ends in close proximity to form a 
‘closed loop’ structure (Gallie, 1991; Gallie, 1998; Svitkin et al., 2009) (figure 1.10). eIF4G has also been 
found to bind many other cellular proteins, such as Mnk1 (Pyronnet et al., 1999), therefore modification 
of eIF4G is predicted to have a dramatic effect on host translation or possibly RNA stability.  
 
During picornavirus infection, the virus induces rapid and almost complete host translational shutoff, 
however it does not affect viral translation and in fact, viral RNA translation is stimulated during the first 
4-5 hours, although this declines rapidly 2 hours after host cell shutoff (Roberts et al., 2000b). Host 
translational shutoff is correlated with eIF4G proteolysis mediated by viral encoded proteases 
(Lamphear et al., 1995; Roberts et al., 2000b). Proteolysis of eIF4G removes the N-terminal eIF4E-
binding domain from the C-terminus which has recognition sites for eIF3 and eIF4A. Thus, eIF4G can no 
longer bring the capped mRNA to the 40S ribosomal subunit required to initiate cap-dependent 
translation, leading to cellular shutoff (Borman et al., 1997; Lamphear et al., 1995). Given that eIF4G 
cleavage generates the large C-terminal domain containing the eIF3- and eIF4A-binding site (also known 
 
Figure 0.10 Cleavage map of eIF4GI. The binding domain for translation factors within the eIF4GI 
molecule is schematically represented. The domain of the interaction between eIF4G and eIF4A 
(shown in bright blue), eIF3 (shown in light grey), eIF4E (shown in black), PABP (shown in dark grey) 
and Mnk1 (shown in dark blue) is indicated. The amino acid position of each individual domain is 
shown below the eIF4G molecule. The arrows and the corresponding numbers illustrate the location 
of the individual protease cleavage sites mediated by cellular caspase 3 or the viral protease.  
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as p100), this product is still capable of binding picornaviral IRES elements, which suffices to promote 
IRES-mediated translation (Lamphear et al., 1995) (figure 1.11).  
The cleavage of eIF4GI and eIF4GII occurs during the infection of HRV, CBV, PV and FMDV. The 2A 
proteases of PV, HRV and CBV, are responsible for eIF4GI and eIF4GII cleavage (Gradi et al., 1998b; 
Kerekatte et al., 1999; Liebig et al., 1993; Svitkin et al., 1999). These picornaviral 2A proteases share the 
same cleavage site in eIF4GI (amino acid position 681/682), except that the 2A protease of PV has an 
extra cleavage site 43 amino acids upstream of the common site (Bovee et al., 1998; Gradi et al., 1998b; 
Lamphear et al., 1995; Zamora et al., 2002) (figure 1.10). Interestingly, the FMDV 2A protease is not 
responsible for eIF4G proteolysis; instead, cleavage is mediated by a leader protein (Lb) protease 
(Kirchweger et al., 1994). The FMDV Lb protease is an alternative papain-like protease which cleaves 7 
amino acids upstream of the general cleavage site of the PV, HRV and CBV 2A proteases (Kirchweger et 
al., 1994). This means that the same functional domains have been separated by the Lb protease 
compared with the domains excised by the 2A proteases (figure 1.10). It is therefore not a surprise that 
the 2A protease also cleaves eIF4GII in the same region, but at a slower rate compared to eIF4GI 
cleavage during HRV and PV infection (Gradi et al., 1998b; Svitkin et al., 1999). Proteolysis of both eIF4G 
isoforms is responsible for host shutoff. In contrast to PV and HRV 2A protease, Lb protease cleaves 
eIF4GII at a much more rapid and efficient rate (Gradi et al., 2004). It is worth noting that 2A from 
members of the picornaviruses, such as EMCV, cannot cleave eIF4G, which suggests the virus may have 
a different mechanism to shuting off host translation i.e. by eIF4E dephosphorylation. In fact, 
dephosphorylation of 4E-BP1 is responsible for the inhibition of cap-dependent translation and host cell 
shutoff (Gingras et al., 1996; Prevot et al., 2003).  
Interestingly, recombinant eIF4G is poorly recognised by HRV 2A and FMDV Lb proteases, unless eIF4G is 
associated with eIF4E. Structural analysis reveals that binding of eIF4G and eIF4E induces a 
conformational change of eIF4G from unstructured into an alpha helix with two turns upon interacting 
with eIF4E (Ohlmann et al., 1997). This conformational change in eIF4G exposes the protease cleavage 
site, therefore, eIF4G is more susceptible to protease cleavage mediated by the 2A and Lb proteases 
(Ohlmann et al., 1997). eIF4GI can also be cleaved by cellular caspase 3 at two other sites during 
apoptosis (Bushell et al., 2000; Roberts et al., 2000a). One might predict that virus infection may activate 
some apoptosis pathways and that eIF4GI cleavage is induced by caspase 3 rather than the viral 
encoded protease (Roberts et al., 2000a). However addition of the caspase inhibitor, z-VAD-fmk, does 
not reduce eIF4G cleavage during PV infection, and when viral RNA replication is blocked with 2mM 
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guanidine to limit 2A protease expression, then eIF4GI cleavage is inhibited by z-VAD-fmk. These various 
pieces of evidence suggest eIF4GI cleavage is specifically induced by the viral protease, but not by 
caspase 3 (Bushell et al., 2000). Furthermore, caspase 3 has a different cleavage specificity compared to 
the viral protease (figure 1.10) and is not activated in early infection (Bovee et al., 1998). Caspase 3 also 
mediates eIF4GII cleavage in a similar fashion as observed in eIF4GI, since both eIF4G isoforms share 
similar sequence homology (Bovee et al., 1998; Prevot et al., 2003; Willcocks et al., 2004). 
 
Cellular shutoff has been observed during FCV infection, similar to the observations found in 
picornavirus infection. Shutoff is achieved by cleavage of eIF4GI and eIF4GII, which is mediated by the 
FCV protease. However, cleavage occurs at different sites to those of the picornaviral protease 
 
Figure 0.11 Schematic of eIF4G cleavage mediated by the picornaviral protease 2A. (Adapted from 
Ohlmann et al., 2003) The proteolysis of eIF4G separates the N-terminus of eIF4G (N) containing the 
eIF4E binding site from the C-terminal domain (C). Consequently, eIF4G lacking the eIF4E-binding 
domain can no longer bring the capped mRNA to the 40S ribosomal subunit required for initiating 
cap-dependent translation, therefore leading to cellular shutoff. However, the remaining C-terminal 
fragment, p100, is capable of binding the IRES element of picornaviruses and promoting viral 
translation initiation.  
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(Willcocks et al., 2004). In MNV infection, eIF4G cleavage has not been observed, supporting the 
evidence that the mechanisms of host shutoff differ between MNV and FCV (Chaudhry et al., 2006). 
Other viruses, such as human immunodeficiency viruses 1 and 2 (HIV-1/HIV-2) also cause the partial 
cleavage of eIF4GI, but translational shutoff is less pronounced compared to picornaviruses (Ventoso et 
al., 2001). HIV PR protease preferentially cleaves eIF4GI at two sites on either side of the eIF3-binding 
domain, which results in the inhibition of de novo initiation of both capped and IRES-mediated mRNAs in 
vitro (Ohlmann et al., 2002). Interestingly, eIF4GII is not cleaved by HIV PR and the lack of eIF4GII 
cleavage ensures significant levels of eIF4F available to support cap-dependent translation during HIV 
infection (Ohlmann et al., 2002). 
1.10.2 PABP cleavage 
PABP plays multiple roles in translation and mRNA stability and turnover (Dehlin et al., 2000; Gallie, 
1998; Gorlach et al., 1994). It has two functional domains, the N- and C- terminal domains. The N 
terminal domain has four non-identical RNA-recognition motifs (RRMs) with different RNA-binding 
affinities and specificities. RRM1 and RRM2 can bind the poly(A) tail, whilst RRM3 and RRM4 have a 
relatively high affinity for A-rich sequences interspersed with other nucleotides (Mangus et al., 2003). 
The conserved C-terminal domain (CTD) consists of a proline-rich region linked to a globular protein-
binding domain (PABC). The CTD itself does not bind to RNA; instead, it has an undefined region used for 
homo-oligomerisation which enhances its affinity for binding to the poly(A) tail. Furthermore, the CTD 
has a conserved PABC motif for multiple protein interactions (figure 1.12) (Mangus et al., 2003).  
The interaction of PABP with the poly(A) tail and eIF4G mediates the circularisation of the mRNA via the 
cap-binding protein, eIF4E, which works in synergy for ribosome recruitment (Gingras et al., 1999b; 
Imataka et al., 1998). Such collective cooperative interactions for mRNA circularisation stimulate 
translation by increasing the binding affinity of eIF4E for the cap protein by stimulating PABP-poly(A) 
binding activities, and by enhancing the activities of the ATPase and RNA helicase (e.g. eIF4A and eIF4B) 
(Bi and Goss, 2000; Borman et al., 2002; Gallie, 1998). Functional analysis demonstrated that depletion 
of PABP reduced the formation of the 48S and 80S preinitiation complex, which could be rescued by the 
addition of recombinant PABP (Wei et al., 1998). Furthermore, this ‘closed’ loop model enables 
terminating ribosomes to be recycled from the 3’ to the 5’ end of mRNA and enhances the 60S subunit 
joining required for translation elongation (Gallie, 1998). In addition to its protein-binding activity, PABP 
has been identified to interact with eIF4B, release factor 3 (eRF3) and PABP-interacting partner 1 (PAIP1) 
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to enhance translation or facilitating ribosome recycling in general (Craig et al., 1998; Uchida et al., 
2002).  
 
Given that PABP is one of the major players in translation initiation, enteroviruses modify PABP through 
proteolysis to mediate host translational shutoff. Typically, PABP cleavage is mediated by viral proteases 
during infection, which separates the 4 RRMs containing the binding domains for poly(A) and eIF4G at its 
N-terminus from its CTD (Joachims et al., 1999; Kuyumcu-Martinez et al., 2002). Removal of the CTD 
results in the inhibition of poly(A) dependent translation and diminishes cellular protein synthesis 
because the interaction with cellular proteins, i.e. eRF3, eIF4B and PAIP1 is abrogated and may 
destabilise the poly(A)-PABP interaction (Kuyumcu-Martinez et al., 2004b; Melo et al., 2003) (figure 
1.13).  
 
Figure 0.12 Diagrammatic representation of the domain structure of PABP. (Adapted from Smith 
and Gary et al, 2010). PABP has two functional domains, the N- and C- terminal domains. The N 
terminal domain has four non-identical RNA-recognition motifs (RRMs) with different RNA-binding 
affinities and specificities. The conserved C-terminal domain (CTD) consists of a proline-rich region 
linked to a globular protein-binding domain (PABC). The CTD itself does not bind to RNA; instead, it 
has an undefined region used for homo-oligomerisation, which enhances the affinity for binding to 
poly(A). Furthermore, CTD has a conserved PABC motif for multiple protein interactions. The arrows 
points to the sites where viral proteases cleave. Typically, PABP cleavage separates the four RRMs at 
the N-terminal domain from the CTD containing PABC and homodimerisation domains. 
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Enterovirus infections such as HRV, CBV and PV, induce a rapid shutoff of host protein synthesis by 3 
hours post-infection, but only 35% of PABP is cleaved at this time point. At 6 hours post-infection, PABP 
is further cleaved by between 60 and 70% (Kuyumcu-Martinez et al., 2002; Kuyumcu-Martinez et al., 
2004b), whereas eIF4G is cleaved efficiently and completely by a much earlier timepoint of infection. 
PABP exists in various conformations via mulitmerisation or formation of a looped structure, which has 
different protease cleavage sensitivity, therefore PABP is cleaved less efficiently (Rivera and Lloyd, 
2008). Nevertheless, in vitro translation is completely inhibited even if only 30% of PABP is cleaved, thus 
verifying that PABP cleavage correlates to host shutoff (Joachims et al., 1999; Rivera and Lloyd, 2008).  
Most PABP in enterovirus-infected cells is proteolysed by the viral encoded 3C protease that cleaves at 
three sites within the proline-rich linker of PABP. Although the enterovirus 2A protease also mediates 
PABP cleavage, it has a single cleavage site in PABP (Joachims et al., 1999; Kuyumcu-Martinez et al., 
2002) (figure 1.12). Nevertheless, both proteases separate the same functional domains (i.e. separation 
of RRMs from the CTD). As previously described, PABP exists in a different configuration with differing 
susceptibility to viral proteases. 2A and 3C proteases have variable specificity for different PABP 
configurations. For example, 3C protease preferentially cleaves PABP from polysome fractions. It 
stimulates cleavage when PABP binds poly(A), in which case 2A-mediated proteolysis is inhibited 
(Kuyumcu-Martinez et al., 2002). Collectively, 3C protease appears to be predominantly responsible for 
host shutoff. Furthermore, a subset of the PABPs is resistant to cleavage, which explains why PABP has 
biphasic cleavage kinetics mediated by the 3C and 2A proteases. However, addition of recombinant 3C-
resistant PABP rescues 3C protease-mediated inhibition of poly(A)-dependent translation (Rivera and 
Lloyd, 2008). 
In vitro translation of PV IRES-driven reporter mRNAs is stimulated by polyadenylation and is greatly 
sensitive to PABP depletion (Bergamini et al., 2000; Svitkin et al., 2007). IRES-mediated translation is 
significantly reduced by eIF4G cleavage or disruption of PABP-eIF4G or PABP-poly(A) interactions. Taken 
together, polioviral IRES-driven translation is stimulated by the eIF4G-PABP interaction (Bergamini et al., 
2000; Michel et al., 2001). PABP cleavage not only abolishes cellular cap-dependent translation, but also 
blocks viral translation (i.e. PV and HAV) because PABP that is either on cellular or viral polysomes is 
susceptible to 3C. However, some remaining intact PABP can be purified from viral polysomes in 
infected cells, which suggests that the presence of an intact form of PABP may support the translation of 
nascent viral RNAs during a productive virus lifecycle (Kuyumcu-Martinez et al., 2002; Kuyumcu-
Martinez et al., 2004b; Rivera and Lloyd, 2008).  
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Experiments with NV or FCV 3C-like proteases show they cleaved PABP in the in vitro assay, and in 
addition, PABP cleavage also occurs during FCV infection. NV and FCV encode a 3C-like protease NS6, 
which has functional similarity to picornavirus proteases and is responsible for cleavage of PABP at 
various sites (figure 1.12) (Kuyumcu-Martinez et al., 2004a). Like the PV 3C protease, NV and FCV 
protease preferentially cleaves PABP associated with ribosomes and the protease inhibits both 
endogenous and polyadenlyated reporter mRNA translation in HeLa cell extracts (Kuyumcu-Martinez et 
al., 2004a). This demonstrates that caliciviruses also exhibit similar translational strategies as PV, i.e. 
PABP cleavage mediates host shutoff. In addition, the poly(A) tail at the 3’ UTR of the NV genome can 
bind directly to PABP (Kuyumcu-Martinez et al., 2004a). It is known that poly(A) stimulates translation 
mediated either by the IRES or the cap structure, however it is not clear if the poly(A) tail, together with 
PABP, can also stimulate VPg-dependent translation (Kuyumcu-Martinez et al., 2004a). Considering that 
most positive strand RNA viruses have a genomic poly(A) tail, PABP cleavage would be expected to 
inhibit not only cellular but also viral translation. In this case, the virus requires to selectively inhibit 
cellular mRNA translation without extensively affecting the viral translation. Since RNA viruses 
eventually terminate translation on their genomes to enable RNA replication, this switch presumably 
 
Figure 0.13 Schematic of PABP cleavage mediated by viral encoded protease. PABP cleavage 
mediated by the viral encoded protease induces cellular translation inhibition, whereby cleavage in 
the flexible linker region or RRM3 separates the N-terminus of PABP with its poly(A)- and eIF4G-
binding domain from the C-terminus. Cleavage is indicated by scissors. PABP cleavage also disrupts 
the interaction between eIF4B and eRF3, and also destabilises the PABP-poly(A) binding (indicated 
by a dotted line). Viruses also induce eIF4G cleavage, which further destabilises the 5’ to 3’end 
linkage and impairs the formation of a close-loop structure, which is necessary for cap-dependent 
translation in the host cell.  
m7
(n)AAA
4E
4G
3
1
4B
PABP 2 3 4 C
eRF34A
                                                             P a g e  | 58 
 
occurs through partial cleavage of PABP, which is therefore not only a strategy to subvert cellular 
translation, but may serve as a switch from translation to replication when necessary (Kuyumcu-
Martinez et al., 2004a). However, the mechanisms by which viruses regulate PABP cleavage and how 
viral translation is stimulated for long enough to produce the mature proteins required for replication 
complex formation have not yet been determined. 
1.10.3 Regulation of eIF4E 
1.10.3.1 Regulation of eIF4E through phosphorylation 
Cellular translation can be regulated through the phosphorylation of eIF4E. eIF4E is phosphorylated on 
serine 209 by an eIF4G-associated Mnk (Mnk1 or Mnk2) to stimulate cap-dependent translation. Viruses 
modulate eIF4E phosphorylation to control host cell translation (Pyronnet et al., 1999). Adenovirus 
produces a late protein, namely 100k, which competes with Mnk1 for binding to the C-terminal end of 
eIF4G, thereby expelling Mnk from binding to eIF4G and phosphorylating eIF4E. The loss of Mnk1 is 
accomplished by impairment of the eIF4E phosphorylation, which strongly correlates with host cell 
shutoff (Pyronnet et al., 1999) (figure 1.14). In contrast, adenovirus late mRNA can still be translated via 
ribosome shunting, stimulated by the 100k protein (Cuesta et al., 2004). Reduced eIF4E phosphorylation 
has been detected in cells infected with viruses such as influenza (Burgui et al., 2007) and EMCV (Kleijn 
et al., 1996), however, the exact mechanism of eIF4E dephosphorylation is not yet understood. 
1.10.3.2 Regulation of eIF4E availability via 4E-BP 
The interaction of eIF4E with eIF4G is required to form a functional eIF4F complex, and together with 
eIF4A is necessary for ribosome recruitment and efficient translation. Therefore, the activity of eIF4E is 
often modulated by viruses to either subvert cellular or enhance viral translation. In normal cells, the 
availability of eIF4E is modulated by the translation repressor, 4E-BP, in a phosphorylation-dependent 
manner. When 4E-BP1 is hypophosphorylated, it prevents eIF4E from binding to eIF4G, thus impairing 
formation of the active eIF4F complex (Gingras et al., 1999a). Consequently, cap-dependent translation 
is inhibited (figure 1.14). When 4E-BP1 is hyperphosphorylated by mTOR kinase, it releases eIF4E, 
allowing the formation of an intact eIF4F complex (Gingras et al., 1999a). 
Type I and II IRES elements of picornaviruses such as EMCV and PV can recruit ribosomes in the absence 
of a cap structure and eIF4E, therefore eIF4E is targeted during virus infection to control cellular protein 
synthesis. These viruses regulate the availability of eIF4E by accumulating hypophosphorylated 4E-BP1, 
which prevents eIF4E from binding to a cap structure, resulting in the impairment of cellular translation, 
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while viral translation is unaffected (Gingras et al., 1996). Other viruses, such as vesicular stomatitis virus 
(VSV), inhibit cellular translation by modulating eIF4E availability through dephosphorylated 4E-BP1 
(Connor and Lyles, 2002) (figure 1.14). 
 
1.10.3.3 Promoting eIF4F complex assembly 
Herpes simplex virus type 1 (HSV-1) stimulates cap-dependent translation by promoting eIF4F assembly. 
ICP6 encoded by HSV-1 interacts with eIF4G to facilitate the eIF4E-eIF4G interaction and induces eIF4F 
assembly, which may be important for virus growth in quiescent cells. Cells infected with ICP6 mutant 
show reduced cellular protein synthesis, since eIF4G is not recruited into the elF4F complex. Although 
Figure 0.14 Schematic model of the modification strategies used by viruses. (Adapted from Pestova 
et al., 2001) Viruses regulate the phosphorylation status of translation factors such as eIF4E and 4E-
BP to either induce synthesis of viral protein or inhibit cellular translation. The mechanisms by which 
viruses modify are indicated by dashed boxes. The diagram depicts that viruses stimulate translation 
generally through induction of 4E-BP phosphorylation or induction of eIF4E phosphorylation. On the 
other hand, they abolish cap-dependent translation by inducing 4E-BP dephosphorylation or 
inhibiting eIF4E phosphorylation.  
4E-BP1
eIF4E
4E-BP1
P
P
eIF4E
mTOR
Induction of 4E-BP1 
dephosphorylation
e.g. VSV, EMCV
Induction of 4E-BP1 
phosphorylation e.g. 
HSV-1
Stimuli 
e.g Growth factors, 
hormones, cytokines
eIF4F assembly
eIF4G
eIF4AeIF4E
Inhibition of cap-
dependent 
translation
Protein synthesis
P
Mnk
Induction of eIF4E 
phosphorylation
e.g. HSV-1 (ICP0)
Inhibition of eIF4E 
phosphorylation e.g. 
Adenovirus (100k)
Kinase cascade
                                                             P a g e  | 60 
 
eIF4E is released from the repressor 4E-BP1 in these cells infected with ICP6-deficient virus, eIF4E is not 
phosphorylated by Mnk due to its inability to bind eIF4G (Walsh and Mohr, 2006). HSV-1 also expresses 
infected cell polypeptide 0 (ICP0), upstream of ICP6, which is required for vegetative replication and 
reactivation of latent infection. ICP0 is responsible for modifying eIF4E and 4E-BP1 through 
phosphorylation (figure 1.14). Inhibition of Mnk dramatically reduces viral replication and translation in 
infected quiescent cells, showing that eIF4E phosphorylation by Mnk is essential for HSV-1 replication 
and protein synthesis (Walsh and Mohr, 2004). In addition to stimulating Mnk required for efficient viral 
translation and replication, HSV-1 also promotes phosphorylation of 4E-BP1 and controls the steady-
state level of 4E-BP1 by proteasomal degradation. Mutants lacking ICP0 are unable to reactivate from 
the latent state (Walsh and Mohr, 2004). Taken together, HSV-1 stimulates eIF4F complex assembly in 
quiescent cells required for replication and translation (Walsh and Mohr, 2004).  
1.10.4 Modification of 5’ to 3’ interactions  
The linkage of PABP and eIF4G is essential for bringing the 5’ and 3’ ends in close proximity to form a 
‘closed loop’ structure (Gallie et al., 1991; Mangus et al., 2003). Disruption of the PABP-eIF4G interaction 
affects the formation of a closed loop configuration which, in turn, destabilises the mRNA and drastically 
decreases translation efficiency (Gallie, 1998; Mangus et al., 2003). This explains why viruses modulate 
the activity of PABP and eIF4G during their productive cycle. For instance, NS1 is an RNA-binding protein 
encoded by influenza which is responsible for viral translation and replication. It associates with the 5’ 
UTR of viral RNA, PABP and the N-terminus of eIF4GI to form a heterotrimeric NS1-eIF4G-PABP complex, 
which consequently stimulates viral translation (figure 1.15C). Since influenza mRNAs are 
polyadenylated, formation of a closed loop structures further enhance the efficiency of translation 
initiation (Burgui et al., 2007).  
Rotavirus RNAs are capped and non-polyadenylated RNAs, which do not cleave PABP or eIF4G during 
infection. Instead, rotaviruses utilise the viral protein, NSP3 to shut-off cap-dependent translation. NSP3 
not only binds strongly to viral RNA, but is also able to bind to the N-terminal region of eIF4GI upstream 
to the eIF4E-regconition sites (Groft and Burley, 2002; Piron et al., 1998). Essentially, NSP3 replaces the 
function of PABP; it bridges the interaction between eIF4GI and the viral mRNA without affecting the 
circularisation of the RNA transcript necessary for viral translation (figure 1.15A). NPS3 mediates the 
eIF4G interaction through its C-terminus, as the purified C-terminus of NSP3 can replace PABP from 
eIF4F in vitro (Piron et al., 1998).  
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The genome of the dengue virus (DV) is also capped, but it does not have a poly-A tail. Despite DV 
lacking a 3’ poly(A) tail, the 3’ UTR of the DV genome has a run of adenosines upstream of a stem loop 
(Polacek et al., 2009) where PABP binds and stimulates translation via the formation of a closed loop 
structure (Holden and Harris, 2004; Holden et al., 2006) (figure 1.15B). Although DV does not inhibit 
cellular protein synthesis, it can be efficiently translated even if the cap-dependent translation is 
impaired (Edgil et al., 2006). 
Other viruses, such as bunyamwera viruses (BUNV), the prototype of the Bunyaviridae family suppress 
translation of polyadenylated cellular mRNAs by changing the subcellular localisation of PABP, while 
Figure 0.15 Model of eIF4F-PABP complex modification utilised by viruses for cellular translation 
inhibition and/or viral translation stimulation. (Adapted from Smith and Gray, 2010) A) Model of 
inhibition of cellular cap-dependent translation by rotavirus NSP3. NSP3 binds to the viral RNA and 
eIF4G N-terminus to facilitate viral mRNA translation. The interaction between eIF4G and NSP3 
blocks eIF4G from binding to PABP, which destabilises end-to end formation and ultimately affects 
the translation of cellular mRNAs. B) Model for DV RNA translation. PABP binds to a run of 
adenosines upstream (indicated by a white box) of the stem loop within the non-polyadenylated 3’ 
UTR of DV RNA and stimulates viral translation. C) Model for influenza virus mRNA translation.  NS1 
binds to the 5’UTR (indicated by a white box) of viral mRNAs and directly interacts with eIF4G and 
PABP, thus stabilizing the linkage between the 5’ to 3’ ends in order to promote viral mRNA 
translation.  
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their mRNAs are translated in a PABP-independent manner (Blakqori et al., 2009). Supportive data 
indicate 3’UTR of BUNV S segment mRNAs that process a translation-enhancing element at the 3’ UTR 
can mediate efficient translation of non-polyadenylated mRNAs. In BUNV infected cells, PABP that 
normally shuttles between nuclear and cytoplasm, accumulates in the nucleus, thereby inhibiting 
translation of cellular mRNAs (Blakqori et al., 2009).  
 
1.11 Project Aims 
Since calicivirus capsids exhibit a high degree of variability which hampers vaccine development as well 
as identifying antiviral strategies targeting viral attachment, antivirals targeting other steps in the virus 
lifecycle are attractive. Translation is the first process which takes place upon entry of positive strand 
RNA viruses into the cell, and this step is essential for subsequent replication. In addition to its role in 
viral translation, calicivirus VPg also appears to serve as a primer for genome RNA replication and it is 
relatively well conserved among caliciviruses. Therefore, the multifunctional nature of VPg makes it 
likely to be a good target for antiviral drugs.  
Because of the lack of an efficient cell tissue culture system and animal model to study the translation 
mechanism of HuCVs, current knowledge is drawn from MNV as it is the only norovirus that replicates 
efficiently in tissue culture, has a small animal model readily available and is easily manipulated in 
reverse genetic system. Given that MNV shares genetic similarity with NV, it is likely that the mechanism 
of translation and replication is conserved between these viruses. FCV that propagates well in tissue 
culture system is another available system to study the mechanism of calicivirus translation.  
The objective of this project was to dissect the translation initiation mechanism utilised by norovirus VPg 
and identify inhibitors of this novel translation as potential anti-viral therapeutics.  
 
The specific aims of this project were as follows: 
Identification of inhibitors of calicivirus translation: 
1. To identify specific peptide-bearing phage which bind and inhibit MNV and FCV VPg using phage 
display 
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Dissection of norovirus translation initiation mechanism: 
1. To identify the functional residues within the norovirus VPg protein 
2. To evaluate whether MNV is a good model for studying human norovirus translation by 
examining the NV-replicon system and generating the genetically engineered MNV expressing 
NV VPg 
3. To identify cellular factors that interact with VPg 
4. To elucidate which canonical translation initiation factor mediates a direct interaction with VPg 
5. To determine the functional role of translation initiation factors in norovirus translation 
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2 Methods and materials 
2.1 Antisera 
Antisera to the MNV VPg were generated by immunizing New Zealand white rabbits with a recombinant 
Lonsdale virus (LDV) VPg that cross-reacted with MNV VPg and were subsequently subjected to affinity 
purification on MNV VPg. Antisera to NS7 of MNV-1 were generated by immunizing New Zealand white 
rabbits (Eurogentech) after providing them with recombinant 3D polymerase previously purified in the 
lab.Antisera to eIF4E (sc-13963) and eIF4A (sc-14211) were purchased from Santa Cruz, while the 
antiserum to PABP (4992) was purchased from New England BioLabs. The antiserum to eIF4G (2498) 
used in tandem affinity purification was bought from New England BioLabs. Antiserum to eIF4GI (15704-
1-AP) used in cap-affinity purification and silencing experiments was purchased from Proteintec Group 
and antiserum to eIF4GII was kindly given from Luis Carrasco (Centro de Biología Molecular Severo 
Ochoa CSIC-UAM, Madrid). Antiserum to DDX9 was purchased from Santa Cruz, while the antiserum to 
the PABP was purchased from Cell Signalling. Antiserum to ABCE1 was purchased from Proteintec 
Group. Antisera to DDX3 and eIF3 were kindly provided by Arvind Patel (MRC Virology Institute, 
Glasgow) and Gerhard Wagner (Biomedical centre, Uppsala) respectively. The antiserum to GAPDH 
(AM4300) was purchased from Ambion Applied Biosystems. The antiserum to histidine (HIS) was 
purchased from Santa Cruz.  The anti-HA antibody (A5477) was purchased from Sigma. Antisera to CAT 
were purchased from Sigma and antisera to fLuc were bought from Promega. 
2.2 Viruses and Cell lines 
MNV was propagated in the murine leukaemia macrophage cell line RAW264.7 cells using Dulbecco 
modified Eagle medium (DMEM) with 10% (v/v) foetal calf serum (FCS), penicillin (100U/ml), 
streptomycin (100μg/ml) and 10mM HEPES buffer. Baby-hamster kidney cells (BHK-21) expressing T7 
RNA polymerase (BSRT7 cells) used during the reverse genetic recovery of MNV from the cDNA clones 
were cultured in DMEM containing 1mg/ml G418. A recombinant fowlpox virus expressing T7 
polymerase was used in cDNA-based genetics recovery system for MNV-1 by infecting BSRT7 cells prior 
to cDNA transfection (Chaudhry et al., 2007). Murine microglial cells (BV2) were maintained in DMEM, 
10% FCS, 1% L-glutamine with penicillin (100U/ml), and streptomycin (100μg/ml). The 293T cells that 
stably expressed pMEP4-NTAP or pMEP4-NTAP MNV VPg plasmids were grown in DMEM containing 
10% (v/v) FCS, 1% (v/v) Pen/Strep, 50 μg/ml hygromycin B and non-essential amino acids. The 
pcDNA4/TO-NTAP derivatives of MNV VPg, RHDV VPg, FCV VPg and NV VPg and the CTAP derivatives of 
MNV and NV VPg that were stably-expressed in 293 TREX cells were grown in DMEM with 10% (v/v) FCS, 
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1% (v/v) Pen/Strep, 5μg/ml blasticidine and 200μg/ml zeocin. BHK-21 cells expressing the NV replicon 
were maintained at DMEM containing 10% (v/v) FCS, 1% (v/v) Pen/Strep and 0.5mg/ml G418. All the cell 
lines were maintained at 37⁰C and 10% CO2.   
2.3 Plasmids 
All the primers used for plasmid construction are listed in table 2.1. A full-length infectious clone 
pT7:MNV 3’RZ that contained a wild type MNV-1 genome under the control of a T7 promoter and a 
mutant that contained a frame shift in the NS7 region of ORF1 pT7:MNV 3’ RZ FS were constructed in 
our laboratory(Chaudhry et al., 2007). 13 cDNA clones expressing a substitution mutant of VPg (K3A, 
K5A, K7A, L21A, D23A, E25A, Y26F, D27A, E28A, S41A, D43A V115A D116A and F123A) were constructed 
by Ian Goodfellow. The plasmid, pMEP4-NTAP MNV VPg and pcDNA4/TO-NTAP NV VPg was made by 
Dalan Bailey, while a pcDNA4/TO-NTAP derivative of RHDV VPg was generated by Guang Qing. 
Plasmids, pcDNA3-HA-4E-BP1-WT, pcDNA3-HA-4E-BP1-4A were provided by Emilio Yángüez (Centro 
Nacional de Biotecnología, Madrid, Spain) and pcDNA3.1+ were supplied by our lab. Constructs, 
pET28a:HIS N-FAG1-532, pET28a:HIS C-FAG 1177-1600, pET28a:HIS M-FAG 533-1176, pET28a:HIS p100 675-1600, 
pET28a:HIS 4GM 654-1131, expressing the truncated eIF4G proteins, N-FAG, C-FAG, M-FAG, p100 and 4GM 
respectively were used to identify the minimal VPg binding domain within eIF4GI and supplied by Prof 
Simon Morley (University of Sussex). 
2.3.1 Construction of MNV infectious clone with MNV VPg displayed with NV VPg using site-
directed mutagenesis based in overlapping polymerase chain reaction 
For constructing an MNV:NV chimera, a full length MNV cDNA clone was used (Chaudhry et al., 2007). 
Site-directed mutagenesis was performed using overlapping extension PCR to construct an MNV cDNA 
clone encoding all the MNV non-structural and structural proteins, but replacing MNV VPg with the 
human NV VPg. Two silent mutations in potential restriction sites were introduced into the backbone of 
MNV cDNA clone (pT7:MNV3’RZ) close to the flanking region of MNV VPg using PCR. For PCR 
amplifications, KOD Hot start (Novagen) was used according to the manufacturer’s protocol. To 
generate the first intermediate PCR fragment, PCR1, the mutagenic primer pair, P1 and P2 flanking MNV 
NS5 (VPg) were used. The PCR1 consisted of a restriction site BamH1 and two silent mutations 
introducing the restriction sites BStBI and NdeI. Meanwhile, another DNA fragment PCR2 was also 
amplified using a mutagenic primer P3 and a flanking primer P4, which in addition to the natural 
restriction site HindIII, encoded a silent mutation generating the restriction site NdeI. After the 
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intermediate PCR products (PCR1 and PCR2) were purified, they were used as templates for generating 
the mutagenic overlapping PCR product, PCR3 and assembled by overlapping extension using primers P1 
and P4. The resulting amplified PCR3 was purified and digested with BamH1 and HindIII (New England 
BioLabs). Following digestion, PCR3 was subsequently purified and ligated into a pre-digested cDNA 
clone of MNV, which produced a plasmid, pT7:MNV3’RZ NS5* containing two restriction sites generate 
by the introduction of silent mutations BStBI and NdeI.  
To genetically engineer the NV VPg insert into the expression construct (pT7:MNV3’RZ NS5*), pNV101 
plasmid was used as the template to amplify the NV VPg insert (PCR4) by two mutagenic primer pairs P5 
and P6. PCR4 bearing two unique restriction sites (BStBI and NdeI) was purified with GFX column 
purification. Subsequently, the pT7:MNV3’RZ NS5*construct and the NV VPg insert were enzymatically 
digested with BStBI and NdeI (New England Biolab). The digested DNA insert was finally ligated into 
pT7:MNV3’RZ NS5*, which yielded a chimeric construct, pT7:MNV3’RZ*NV NS5/VPg. The mutagenised 
region was fully sequenced using sequencing primers 2392F, 3734R, 3734F and 4450R. The primers used 
for construction of MNV:NV chimera are listed in table 2.1.  
2.3.2 Construction of NTAP derivative of MNV VPg and its mutants F123A and NTAP 
derivative of FCV VPg 
The pT7:MNV 3’RZ F123A MNV VPg and pQ14 were used as templates to construct plasmids, 
pcDNA4/TO-NTAP derivatives of MNV VPg F123A and NTAP derivatives of FCV VPg respectively using 
KOD Hot start (Novagen). The primers used for amplifying MNV F123A were IGIC115 and IGIC301; 
primers used for amplifying FCV VPg were IGIC185 and IGIC300.The PCR products and the expression 
vectors, pcDNA4/TO-NTAP were digested with SgfI and BSiWI. Similarly, for generating the pcDNA4/TO-
CTAP derivative of NV VPg plasmid, the NV VPg insert DNA was PCR amplified from pNV101 using 
forward primer IGIC575 and IGIC406. To construct the pcDNA4/TO-CTAP of MNV VPg construct, the 
MNV VPg insert was PCR amplified using forward primer IGIC573 and IGIC389, which used pT7:MNV 
3’RZ as a template. The DNA inserts and the expression construct, pcDNA4/TO-CTAP were digested with 
ClaI and BSiWI. The inserts were successfully cloned into the phosphatase-treated construct.  
For constructing the pcDNA4/TO-NTAP derivatives of wild type MNV VPg, pMEP4-NTAP MNV VPg was 
digested with BsiWI and SgfI (New England Biolabs) to remove MNV VPg insert. The insert was then re-
ligated into another expression construct, pcDNA4/TO-NTAP. All plasmids were sequenced prior to use. 
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Oligos Polarity Oligo sequence Description
P1 
(IGIC568) F
GACCTGGATCCTTTGACATCTTCGAAGATGACG
ATGATGGGTGGTAC
PCR1 and PCR3 mutagenic primer;
introduce unique BStB1 site into MNV
cDNA clone
P2 
(IGIC569) R
GAACTGCACAACACGGGACCATATGGAGACTG
GGGCCTCAAAG
PCR1 mutagenic primer; introduce
unique Nde1 site into MNV cDNA clone
P3 
(IGIC570) F
CTTTGAGGCCCCAGTCTCCATATGGTCCCGTGTT
GTGCAGTTC
PCR2 mutagenic primer; introduce
unique Nde1 site into MNV cDNA clone
P4 
(3734R) R
CGCGTGGTTCTGAATAGGGCTTAAGCTGATCTC
GC PCR2 and PCR3 flanking primer 
P5 
(IGIC571) F
GACATCTTCGAAGATGACGATGATGGGTGGTA
CCACTCTGAGGGAAAGAACAAAGGCAAGACC
PCR4 mutagenic primer; amplifying NV
VPg with an unique BStB1 site
P6 
(IGIC572) R
AACACGGGACCATATGGAGACTGGGGCTTCAA
AATTGATCTTTTCATTATAATC
PCR4 mutagenic primer; amplifying NV
VPg with an unique Nde1 site
Oligos Polarity Oligo sequence Description
IGIC115 F
TTTAAACGTACGGGAAAGAAGGGCAAGAACA
AGAAGGG
 MNV F123A  VPg into pcDNA4/TO-NTAP 
construct, Sgf1
IGIC301 R
TTTAAAGCGATCGCGTTACTCAGCGTTGATCTTC
TCGCCGTAG
 MNV F123A  VPg into pcDNA4/TO-NTAP 
construct,  BsiWI site
IGIC 185 F
TTTAAACGTACGGCCAAAGGAAAAACAAAGTC
AAAAG
WT FCV VPg into pcDNA4/TO-NTAP  
construct
IGIC 300 R
TTTAAAGCGATCGCGTTATTCTTCAGCAAAGCT
AACATCATAG
WT FCV VPg into pcDNA4/TO-NTAP  
construct
IGIC 575 F
CCATCGATACCATGGGAAAGAACAAAGGCAA
GACC
NV VPg into pcDNA4/TO-CTAP construct, 
ClaI site
IGIC 406 R TTTCGTACGTTCAAAATTGATCTTTTCATTA
NV VPg into pcDNA4/TO-CTAP construct, 
BsiWI site
IGIC 573 F
CCATCGATACCATGGGAAAGAAGGGCAAGAA
CAAG
MNV VPg into pcDNA4/TO-CTAP 
construct, ClaI site
IGIC 389 R TTTCGTACGCTCAAAGTTGATCTTCTCGCCG
MNV VPg into pcDNA4/TO-CTAP 
construct, BsiWI site
Oligos Polarity Oligo sequence Description
IGIC464 F CAAACATCTTTCCCTTGTTC primer for detecting MNV genomic RNA
ICIG 465 R TGGACAACGTGGTGAAGGAT primer for detecting MNV genomic RNA
For construction of MVN:NV chimera
For qRT-PCR
Primers for cloning VPg into TAP tagged expression plasmid
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2.4 Polymerase chain reaction (PCR) 
All PCR amplifications were performed using KOD Hot stat (Novagen) according to the manufacturer’s 
protocol, unless otherwise stated and an Eppendorf thermal cycler was used for the PCR amplification. 
PCR amplification was subsequently performed for 30 cycles which consisted of a denaturation step at 
95⁰C for 20s, annealing step at 55-60⁰C for 10s and extension at 72⁰C for 15 s/kb to be amplified. 
Reactions were subsequently placed at 4⁰C followed by storage at -20⁰C until further use. The PCR 
products were purified using the GFX PCR DNA and Gel Band Purification kit (GE Healthcare) as 
described in manufacturer’s manual. 
2.5 Transformation and plasmid midi-preparation 
NEB Turbo (New England Biolabs) and α-Select Bronze Efficiency Escherichia coli (E.coli) cells (Bioline) 
were used for amplifying cDNA constructs and all transformation was carried out according to the 
manufacturer’s protocol. The plasmid DNA was extracted from 100ml E.coli cultures using a PureYield 
Midiprep DNA purification system (Promega, USA) according to the manufacturer’s instructions. 
Oligos Polarity Oligo sequence Description
IGIC128 R TTTTTTTTTTTTTTTAAAATGC primer used for RT-PCR
6831F F GCCCAGAAGGATCTCACTCTGATGG primer used for RT-PCR
Oligos Polarity Oligo sequence Description
2392F F
GTGTCAGAAGGATAAAGGAGGCCCGCCTCCGC
TGC MNV-1 sequencing primer
3734R R
CGCGTGGTTCTGAATAGGGCTTAAGCTGATCTC
GC MNV-1 sequencing primer
 3734F F
GCGAGATCAGCTTAAGCCCTATTCAGAACCAC
GCG MNV-1 sequencing primer
 4450R R CCAAACTATTCAGCTGTGTGGTGCAAGGGC MNV-1 sequencing primer
Oligos Polarity Oligo sequence Description
IGIC218 F TTATTCGCAATTCCTTTAGTGGTACCTTTC PCR amplification of phage DNA
IGIC219: R GCCCTCATAGTTAGCGTAACGATCTAAAG PCR amplification of phage DNA
Primer for phage amplification
Sequencing primers
For RT-PCR
Table 2.1 List of the primers used. The sequences of all primers are depicted in 5’ to 3’ direction. 
Polarity indicates whether the primer is a forward (F) or reverse (R) primer in the PCR reaction. For 
the MNV-1 sequencing primer, the number used in the primer name represents the genome position 
in the full-length MNV-1 cDNA clone pT7:MNV3’RZ.  
                                                             P a g e  | 70 
 
2.6 Bioinformatics tools 
All vector map and oligos manipulation were made using VectorNTI. Alignment of peptide sequences 
was performed using ClustalW (http://www.genome.jp/tools/clustalw/). Scaffold 2 was used for 
analysing the mass spectrometry data preformed at Genome Quebec Innovative centre (McGill 
University) in Canada.  
2.7 Transfection 
2.7.1 DNA transfection by lipofectamine 2000 
7.5x105 293 cells were transfected with 1μg of DNA plasmid using 4μl of Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s instructions.  
2.7.2 Electroporation (NEON transfection system) 
Prior to transfection, the BV2 cells were treated with trypsin to disassociate cells and washed with 1x 
PBS. For each transfection, 100ul of BV2 cells (6x106 cells) were mixed with 1μg of DNA or 250pmole 
siRNA using a Neon pipette (MPP100) and were placed into the Neon transfection apparatus 
(MPK10096) according to the manufacturer’s instructions. The instrument parameters for the 
transfection were optimised as 1700 volts at 10ms for 3 pulses. Immediately after the transfection, the 
cells were resuspended in maintenance medium (DMEM+10% FCS+ 1%NaHCO3 + 1%L-glutamine) and 
incubated at 37⁰C with 5% CO2 in an incubator.  
2.8 Western blot 
For a conventional western blot analysis, the cells were lysed directly into radioimmunoprecipitation 
(RIPA) buffer (50mM Tris–HCl pH 8.0, 150mM NaCl, 1mM EDTA, 1% Triton X-100 and 0.1% SDS). The 
protein concentration of the cell lysate was determined using the BCA protein assay (Pierce) and an 
equal amount of protein from each lysate was mixed with the reducing SDS-PAGE sample buffer and 
heated. The protein samples were then resolved by SDS-PAGE and subsequently transferred to a 
polyvinylidene fluoride (PVDF) Immobilon-P transfer membrane (Millipore) by semi-dry blotting 
apparatus according to the manufacturer’s instructions. Next, the membrane was blocked with either 
5% milk powder in PBST (0.1% Tween 20 in PBS) or 5% bovine serum albumin in PBST. After blocking, the 
membrane was incubated with the primary antibody for 2 hours or overnight. The incubation duration 
depended on the sensitivity of the antisera. The membrane was washed 3 times after incubation with 
primary antibodies. A secondary horseradish peroxidase (HRPO) conjugated antibody was applied for 1 
hour and the membrane was washed twice in PBST and twice in PBS. For the detection of secondary 
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antibodies conjugated with horseradish peroxidise, chemiluminescence substrate (ECL detection 
substrate, Amersham-Biosciences) was used according to the manufacturer’s instructions. 
For a quantitative western blot analysis, the samples were prepared and resolved in SDS-PAGE gel. 
Instead of using a standard pre-stained protein marker, a two-colour fluorescent protein marker (LI-COR 
Odyssey, 928-40006) was used to enable the estimation of the size of the protein bands. After 
electrophoresis, the proteins were transferred onto a Whatman Protran nitrocellulose membrane 
(BA85, pore size 0.45 μm) using a semi-dry blotting apparatus. The blotting procedure was performed as 
described above except that secondary antibodies conjugated with fluorescent dye were used and 
detected using an LI-COR Odyssey Infrared imaging system according o manufacturer’s protocol. 
2.9 Phage Display 
The Ph.D.-12™ Phage Display Peptide Library Kit (New England Biolabs, Ipswich, MA, U.S.A.) contained a 
12mer peptide phage library, which exhibited various genetically-engineered peptide variants and was 
used to select small peptides that bound to VPg.  The kit was also supplied with E. coli strain ER2738 to 
enable phage to be propagated and grown on tetracycline containing media. 
2.9.1 Panning 
The affinity selection of peptide-displayed phage, so-called panning, was carried out according to the 
manufacturer’s protocols with a few variations. Two approaches were examined in the study, namely 
solution binding and plate-binding approaches.  
For solution binding, 5μg samples of the target protein were immobilised on 25μl of Ni-CAM agarose 
beads (50% slurry, HIS–select resin from Sigma) in TBS + 0.1% Tween 20 (TBST/0.1%). The positive 
control for the experiment was streptavidin, which was immobilised with strepavidin covalently coupled 
to agarose (Ultralink beads, Thermo Scientific). After the binding reaction, beads were blocked with 
blocking buffer (5g/ml BSA in 50μl TBST/0.1%). Prior to solution panning, a negative selection was 
preformed whereby 10μl  of a phage library (1.0 x 1011 pfu/ml) was incubated with 25μl of Ni-CAM beads 
alone to reduce the chances of selecting phage binding to the beads. The unbound phage from the 
negative selection were added to the protein-resin complexes and were mixed gently every 5 mins 
during the 30 minutes incubation at room temperature. The resin-protein-phage complexes were 
pelleted by centrifugation at 800 x g for 2 minutes and were subsequently washed 10 times with 1ml 
TBST/0.1% to remove unbound phage. The phage selectively bound to proteins were eluted using 
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200mM of imadazole, while the positive control, streptavidin-binding phage, were eluted with 0.1mM  
biotin. The phage supernatant was separated from the protein-resin complexes using SpinX 
microfiltration columns. A small aliquot of phage (unamplified phage) was kept to measure the phage 
titre. The remaining phage supernatant was amplified in E. coli, titred by the plaque assay, and purified 
by polyethylene glycol precipitation as described by the manufacturer. Three rounds of panning were 
performed to enrich the phage with a high affinity for the target. 
For the plate-binding approach, a 96-well plate served as a solid support where the target protein was 
immobilised. Briefly, 1.5μg of the target protein in 150μl of coupling buffer (0.1M sodium carbonate 
NaHCO3, pH 8.6) was coated on the plate overnight at 4⁰C with gentle agitation. After incubation, the 
coating solution was removed and the protein-coated plate was blocked in 150μl of blocking buffer. 
Subsequently, 10μl of the phage library (2 x 1011 pfu/ml) was added to the well. After one hour of 
incubation, the unbound phage was discarded and the plate was washed 10 times with TBST 0.1%. Then, 
the phage bound on the plate was eluted using a general buffer (0.2M glycine-HCl (pH 2.2), 1mg/ml BSA 
and neutralised with 1M of pH 9.1Tris-HCl). The phage was titred, amplified and purified, the same as in 
the solution-binding approach. The amplified phage was used in the next successive round of panning. A 
total of five rounds of panning was performed with a few parameters changed to increase the stringency 
of isolating the favourable peptides for VPg.  
2.9.2 Characterisation of binding phage clones 
Phage selected from the 3rd round of solution-binding panning and the 5th round of plate-binding 
panning were characterised by enzyme-linked immunosorbent assays (ELISA) and their amino acid 
sequences were determined by sequencing. After the phaqe pool was titred using a plaque assay, 
several individual plaques were isolated, amplified and purified according to the manufacturer’s 
protocol. A plaque PCR was performed to amplify the inserted DNA sequnce of the peptide displayed on 
the phage clones by using a PCR primer set IGIC218 and IGIC219. The amplified PCR product was purified 
using GFX PCR DNA and gel band purification kit (GE healthcare) and sequenced (Imperial College MRC 
Sequencing Service) using the provided sequencing primer (5´- CCC TCA TAG TTA GCG TAA CG –3´). 
The phage pools or phage clones isolated from the last round of panning against the MNV and FCV VPg 
were examined for their binding affinity for VPg using ELISA as described in the manufacturer’s 
instructions. Briefly, 375g/ml of the target proteins, MNV VPg-HIS and FCV VPg-HIS and BSA (as a 
negative control) in 150l of coupling buffer were immobilised on a 96-well ELISA plate. After overnight 
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incubation at 4⁰C with agitation, the wells were blocked with BSA for another 1-2 hours and 
subsequently washed with TBS+0.5% Tween20 (TBST/0.5%) 6 times. In a separate plate which had been 
previously blocked with BSA, the phage pool or phage clones to be characterised were two-fold serial 
diluted. Later, the diluted phage suspensions were transferred to the respective target proteins that had 
been previously coated on an ELISA plate and allowed to bind for 1-2 hours at room temperature. 
Thereafter, the unbound phage were removed by washing 6 times with TBST/0.5%, while the bound 
phage which remained on the plate were incubated with 200μl of 1/5000 diluted HRP-conjugated anti-
M13 antibody in the blocking buffer for 1 hour. Subsequently the plate was washed 3 times with 
TBST/0.5% and was incubated with 50μl of tetramethylbenzidine (TMB) substrate (Pierce). The reaction 
was stopped with 50μl of 1M HCl and the plate was read at 450nm absorbance using a plate reader.  
To characterise whether or not the peptide displayed on individual phage clones could specifically bind 
to its respective target, the proteins used were HIS-4E-BP1, HIS-FCV VPg, untagged LDV VPg, FCV VPg-
HIS and MNV VPg-HIS, which were all previously purified in the laboratory. These recombinant proteins 
were immobilised on the plate and the ELISA was performed as described above. 
2.10 MNV reverse genetics 
2.10.1 Recovery of MNV using cDNA-based reverse genetics system 
MNV and mutant viruses were rescued from respective cDNA clones using the reverse genetics system 
based on recombinant Fowlpox expressing T7 RNA polymerase (Chaudhry et al., 2007). Briefly, BSRT7 
cells were plated in 6-well plates at a density of 7.5 x 105 cells per well in antibiotic-free DMEM with 10% 
FCS and incubated overnight at 37⁰C with 5% of CO2. The following day, the cells were incubated for 1 
hour in 700 μl of antibiotic-free DMEM (10% FCS) with fowlpox virus expressing T7 RNA polymerase 
(based on the virus titre in chick embryo fibroblasts) at an m.o.i of 0.5 p.f.u. per cell. After an hour, 2ml 
of antibiotic-free DMEM (10% FCS) was added and the cells were further incubated for an hour. After 2 
washes in antibiotic-free DMEM (10% FCS), 1 μg of each MNV cDNA construct was transfected using 
Lipofectamine 2000 according to the manufacturer’s instructions. At 24 hours post-transfection of DNA, 
the cells were freeze-thawed at -80°C to release virus particles and viral titre was determined using 
TCID50 on RAW264.7 cells. The expression of viral protein was analysed by western blot. 
2.10.2 Recovery of MNV using RNA-mediated reverse genetics system 
Virus could be rescued from capped RNA that was in vitro transcribed from cDNA clones of WT MNV or 
different MNV VPg mutants (Yunus et al., 2010). Firstly, the cDNA clones containing NheI site at the last 
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adenine nucleotide of the 26mer poly(A) tail were linearised using the NheI enzyme and used as a 
template in reactions prior to DNA purification. The full length RNA transcript was generated by in vitro 
transcription reaction containing 200mM HEPES pH 7.5, 32mM magnesium acetate, 40mM DTT, 2mM 
spermidine, 7.5mM of each NTP, 60ng of linearised DNA template and 50μg/ml of T7 RNA polymerase. 
The reaction mix was then incubated at 37°C for at least 2 hours and was treated with DNaseI at a final 
concentration of 0.1 unit/µl (New England Biolabs) at 37°C for 30 minutes. The newly transcribed RNA 
was then precipitated with 2.5M of lithium chloride at -20°C for 30 minutes. The precipitated RNA was 
then resuspended in RNA storage solution (Ambion) after washing in 70% ethanol. The RNA transcripts 
used for reverse genetics recovery were subjected to post-transcriptional enzymatic capping using the 
ScriptCap system from Epicentre, according to manufacturer’s instructions. After capping, RNA was 
subsequently purified and precipitated in lithium chloride and was stored in RNA storage solution. 
Prior to transfection, all RNAs were normalised to a concentration of 1μg/μl in RNA storage solution 
(Ambion). For the recovery of MNV, 1ug of RNA was transfected into BSRT7 cells using lipofectamine 
2000. At 24 hours post-transfection of RNA, cells were freeze-thawed in -80°C to release virus particles 
and viral titre was determined using TCID50 on RAW264.7 cells. The expression of viral protein was 
analysed by western blot. 
2.11 Determining virus titre using TCID50 
The virus stock of an unknown titre was serial-diluted 10 fold using DMEM medium with antibiotics. A 
total of 8 dilutions were usually made, ranging from 10-1
 
to 10-8. 50μl of each dilution was transferred 
into 6 wells (along a row working down the plate) of a 96-well flat-bottomed plate. The viruses were 
subsequently overlayed with 1 X 104 RAW264.7 cells in 100μl DMEM and the plate was incubated for 5-7 
days until a significant cytopathic effect was observed. The virus titre (TCID50/ml) was determined by 
scoring the sign of the cytopathic effect and calculated using standard formulas (Reed &Muench, 1938). 
2.12 Total RNA extraction 
To extract the total RNA from infected or transfected cells, GenElute™ Mammalian Total RNA Miniprep 
Kit (Sigma Aldrich) was used according to the manufacturer’s instructions. The purified RNA was then 
quantified using spectrophotometer and qualitatively inspected by visualisation on agarose gel. 
2.13 Reverse transcription (RT-PCR) 
Reverse transcription (RT) was performed on the total RNA extracted from cells infected or transfected 
with the various clones. Moloney murine leukemia virus (M-MLV) reverse transcriptase (Invitrogen) was 
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used in the RT reaction according to the manufacturer’s instructions. The specific reverse sequencing 
primer IGIC128 (Table 2.1) was used as RT primer for the RT reactions. The desired or mutated region of 
the viral genome was then PCR amplified by primer 6831F and IGIC128 using GoTaq Flexi polymerase 
(Promega) according to the manufacture’s protocol. The PCR product was visualized on agarose gel. 
2.14 Cap affinity chromatography 
6x105 cells were lysed in 120µl CAP lysis buffer (1% TX100, 100mM KCl, 0.1mM EDTA, 10% glycerol, 
2mM MgCl2, 20mM HEPES pH7.6 and protease inhibitors cocktail). 100µl of the lysate was incubated 
with the prewashed cap-sepharose (Pharmacia) for two hours at 4⁰C to enable binding to take place and 
the remaining lysate was kept for western blot analysis. After the binding reaction, the cap sepharose-
bound proteins were centrifuged at 3000 x g for 5 minutes and the unbound proteins were removed by 
washing 3 times with CAP lysis buffer in the absence of 1% TX100. Subsequently, the sepharose-bound 
proteins or eIF4E-containing complexes were isolated and eluted with the SDS-PAGE-reducing sample 
buffer. The samples were finally subjected to an SDS-PAGE and were analysed by western blot. 
2.15 Tandem affinity purification of TAP derivatives 
The two expression systems, tetracycline inducible system (pCDNA6/TR and pcDNA4:TO NTAP or 
pcDNA4:TO CTAP) and cadimium chloride (CdCl2) inducible system (pMEP4-NTAP) were used to clone 
the genes of interest i.e. genes encoding MNV VPg, FCV VPg, RHDV VPg and NV VPg. Both inducible 
systems expressed a TAP tag (containing two protein G units and a streptavidin-binding peptide). For the 
CdCl2 inducible system, transfected 293T cells were selected with 50 μg/ml hygromycin B (Roche) and 
were later induced with 10 μM CdCl2 for 16 hours. For the tetracycline inducible system, 293 TREX cells 
were selected with 5μg/ml blasticidine and 200μg/ml zeocin, and were induced with 1µg/ml doxycycline 
(a tetracycline derivatives) prior to purification. 16 hours post-induction, the cells from 10x F175 flasks 
(approximately 3x107 cells/flask) were harvested and washed 3x in ice-cold PBS. The cell pellets were 
lysed in 5ml lysis buffer (50mM pH7.5 Tris-HCl, 125mM NaCl, 5% Glycerol, 0.2% NP-40, 1.5mM MgCl2, 
25mM NaF, 1mM Na3VO4 and protease inhibitor cocktail) for 10-15 minutes. Subsequently, the lysates 
were freeze-thawed twice (liquid nitrogen then 37⁰C water bath) and spun in a 4⁰C centrifuge at 13,000 
x g for 10 minutes. A 20µl sample (sample 1) was kept for further analysis. 
For the first immunoprecipitation, the cleared lysates were incubated with 400μl of packed rabbit IgG 
agarose beads (previously washed in lysis buffer) at 4⁰C overnight. The reactions were spun at 1245 x g 
and the supernatant was removed and kept for analysis (sample 2). The collected beads were washed 3 
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times with 1ml of lysis buffer followed by three washes in TEV-protease cleavage buffer (10mM pH7.5 
Tris-HCl, 100mM NaCl, 0.2% NP-40). The bound protein was treated with 20 units of TEV protease (2μl) 
in TEV buffer (Invitrogen) according to the manufacturer’s instructions and incubated overnight at 4⁰C. 
Before the addition of enzymes, a 20ul sample including the beads, was kept for analysis 
For the second immunoprecipitation, IgG beads were spun at 1245 x g. A 20μl supernatant containing 
the cleaved protein was kept for analysis and the remaining beads were added to 250μl lysis buffer. The 
beads were resuspended and spun repeatedly three times. The supernatant samples containing the 
cleaved protein were pooled after each round of washing, while the remaining beads were retained as 
sample 5. The collective supernatant was incubated with 80ul packed Ultralink Immobilized Streptavidin 
Plus (Pierce) beads (20µl of supernatant (sample 4) was kept for analysis). After overnight incubation, 
the reactions were spun at 1245 x g. The supernatant was kept for analysis (sample 6), while the beads 
were washed 3 times in lysis buffer. The SBP-tagged proteins were subsequently eluted by incubating 
1mM D-biotin in 500µl PBS overnight at 4⁰C. The beads were spun at 1500 x g and the elution with fresh 
biotin buffer was repeated by incubating for a further 3 hours. The pooled supernatant was 
concentrated using VivaSpin 500TM column (Vivascience) and labelled as sample 7. The remaining 
Streptavidin beads were resuspended with the reducing sample buffer and referred to as sample 8, and 
retained to measure the efficiency of the biotin elution.  
The concentrated elute S7 was run on a reducing SDS-PAGE gradient gel and silver-stained to examine 
the presence of VPg and its associated proteins after purification. Once purified, the sample was 
subjected to SDS PAGE gel electrophoresis and the resolved gel was subsequently stained with 
coomassie-blue. The purified proteins were finally identified by mass spectrometry (Genome Quebec 
Innovative centre, McGill University) for protein identification. 
2.16 Capture enzyme-linked immunosorbent assay (Capture ELISA) 
To assess any direct binding between eIF4E-HIS and various derivatives of VPgs, an ELISA-based binding 
assay was preformed. The proteins examined included the wild type and F123A mutant form of Cherry-
MNV VPg-HIS, HIS-4E-BP1 and Cherry-MNV ORF4-HIS, which were previously made by our lab members 
(note that the recombinant HIS-4E-BP1 and Cherry-MNV ORF4-HIS proteins were used as positive and 
negative controls respectively) 
Briefly, the recombinant VPg proteins and the controls (2µg/well in 100µl ELISA diluents containing 
20mM HEPES pH7.6, 0.1mM EDTA, 10% Glycerol, 100mM KCl, 1mM DTT) were coated on the wells of an 
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enzyme-linked immunosorbent assay (ELISA) plate overnight at 4°C, and the wells were blocked with 5 
µg BSA for an hour. After incubation, eIF4E-HIS was serially-diluted in ELISA diluent with 0.1% FCS and 
Tween20. The diluted proteins were then transferred to the target coated plate and incubated for 1-
2 hours at 4°C. The interaction of eIF4E with VPg was determined using an anti-eIF4E antibody and 
peroxidase-labelled goat anti-mouse immunoglobulin G (IgG). The wells were washed three times with 
ELISA diluents plus 0.1% FCS and 0.1% Tween20 between incubations and subsequently, 50μl of TMB 
substrate (Pierce) was added. Finally, 50μl of 0.5M HCl was added to the plate to stop the enzymatic 
reaction, and the plate was read at 450nm absorbance.  
2.17 Identification of the minimal VPg binding domain within eIF4GI 
Constructs expressing the truncated eIF4G proteins, N-FAG, C-FAG, M-FAG, p100 and 4GM (pET28a:HIS 
N-FAG1-532, pET28a:HIS C-FAG 1177-1600, pET28a:HIS M-FAG 533-1176, pET28a:HIS p100 675-1600, pET28a:HIS 
4GM 654-1131) (Ling, 2005; Bushell, 2000) were co-transfected with either an infectious clone of wild type 
MNV (pT7:MNV 3’RZ ) or an MNV mutant with alanine substitution at position F123 of the VPg protein, 
F123A (pT7:MNV 3’RZ F123A) into FPV-infected BSRT7 cells using lipofectamine 2000 (Invitrogen). The 
empty plasmid, pcDNA3.1+ was used as a negative control. 24 hours post-transfection, the cells were 
lysed in 120µl of a standard CAP lysis buffer (1% TX100, 100mM KCl, 0.1mM EDTA, 10% glycerol, 2mM 
MgCl2, 20mM HEPES pH7.6 and protease inhibitor cocktail).  
The clear lysate was then added to the prewashed Ni-CAM beads (25 µl bead volume) with 120µl of CAP 
lysis buffer (without 1% TX100). The reaction mix was incubated in a rotator at 4°C. After overnight 
incubation, the beads were washed five times using a higher ionic strength of CAP buffer (200mM KCl, 
0.1mM EDTA, 10% glycerol, 2mM MgCl2, 20mM HEPES pH7.6) in the absence of TX100. The supernatant 
was discarded and the protein-beads complex was subsequently resuspended in 45µl of reduced protein 
sample buffer (0.5M Tris-HCl (pH 6.8), 4.4% (w/v) SDS, 20% (v/v) glycerol, 2% (v/v) 2-mercaptoethanol, 
and bromophenol blue in distilled water). The purified protein was resolved in an SDS-PAGE gel and 
analysed by western blotting. The expression of HIS-eIF4G fragments and VPg were detected by anti-HIS 
and anti-VPg antibodies respectively. 
2.18 Determining the direct interaction between the central domain of eIF4G 
and VPg using HIS- pull down assay 
Constructs encoding truncated eIF4G proteins, C-FAG and 4GM (pET28a: HISC-FAG 1177-1600 andpET28a: 
HIS4GM 654-1131) were driven by a T7 promoter and expressed in an E.coli-based cell-free protein 
                                                             P a g e  | 78 
 
expression system (Promega). The production of the recombinant proteins was carried out according to 
the manufacturer’s protocols.  The reaction mix was then incubated in a 37°C shaker for an hour. After 
incubation, the cell extract was mixed with CAP lysis buffer (1% TX100, 100mM KCl, 0.1mM EDTA, 10% 
glycerol, 2mM MgCl2, 20mM HEPES pH7.6 and protease inhibitors cocktail). The protein extract was 
subsequently mixed with pre-washed Ni-CAM beads. After overnight incubation, the beads were 
washed twice using CAP buffer. Subsequently, 8μg of the non-tag MNV VPg protein was added to the 
protein-coupled beads, which were left to incubate at 4°C in a rotator for four hours. The protein-
coupled beads were washed four times with a higher ionic strength of CAP lysis buffer (1% TX100, 
200mM KCl, 0.1mM EDTA, 10% glycerol, 2mM MgCl2, 20mM HEPES pH7.6) to remove any non-specific 
protein associated with them. The final precipitated protein sample was fractionated using a SDS-PAGE 
gel. The binding of HIS-eIF4G fragments and VPg was analysed by a western blot and were detected by 
anti-HIS and anti-VPg antibodies. 
2.19 Silencing of eIF4GI and eIF4GII using siRNA 
For the transfection of 293T cells with siRNA, 6.3x105 of cells in DMEM +10%FCS were seeded in poly-L 
lysine pre-treated 6-well plates. After five hours, 250pmole of siRNA (eIF4GI siRNA: 5’-CCC-AUA-CUG-
GAA-GUA-GAA-G- 3’; eIF4GII siRNA: 5’-CAA-AGA-CCU-GGA-CUU-UGA-3’; NS siRNA: 5’- GCG-CGC-UUU-
GUA-GGA-UUC-G-3’) were transfected into the cells using lipofectamine 2000 according to the 
manufacturer’s protocol. After overnight incubation at 37⁰C, the cells were re-seeded after being 
counted with trypan blue and re-transfected with the same set of siRNAs (250pmole). 24 hours after the 
second transfection, cells were seeded in various size dishes to enable the effect of siRNA mediated 
depletion on viral protein production, viral RNA levels and viral titre; 8x105 cells were seeded per well of 
a 6-well plate used for western blot analysis;  4x105 cells were seeded in a 12-well plate prepared for 
RNA quantification using quantitative PCR(qPCR).; and 2x105 cells were seeded in a 24-well plate for 
samples of infectious virus used for quantifying the virus yield. After the cells were settled, they were 
transfected with infectious VPg-linked RNA (40ng of RNA for cells in the 6-well plate; 20ngRNA for cells 
in the 12-well plate and 10ng RNA for cells in the 24-well plate) using lipofectamine 2000. The 
transfection procedure was followed according to the manufacturer’s protocol.  
Samples were collected at 0, 11, 16 hours post-transfection. Samples from the 6-well plate were lysed 
with RIPA and the protein expression was determined using western blotting. The expression of eIF4GI 
and eIF4GII were detected by anti-eIF4GI (15704-1-AP, ProteinTech group) and anti- eIF4GII antisera 
(Luis Carrasco ,Centro de Biología Molecular Severo Ochoa CSIC-UAM) respectively, while the expression 
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of GAPDH and NS7 was detected by anti-GAPDH (AM4300, Ambion applied biosystems) and anti-NS7 
antisera. The level of protein expression was quantified by densitometry (Image J or LI-COR imaging 
system). Samples from the 12-well plate were subjected to RNA extraction using GenEluteTM system, 
which was later used to measure the viral genomic RNA synthesis by qPCR. Samples from the 24-well 
plate were freeze-thawed and later used to determine the viral titre by TCID50 on RAW264.7 cells. 
To analyse the effect of siRNA on cellular translation, the cells were transfected with a 5’cap-CAT-PTV 
IRES-fLuc bicistronic RNA reporter 24 hours after the re-transfection of siRNAs. At 6 hours post-
transfection of the RNA reporter, the cells were lysed and analysed by western blot. 
2.20 RT- qPCR 
The total RNA extracted from each time point was then used to determine the copy number of genomic 
RNA using two-step reverse transcriptase quantitative PCR (RT-qPCR). The cDNA synthesis was 
performed using M-MLV reverse transcriptase (Promega) with the IGIC464 primer, and the newly 
synthesised DNA templates were subjected to qPCR using the Mesa Blue qPCR Mastermix for SYBR assay 
(Eurogentech) using the primers IGIC464 and ICIG 465. 
Briefly, a viral standard genomic RNA that corresponds to approximately the first 1200 nucleotides was 
previously prepared by in vitro transcription reaction and quantified by my colleague Dr Surender 
Vashist. The original stock of RNA standard contained 1011 viral genome copies/μl, which  was 
subsequently diluted by performing 10-fold serial dilutions in RNA dilution buffer (10ng/µl yeast RNA, 
Ambion Cat #AM7118) to give viral RNA standards ranging between 108 and 103 genome copies per μl. 
For each RNA sample, M-MLV reverse transcriptase (Invitrogen) was used in the RT reaction according 
to the manufacturer’s instructions. Thereafter, qPCR reactions were carried out in duplicate using the 
MESA Blue qPCR MasterMix Plus for Syber Assay (Eurogentech) and transferred onto 96-well qPCR 
plates (Thermo Scientific). 20 ng of the RNA samples or 1 μl of each diluted viral RNA standard was 
mixed in 20 μl reactions containing the MNV genomic primers IGIC464 and ICIG 465. Reactions 
containing ddH2O and RNA dilution buffer were used as a control. DNA was amplified in a real time PCR 
machine (ABI 7900 ) using a 10 min heat denaturing step (95°C for 10 min) followed by 40 cycles of 94°C 
for 15 sec,58°C for 30 sec and 72°C for 30 sec). The viral genome copy number was calculated by 
interpolation from the standard curve that was generated using serial dilutions of standard RNA. The 
detection limit was established by setting the threshold of detection to the values seen by qPCR reaction 
of a negative control i.e non-infected cell sample.  
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2.21 Analysis of the effect of 4E-BP1 overexpression on the eIF4G-eIF4E 
complex 
The plasmids, pcDNA3-HA-4E-BP1-WT, pcDNA3-HA-4E-BP1-4A and pcDNA3.1+ (empty vector as a 
negative control) were used (Burgui et al., 2007). 0.5μg of the plasmids was transfected into BV2 cells 
(6x106 cells) using NEON transfection system as described above. Immediately after transfection, the 
cells were resuspended into fresh maintenance medium (DMEM+ 10% FCS+ 1% NaHCO3 + 1% L-
glutamine) and seeded on a 6-well plate. After 6 hours of incubation at 37⁰C with 10% CO2, the cells 
were harvested and lysed in cap lysis buffer. The samples were then subjected to a standard cap affinity 
chromatography. Finally, the expression of 4E-BP1 derivatives was detected by anti-HA antibodies 
(A5477, Sigma) and quantified by densitometry (ImageJ). 
2.22 Analysis of the effect of 4E-BP1 overexpression on MNV mRNA translation 
6x106 BV2 cells were transfected with 0.5μg of DNA (pcDNA3-HA-4E-BP1-WT, pcDNA3-HA-4E-BP1-4A 
and pcDNA3.1+) as described in section 2.21 and were infected with MNV at an m.o.i of 3 at 2 hours-
post transfection. The cells were incubated at 37⁰C for an hour and washed with fresh medium. 
Subsequently, they were plated on an appropriate tissue culture plate. Samples were then extracted at 
9, 12, and 20 hours post-transfection, and were later used to determine the protein expression, genomic 
RNA copy number and viral titre. The expression of 4E-BP1 derivatives was detected by anti-HA 
antibodies (A5477, Sigma) and the level of expression was quantified by densitometry (Image J or LI-COR 
imaging system). To measure the cellular translation, the cells were transfected with 0.5μg of 5’cap-CAT-
PTV IRES-fLuc bicistronic RNA reporter 12 hours after transfection of the DNA construct. At 6 hours post-
transfection of the RNA reporter, the cells were lysed and analysed by western blot. 
2.23 In vitro translation and CAT/fLuc assay 
Briefly, the 5’cap-CAT-PTV IRES-fLuc bicistronic RNA was in vitro transcribed from XhoI linearised 
pGEM:Cap-CAT:PTV IRES-fLuc plasmid whereby the 5μl of DNA was incubated with a 45μl of reaction 
mix containing 200mM HEPES pH7.5, 32mM magnesium acetate, 40mM DTT, 2mM spermidine, 7.5mM 
of each NTP (ATP, UTP, GTP and CTP), 40 unit of RNAse inhibitor (Promega), 250ng of DNA template and 
5l of T7 RNA polymerase (0.5mg/ml). The reaction was incubated at 37⁰C for at least 2 hours. 
Thereafter, the reaction mix was treated with 2μl of DNaseI for 30 minutes at 37⁰C. The quality of the 
newly-synthesised RNA was purified using lithium chloride as described previously and was resuspended 
in 40μl of RNA storage solution. The transcribed RNA was capped according to the manufacturer’s 
                                                             P a g e  | 81 
 
protocol using a ScriptCAPTM m7G capping system (Epicentre). 1μg of the 5’cap-CAT-PTV IRES-fLuc 
bicistronic RNA was transfected into the examined cells using a NEON system. At 6 hours post-
transfection, the cells was lysed and subjected to western blot. The expression of CAP and fLuc was 
detected by anti-CAT and anti-fLuc antibodies, and quantified by densitometry (Image J or LI-COR 
imaging system). 
  
                                                             P a g e  | 82 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 3: Identification of MNV 
and FCV VPg-binding peptides 
through phage display 
 
                                                             P a g e  | 83 
 
3 Introduction 
As an RNA virus, noroviruses exist as a spectrum of genetically related variants with different degrees of 
fitness, known as viral quasispecies (Domingo and Holland, 1997; Domingo et al., 1997). The dynamic 
population of this virus is due to the error-prone nature of the RNA polymerase, NS7 during RNA 
replication (Steinhauer et al., 1992). The existence of human norovirus quasispecies enables the virus to 
adapt to a rapidly-changing environment and escape from the host immune system (Coffin, 1995; 
Domingo et al., 1996; Eigen, 1993).  However, such dynamic variants are thought to hamper the 
development of a vaccine due to high degree of genetic variation. Given that cross protection has not 
been demonstrated in human volunteer studies (Lindesmith et al., 2005), a multivalent vaccine may be 
required to target all norovirus genogroups (LoBue et al., 2006). Furthermore, protective immunity 
against primary human norovirus infection is short-lived (Parrino et al., 1977), which complicates the 
development of effective vaccines. As a protective measure against the spread of the virus, quarantine is 
rather costly and economically impractical, therefore antiviral therapy is another possible approach to 
control norovirus outbreaks. Potential antiviral therapies could target host factors involved in virus-
specific processes, such as translation. However, the drawback of such a therapy is their detrimental 
effects on the host cells. Given that norovirus translation initiation is a virus-specific process, which 
requires VPg to recruit translation initiation factors, targeting this process as an antiviral strategy would 
potentially inhibit viral translation whilst avoiding detrimental bystander effects on the host cells. To 
date, there are no licensed antivirals against noroviruses, thus targeting the virus-specific VPg as a key 
protein involved in viral translation and replication, perhaps using peptide inhibitors, may be an 
attractive antiviral therapy. 
Phage display is a powerful selection tool often used to identify peptides with specific binding properties 
from a large phage library displaying many genetically engineered peptide variants. This method relies 
on using a target protein to affinity purify phage that display binding peptides on their surface. The 
purified phage are then propagated in Escherichia coli (E. coli) and the process repeated. In this way, 
peptides that bind specifically to a target in vivo and in vitro can be selected and used as inhibitors, 
without any knowledge of the structural and chemical properties of the target protein (Sidhu, 2000; 
Sidhu, 2001). 
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3.1 Overview of phage display 
A phage display peptide library was used in this study in an attempt to select small peptides that 
selectively block the function of VPg. The aim of identifying anti-VPg peptide was to either use them 
directly as a possible anti-viral therapy against norovirus infection or by enabling the identification of 
functional sites on VPg that could then be targeted with small molecule inhibitors. If peptides that bind 
and inhibit VPg could be identified, they could then be used to develop a high throughput assay to 
identify small molecules that prevent the binding of the peptide to VPg by potentially binding the same 
site on VPg. The peptide library, purchased from New England Biolabs, consisted of a large collection of 
phage, with different 12-mer peptide sequences displayed on the coat protein, pIII of the M13 
filamentous bacteriophage. Each phage presents five copies of displayed peptides clustered at its end. 
This diverse peptide library had about 4.1x1015 different 12-mer polypeptides, and the input number of 
phage in any one experiment was typically 1011. In order to isolate the members of the library that 
bound to the target, the target was coated onto a solid support such as a plate or affinity resin, and then 
incubated with the library as depicted in figure 3.1. The phage that had desirable binding property for 
the target protein bound to the solid support via the target protein, while the non-binding phage would 
be removed by subsequent washing steps. Any bound phage can then be eluted and propagated in the 
E. coli ER2738 host, and each round of amplification would selectively enrich phage with favourable 
binding properties for VPg. This affinity selection process is called panning. To obtain an optimal 
selection of phage with the desired properties against the target protein, in this case VPg, panning is 
usually repeated multiple times. Furthermore, negative selection can be performed to remove any 
phage with undesired properties such as any off-target binding to resin or plate. After multiple rounds of 
panning, the selected phage are then screened to examine the individual binding properties to the 
target protein by affinity binding assay i.e. ELISA assay. The amino acid sequences of peptides displayed 
on the particular phage are subsequently determined by sequencing the coding region of the phage 
DNA. 
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Figure 3.1 Overview of the process of phage display. A library of M13 phage displaying variants 
of 12-mer peptides (supplied by a Ph.D.-12™ Phage Display Peptide Library kit) was used to 
isolate peptides with an affinity to the protein target VPg. The target was immobilised on a solid 
support such as A) an ELISA plate, or B) affinity resin. Those phage displaying peptides with an 
affinity to the target were bound to the solid support, while the unbound phage were removed 
by a subsequent washing step. The bound phage were ultimately eluted and amplified in E.coli. 
This process of isolating members of phage-displayed peptides bound to the target is called 
panning, and this was repeated several times for an optimal selection of phage with the desirable 
properties against the target. Two panning approaches were used in this study; plate-binding and 
solution-binding panning, whereby the target was immobilised on A) an ELISA plate or B) Ni-CAM 
agarose beads respectively. After several rounds of panning, individual clones isolated from the 
phage pool were sequenced to determine the peptide sequence and were characterised for their 
reactivity with the target by ELISA.  
 
Washing to remove unbound phage
Elution of bound phage
PHAGE CHARACTERISATION
Phage amplification
Phage
A) ELISA plate 
B) Affinity beads such 
as Ni-CAM agarose
PANNING
Phage bound to target protein
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3.2 Identification of potential VPg binding peptides using a solution-binding 
panning approach 
The initial attempt to identify phage that bound MNV or FCV VPg using a solution-binding panning 
approach, whereby the C-terminal HIS-tagged VPg protein (MNV VPg-HIS or FCV VPg-HIS) was bound to 
Ni-CAM agarose beads before the panning. As a positive control, ultra-linked streptavidin agarose was 
utilised to validate the efficiency of the panning process, as elution could be performed with biotin, the 
natural ligand which is known to identify peptides with the consensus HPQ (Devlin et al., 1990; Gissel et 
al., 1995). This control experiment was performed by my lab colleague, Amir Yunus alongside with my 
experiment. Prior to each round of solution-binding panning, a negative selection was performed 
against nickel (Ni-CAM) agarose beads to minimise the chance of selecting phage with a high specificity 
for the nickel agarose. The negatively selected phage were then incubated with VPg-coated resin. After 
the binding reaction, the phage-protein complexes were extensively washed to remove any non-
specifically bound phage. The phage that bound to the target protein were eluted with imidazole and 
propagated in E. coli. A total of three rounds of solution-binding panning were carried out to enrich the 
phage displaying a specific VPg-binding sequence motif after the negative selection (figure 3.2). 
The amount of phage eluted at each round of panning increased by 10 to 100 fold indicating the phage 
were enriched (data not shown). After the third round of panning, the phage pools were amplified and 
were used in the binding assay to determine if VPg binding phage had selected. The phage pool was 
incubated with VPg coupled Ni-CAM beads or Ni-CAM beads alone. After extensive washes and specific 
elution with imidazole, the eluted phage was titrated. The result revealed that the phage titres from 
both selections were similar, indicating that the phage selected against either the FCV VPg-HIS or MNV 
VPg-HIS fusion proteins did not specifically bind to VPg, despite the fact that the phage were negatively 
selected with Ni-CAM resin prior to panning. The individual phage clones were selected from the phage 
pool and sequenced after the final round of panning. Peptide sequence analysis illustrated that there 
was no consensus sequence among any of the isolated phage clones (table 3.1), although sequencing 
reactions of five clones isolated from the library of FCV VPg-binding phage were not of sufficiently high 
quality to ensure certainty of this. Interestingly, the sequence of the isolated phage indicated they were 
histidine rich. This suggested that they were isolated due to the affinity of histidine for the Ni-CAM 
agarose, rather than by virtue of binding to VPg (table 3.1). In contrast, all phage clones that were 
isolated from the streptavidin panning, as the positive control, predominately displayed the conserved 
peptide HPQ motif sequence (table 3.1). This data is consistent with previous reports of phage display 
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showing the HPQ motif is the most conserved sequence displayed on steptavidin-binding phage (Devlin 
et al., 1990). In conclusion, although a VPg-binding peptide was not found using the solution-binding 
approach, the panning process against strepavidin was successful, confirming that the phage display 
library was functional and could be used to identify the VPg-binding phage.  
 
 
Figure 3.2 Overview of the solution-binding process. Before panning was carried out, a negative 
selection was performed to reduce the isolation of phage with a high affinity for resin, whereby 
the phage library was incubated with Ni-CAM agarose. Meanwhile, the target proteins (MNV 
VPg-HIS or FCV VPg-HIS) were immobilised with Ni-CAM resin. Thereafter, the negatively selected 
phage were exposed to the protein-resin complexes. Subsequently, the unbound phage were 
removed by extensive washing and those phage that specifically bound to VPg-resin complexes 
were eluted using imidazole. The isolated phage were then amplified in E. coli. This panning 
process was repeated twice, and streptavidin served as a positive control for the experiment.  
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unbound phage
Phage  elution
Phage characterisationAmplification of 
the eluted phage
Binding to VPg-coated Ni-
CAM agarose
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Ni-CAM agarose.
VPg 
coupled to 
beads
Phage
Ni-CAM 
agarose
3 rounds of 
panning
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Table 3.1 The peptide sequence of phage clones using a plate-binding panning approach. The 
phage clones selected from the third round of panning against VPg were isolated. The peptide 
displayed on the phage was sequenced to identify the consensus motif. A) The sequence of ten 
clones selected against MNV VPg. B) The sequence of individual clones selected against FCV VPg. 
Histidine is highlighted in dark grey. C) Individual clones selected from the positive control 
streptavidin were sequenced, and they shared a consensus HPQ motif (highlighted as pale grey 
colour).  
A
B
C
CLONE INSERT SEQUENCE
M1 I P H H H T N V H K H S
M2 S A W H S H P P X E A W
M3 H V Y N N H F T S P A
M4 H H W A H Q P V V T X T
M5 A H M R H V P V G H G S
M6 S H T S H A G P Y H M L
M7 E L L H L S H N A V R S
M8 Q P L H F R T T P H W G
M9 S I H S L T S L P L S K
M10 G L T X V N R P P H H L
CLONE INSERT SEQUENCE
F1 Q S F S T N V L H T H H
F2 S S S V N S S H H I H R
F3 H S L S H N P Y S T P S
F6 F E G T H K Q Y P A H S
F7 H I H M A P T S K H I D
CLONE INSERT SEQUENCE
Steptavidin  1-
10 S T Y F D P H G T H P Q
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3.3 Identification of potential VPg-binding peptides using a plate-binding 
panning approach 
 
As VPg-binding peptides were not identified using a solution-binding panning approach, a plate-binding 
approach was preformed, whereby the HIS-tagged derivatives of MNV or FCV VPg were immobilised on 
an ELISA plate. The peptide library and the total amount of phage input into each round was the same as 
that used in the solution-binding approach. The major difference between the solution- and plate-
 
Figure 3.3 Overview of the process of plate-binding panning. The target proteins, MNV or FCV 
VPg, were immobilised on an ELISA plate.  After the targets were coated on the plate, a phage 
display peptide library was added. Any phage which did not bind to VPg were removed by 
extensive washing, while the bound phage were eluted using glycine after the washing 
procedure. The eluted phage were then amplified in E. coli. This panning process was repeated 
five times.  A negative selection was performed at the beginning of each round of panning 
(except the first round), whereby the phage pool was exposed to BCA coated on an ELISA plate. 
Streptavidin was used as a positive control of the experiment, and phage bound to the 
streptavidin were eluted using biotin.  
Washing
Elution of any bound phage
Phage characterisationPhage amplification
Phage
VPg on ELISA 
plate
Binding to VPg-coated plate
Panning up to 
five times
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binding panning approaches was that VPg was coupled on Ni-CAM resin and an ELISA plate respectively; 
therefore, phage bound to the plate-immobilised VPg were eluted by glycine. After the affinity selection 
of the VPg-binding phage, the phage were amplified and titrated, and used for subsequent rounds of 
panning (figure 3.3). In addition, several conditions were changed in every round of panning to increase 
the stringency of the selection; for example, increasing the concentration of Tween-20, reducing the 
binding period of the phage with target proteins and increasing the duration of negative selection and 
number of rounds of panning (table 3.2). From the third round of panning onward, the amount of VPg 
coupled on a plate was also reduced to optimise the affinity selection of the VPg-binding sequence 
displayed on the phage. In total, five rounds of panning of the 12-mer phage library were performed as 
detailed in table 3.2.  
 
As a positive control, streptavidin was immobilised on a plate and streptavidin-binding phage were 
eluted by biotin. Table 3.3 summarises the titre of phage used in panning, the yield of phage selected 
after panning, and the titre of the amplified stocks after each round of panning. The titre of phage 
isolated after the initial rounds of panning was reduced, suggesting that affinity selection of the phage 
displaying a favourable peptide sequence had occurred. The rise in phage titre after round three 
indicated that phage with a high specificity of VPg was possibly being enriched. 
 
Table 3.2  Selection conditions for plate-binding selection of VPg binding phage. The conditions 
were changed during five rounds of panning.  The conditions of the third, fourth and fifth round 
of panning remained the same. a A negative selection was performed whereby phage were 
exposed to BSA overnight; b A negative selection was performed three times whereby phage 
were exposed to BSA overnight  in the first round, two hours in the second round and one hour 
in the final round of panning. 
Round 1 Round 2 Round 3 Round 4 Round 5
% of Tween 20 in TBS 0.1 0.3 0.5 0.5 0.5
Incubation time for phage-
protein binding reaction (mins)
60 15 5 5 5
Number of rounds of negative 
selection
0 1 
(a)
3 
(b)
3 
(b)
3 
(b)
Amount of VPg (μg) 1.5 1.5 0.5 0.5 0.5
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To examine whether the phage pool isolated from the fifth round panning against the MNV and FCV VPg 
could bind to the respective targets, an ELISA was preformed as described in methods and materials. 
Briefly, MNV or FCV VPg was immobilised on an ELISA plate, and the selected phage pool was tested for 
its ability to bind VPg by ELISA using antisera to M13 to detect phage binding. The phage pool was also 
examined for any off-target binding by testing the ability to bind BSA. These data indicated that the 
phage pool panned against MNV or FCV VPg specifically bound to the respective target, but did not bind 
to BSA. In addition, the phage pool selected against MNV VPg bound better than those panned against 
FCV VPg (figure 3.4). The phage pool from the fourth round of panning against streptavidin was also 
examined for binding ability to streptavidin and this pool was found to bind to its target, but not to BSA, 
indicating that the phage displayed a streptavidin-binding peptide (data not shown). This binding assay 
also correlated with the peptide sequence analysis, where a typical streptavidin-binding motif, HPQ, was 
identified from 10 individual clones (data not shown). 
 
Table 3.3  Phage yield and titre during the plate-binding panning for VPg-binding phage. After 
panning against MNV VPg, FCV VPg and streptavidin as the positive control, the eluted phage 
were titred before and after amplification in the E. coli host. After amplification, the phage were 
used in the subsequent round of panning, indicated as phage input. A) Phage yield and titre of the 
FCV or MNV VPg-binding phage. B) Phage yield and titre panned against the positive control, 
streptavidin. 
 
A
B
Unamplified 
phage (pfu/ml)
Amplified phage
(pfu/ml)
Unamplified 
phage (pfu/ml)
Amplified phage
(pfu/ml)
1
st
1 x 10
11
2.50 x 10
8
1.12x 10
13
5.20 x 10
7
8.32 x 10
13
2
nd
1 x 10
11
4.47 x 10
6
9.85 x 10
12
2.83 x 10
6
1.23 x 10
13
3
rd
1 x 10
11
2.00 x 10
6
6.50 x 10
12
1.85 x 10
7
5.70 x 10
12
4
th
1 x 10
11
3.67 x 10
7
4.20 x 10
12
1.71 x 10
8
4.90x 10
12
5th 1 x 1011 1.86 x 108 5.60 x 1012 1.07 x 1010 3.10 x 1012
Number of
panning
MNV VPg FCV VPgPhage 
input 
Unamplified 
phage (pfu/ml)
Amplified phage
(pfu/ml)
1
st
1 x 10
11
1.9 x 10
8
1.0 x 10
13
2
nd
1 x 10
11
8.0 x 10
7
1.3 x 10
13
3
rd
1 x 10
11
2.5 x 10
6
5.1 x 10
12
4
th
1 x 10
11
1.5 x 10
7
8.3 x 10
12
5th 1 x 1011 - -
Number of
panning
Phage 
input 
Streptavidin
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To determine the consensus VPg-binding motif, 10 clones isolated from the final round of panning 
against MNV or FCV VPg were sequenced (table 3.4). Most of the peptide sequences were longer than 
the expected 12-mer peptide, with the exception of the MNV VPg binding phage clone M5, and the FCV 
VPg binding phage clone F5.  Sequence analysis of these two clones suggested that the phage contained 
a single insert (table 3.4), which correlated with the PCR data (data not shown). This is likely a 
consequence of multiple sequences inserted into the M13 genome during cloning, whereby these clones 
had picked up and ligated more than one insert. In addition, information from the supplier has 
  
Figure 3.4 Characterisation of phage using an ELISA assay. A) The amplified phage pool panned 
against MNV VPg was characterised by examining its reactivity to MNV VPg and BSA as a negative 
control using an ELISA assay. B) The amplified phage pool panned against FCV VPg was 
characterised by examining reactivity for FCV VPg and BSA as a negative control. The binding 
activity of phage with the target protein was detected by an HRP-conjugated anti-M13 phage and 
was quantified at 450nm using a plate reader to measure the absorbance. The experiment was 
assayed in triplicate. 
A
B
Fifth round of phage pool
6 7 8 9 10 11
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0
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mentioned that affinity selection of phage displaying multiple inserts would occur if the target protein 
preferentially binds to longer ligands. Our sequencing data revealed that the clones displaying long 
peptide sequences were found to have two inserts (table 3.4), suggesting that both FCV and MNV VPg 
selectively bind to longer peptides. Table 3.4 showed that eight clones (clone M2, M3, M4, M6-M10) 
isolated from the phage pool panned against MNV VPg and nine clones (clone F1-F4, F6-F10) selected 
against FCV VPg displayed a longer peptide sequence than expected (table 3.4B). It is worth noting that 
the MNV VPg binding phage clone M1 did not have an insert (data not included in the table). It has been 
suggested from the supplier that clones which did not express the pIII fusion protein grew better, 
therefore their number increased with each round of panning. 
Based on the alignment of the amino acid sequence, six clones (e.g. clone M3, M4, M7-M10) isolated 
from panning against MNV VPg shared an identical sequence of (WPALSTTHSDCCKGSKSQTTKKRY). 
Interestingly, clone M2 together with these six identical clones shared a conserved core motif 
indentified as Lys-Lys-Arg (KKR), while M2 and M6 had a core conserved peptide sequence that is Arg-
Arg-Asn (RRN) or Lys-Arg-Lys (KRK), as shown in table 3.4A. Peptide sequence analysis also revealed that 
there is sequence homology among clones F1-4 and F6-10 panned against FCV VPg (table 3.4B). Nine out 
of ten clones had an identical peptide sequence of ISPTTPASLETVREQTPLYPGSKR. It is clear that FCV VPg 
bound to phage with longer peptides, similar to MNV VPg bound phage. As expected, sequence analysis 
of the streptavidin-binding phage clones predominantly produced a single conserved HPQ motif 
sequence (table 3.4B). 
To investigate whether or not the isolated phage clones exhibited a specific binding capacity for MNV or 
FCV VPg, an ELISA assay was preformed, whereby the target proteins, either MNV or FCV VPg, were 
immobilised on a plate and later incubated with phage clones. After the binding reaction of the phage 
with the respective VPg, the bound phage were detected by anti-M13 phage antisera. In this 
experiment, MNV VPg binding phage M2, M3, M4, M5 and M6 and FCV VPg binding clones F4, F5, and 
F6 were individually examined for their binding activity to their respective target proteins. For MNV-VPg, 
clones M7-10 were excluded from the assay as they had the same peptide sequence as M3 and M4, 
whilst for FCV VPg F1-F3 and F7-F10 were excluded on the basis that their sequence was identical to the 
examined F4 and F6. Prior to the ELISA assay, all examined clones were subjected to large-scale 
amplification, purification and titration.  
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Table 3.4  Characterisation of phage using an ELISA assay. A) The peptide sequence of 10 phage 
clones derived from panning against MNV VPg after the fifth round of selections. All peptide 
sequences contained a multiple insert, with the exception of clone 5. Clone 1 was not included in 
the table, since it did not have an insert. Clones 3, 4, 7, 8, 9 and 10 shared the same peptide 
sequence, which suggests that this is the most favourable VPg-binding sequence. These clones 
together with clone 2 shared a conserved core sequence, the KKR motif that is highlighted in a 
dark grey colour. B) The peptide sequence of 10 phage clones derived from panning against FCV 
VPg after the fifth round of selections. All peptide sequences contained multiple inserts except 
clone 5. Other than this, all phage clones shared the same peptide sequence, suggesting that this 
may be the most favourable conserved sequence that bound to FCV VPg. 
A
B
C
CLONE
F1 I S P T T P A S L E T V R E Q T P L Y P G S K R
F2 I S P T T P A S L E T V R E Q T P L Y P G S K R
F3 I S P T T P A S L E T V R E Q T P L Y P G S K R
F4 I S P T T P A S L E T V R E Q T P L Y P G S K R
F5 A H Q F N T H A L P V R
F6 I S P T T P A S L E T V R E Q T P L Y P G S K R
F7 I S P T T P A S L E T V R E Q T P L Y P G S K R
F8 I S P T T P A S L E T V R E Q T P L Y P G S K R
F9 I S P T T P A S L E T V R E Q T P L Y P G S K R
F10 I S P T T P A S L E T V R E Q T P L Y P G S K R
FIRST INSERT SECOND INSERT
CLONE INSERT SEQUENCE
Steptavidin  
1-10 S T Y F D P H G T H P Q
CLONE
M2 L E A T G H R P S R G S S M I K K R K P S H F P
M3 W P A L S T T H S D C C K G S K S Q T T K K R Y
M4 W P A L S T T H S D C C K G S K S Q T T K K R Y
M5 H P H Y R H L G T A L P
M6 G Y A E I E K N N N P P K P R R N H D S R P I D
M7 W P A L S T T H S D C C K G S K S Q T T K K R Y
M8 W P A L S T T H S D C C K G S K S Q T T K K R Y
M9 W P A L S T T H S D C C K G S K S Q T T K K R Y
M10 W P A L S T T H S D C C K G S K S Q T T K K R Y
SECOND INSERTFIRST INSERT
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The binding analysis showed that clones M2, M3, M4 and M6 isolated using MNV VPg differentially 
bound to MNV VPg. Clones M3 and M4 bound to MNV VPg better than clones M2 and M6 (figure 3.5A). 
Although clones M2 shared a common KKR motif with clones M3 and M4, this motif was not sufficient 
to bind its respective VPg strongly. In contrast, clone M5 did not bind to MNV VPg (figure 3.5A).  
 
Figure 3.5  Characterisation of individual phage clones for their binding reactivity to VPg. A) The 
amplified phage clones (M2, M3, M4 , M5 ,M6 ) derived from panning against MNV VPg were 
characterised by examining their reactivity  to MNV VPg and BSA as a negative control using an 
ELISA assay. B) The amplified phage clones (F4, F,5, F6) selected from panning against  FCV VPg 
were characterised by determining their reactivity to FCV VPg and BSA as a negative control using 
an ELISA assay. The binding activity of phage with VPg was detected by an HRP-conjugated anti-
M13 phage and was quantified using a plate reader.  
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Analysis of the FCV binding phage using the ELISA based binding assay indicated that clones F4 and F6 
isolated using FCV VPg bound well to their respective target, whereas clone F5 did not (figure 3.5B). The 
data indicated the clone F5 had the lowest or no binding ability to FCV VPg. Interestingly, when the 
concentration of phage reached over 10 9.25pfu/ml, an inhibitory effect of the phage on the VPg-binding 
activity was observed (figure 3.5B), whereby the phage concentration inversely correlated with its 
binding capacity for FCV VPg. The most likely explanation for this could be that the phage were 
aggregating at the higher concentrations, but this would have to be a characteristic caused by the 
peptide sequence, as this was not observed for MNV-VPg binding phage. 
To further examine the binding specificity of phage clones selected against MNV or FCV VPg, a cross 
binding assay was performed.  An ELISA-based binding assay was used to measure the binding ability of 
each phage clone against a variety of recombinant proteins. In this assay, the recombinant proteins HIS-
eIF4E binding protein (HIS-4E-BP1), HIS-FCV VPg, untagged VPg from Lordsdale norovirus (LDV) FCV VPg-
HIS and MNV VPg-HIS were used. In this experiment, the phage clones were exposed to the various 
recombinant proteins that were immobilised on an ELISA plate, and the binding of examined proteins 
with the phage clone was detected using anti-M13 antisera. M5 and F5 were used a negative control, 
since they did not bind to MNV or FCV VPg respectively in previous assays (figure 3.5A). M2, M4 and M6 
were examined, as they represented the various sequences that were isolated. For the FCV-VPg binding 
phage, clone F4 that contained a conserved long peptide sequence identical with 9 out of the 10 clones 
was chosen for this assay. The cross binding assay revealed a complex binding pattern (figure 3.6). MNV 
VPg-phage clones M4 and M6, has previously shown to bind to their respective target, essentially bound 
to all the HIS-tagged proteins used, but not to non-HIS tagged protein (figure 3.6). It appeared that these 
clones bearing a long peptide had binding specificity for histidine. Interestingly, clone M2 that shared a 
core KKR motif with M3-4 and M7-M9 bound to all recombinant HIS-tagged fusion protein except HIS-
4E-BP1. The FCV VPg-binding phage clone, F4 bound to all HIS-tagged fusion proteins, suggesting it 
selectively bound to HIS-tag, not the target protein. However, all these phage clones lacked the ability to 
interact with either streptavidin or BSA as a control. With the above observation, isolation of phage 
clone bearing the non-specific protein binding activity was due to the presence of HIS tag fused with 
recombinant protein, and indeed, further examination on their binding ability to other HIS or non-HIS 
fusion proteins should be preformed to make a conclusive statement. A lesson gained from this 
experiment was that the target protein should not be fused to any tag, even if the size of the tag was 
relatively small (i.e. as small as 6 peptides long). In summary, the phage clones panned against MNV or 
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FCV VPg using plate-binding panning approach did not bind to their respective target.  Due to time 
constraints, panning using untagged protein could not be performed. 
 
3.4 Discussion 
Treatment of human norovirus typically relies on the replenishment of electrolytes or through anti-
emetic medication, combined with a general approach to prevent the dissemination of a highly 
contagious disease is through quarantine of infected individuals (Gould, 2009; Moe, 2001; Anderson, 
2010; Glass, 2009). As highlighted in the introduction, the development of norovirus vaccine has been 
complicated due to the substantial strain variation and lack of consistent long-term protection (Estes et 
 
Figure 3.6 Characterisation of phage clones for their binding reactivity to different HIS-proteins 
or non-HIS proteins. An ELISA assay was performed to determine whether or not the phage 
clones were bound to other proteins, whereby 0.2 µg of 4E-BP1-HIS, untagged LDV VPg, FCV VPg-
HIS, HIS-FCV VPg, Cherry-MNV VPg-HIS and BSA (negative control) were immobilised on the ELISA 
plate. A total of 5 x 1011 p.f.u./ml phage clones was subjected to the binding reaction with 
respective targets on the ELISA plate. The binding activity was detected using an HRP-conjugated 
anti-M13 antibody, after extensive washing with TBST. A TMB solution was used as a substrate 
and the reaction was stopped using HCl. The plate was then read at 450 nm. 
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al., 2006). Considerable efforts to design human norovirus vaccines have based on the assembly of virus-
like particles (VLPs) derived from capsid protein, in which VLPs are antigenically similar to native 
norovirus virions (Ball et al., 1999; Guerrero et al., 2001; Herbst-Kralovetz et al., 2010). Vaccination of 
mice with VLPs elicits two humoral responses: serum IgG and mucosal IgA responses (T-helper cell 1 
response) (Ball et al., 1999; Guerrero et al., 2001; Herbst-Kralovetz et al., 2010). For the production of an 
efficacious vaccine, the VLP-based approach should stimulate the specific adaptive immune response to 
all prevalent strains, and may require multiple antigen exposure. Since the generation of a vaccine has 
been particularly challenging, potential antiviral strategies is at least conceivable based on the increasing 
knowledge of MNV as a surrogate model. This method could be particularly useful for a ‘ring-fence’ 
treatment to control dissemination of the virus in places with close living conditions and where close 
person-to person contact is unavoidable. Possible antiviral approaches have been focused on the 
structure and function of viral proteins during the replicative life cycle, such as targeting the attachment 
of virions, release of the viral genome and viral genomic RNA. Given that all caliciviruses have stem loop 
and hairpin structures at their 5’ and 3’ genome ends and that disruption of these secondary structures 
impaired viral replication in vitro (Simmonds et al., 2008), nucleic acid-based strategies using antisense 
approach would be attractive area to study. The antisense approach uses DNA oligonucleotides to target 
a conserved region of the viral genome. Currently, phosphorodiamidiate morpholino oligomer (PMO) 
has been reported to treat FCV infection in a dose-dependent manner in a clinical trial (Smith et al., 
2008). This nucleic acid analog targeting at the 5’UTR of the FCV genome blocks access of other 
molecules to a specific sequence within the genome and disrupts the RNA-RNA or the RNA-protein 
interactions, thereby silencing gene expression (Smith et al., 2008). Peptide-linked PMP (PPMO) is 
another PMO with an improved stability and efficiency of drug delivery, which targets the sequence 
close to the 5’UTR of MNV genome (Bok et al., 2008). It readily penetrates into cells, is resistant to 
nuclease (Amantana et al., 2007) and more importantly, it has been reported to cause a reduction in 
viral translation in vitro (Bok et al., 2008). These experimental data indicated PPMO may be a promising 
approach for the treatment of norovirus infection, however the challenge is the efficient delivery of 
PPMO, since MNV and human norovirus infects intestine.  
Translation is the first step after viruses entered the cells. Initiation of viral protein synthesis is 
dependent on the interaction of VPg with cellular translation factors, therefore VPg is considered as one 
of the most desirable targets in the development of calicivirus therapeutics. As a component of the 
eIF4F complex, eIF4A having the helicase activity has shown to be indispensable for MNV and FCV mRNA 
translation in the rabbit reticulocyte lysate system. Treatment of FCV with a small molecule called 
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hippuristanol derived from the sea fan coral Issis hippuris has proven to block viral protein synthesis 
(Chaudhry et al., 2006). This small molecule selectively interacts with the C-terminus of eIF4A, thereby 
inhibiting the RNA binding, helicase and ATPase activity of eIF4A (Bordeleau et al., 2006). Despite 
hippuristanol substantially causing reduction in viral translation, it is expected to induce toxicity to cells 
due to the impairment of cellular translation (Chaudhry et al., 2006). Nevertheless, the observations 
highlighted that the novel mechanism of viral translation initiation could be targeted for anti-viral drug 
development.  
Besides mimicking the cap structure to recruit translation initiation factors, VPg also functions in viral 
replication (Belliot et al., 2008; Kaiser et al., 2006; Rohayem et al., 2006) and possibly encapsidiation 
(Kaiser et al., 2006). Hence, the development of antiviral strategies aiming at blocking or destabilising 
the interaction of VPg with cellular factors or viral factors is of interest. An attractive approach is using 
phage display to identify antiviral compounds that interfere with the activity of VPg. The application of 
phage display has been extensively explored, for example for identifying cellular markers (Jensen et al., 
2003), enzyme inhibitors (Dennis et al., 2000; Hyde-DeRuyscher et al., 2000), receptor ligands (Koivunen 
et al., 1995; Lee et al., 2002; Pasqualini et al., 1995), and importantly, in drug discovery (Ferrer and 
Harrison, 1999). Recently, a phage displaying peptide to the avian H5N1 influenza virus was capable of 
distinguishing the virus from other avian viruses, and could potentially be used as a diagnostic test to 
identify pathogenic H5N1 (Wu et al., 2011). A recent study has also successfully identified a peptide 
blocking HCV NS5B polymerase activity (Kim et al., 2008). As an initial attempt to isolate peptides that 
bound to VPg, a solution-binding panning approach was used; however, the selected MNV VPg and FCV 
VPg binding phage did not appear to express peptides that bound to their respective VPg. In contrast, 
the same approach successfully identified specific streptavidin-binding phage using Ultra-linked 
streptavidin resin. The subsequent sequence analysis revealed all selected clones shared the conserved 
HPQ that is considered to be the favoured streptaviding binding peptide. This data indicates that the 
phage display system is able to select phage with specific binding activity when exposed to target 
protein. Hence, a plate-binding panning approach was pursued in an attempt to identify phage that 
bound to MNV VPg or FCV VPg. The ELISA assay demonstrated that the phage pool selected from MNV 
VPg or from FCV VPg bound to its respective target. However, a cross reactivity assay which measured 
the ability of each phage clone to bind to a variety of recombinant proteins showed that FCV VPg and 
MNV VPg binding phage clones not only bound to their respective target, but also could bind to almost 
all HIS-tagged fusion proteins. The observation of non-specific protein binding of phage suggested the 
peptides displayed on those clones were likely to react with the HIS-tag, although further examination of 
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their binding capacity was unable to confirm such an assumption due to time constraints. The failure to 
isolate VPg-binding phage could be because the recombinant VPg proteins used in our experiments 
were fused with a HIS-tag, which increased the probability of isolating phage with binding ability to HIS 
tag. If time allowed, a revised panning protocol that used an untagged VPg could be a better alternative 
to minimise the chance of selecting HIS-binding phage. Another contributing factor of isolating non-
specific binding phage could be due to the general elution buffer, glycine, used in the panning 
procedure. Instead of using glycine, a specific ligand against target protein as a specific elution buffer 
could be used to increase the stringency of isolating phage with desirable binding properties. A good 
specific elution buffer for VPg-binding phage could be a known protein that binds to VPg such as eIF4E, 
or even antisera to MNV VPg. Hence, it is worth examining a range of VPg-binding proteins that could 
potentially be used as specific elution buffer during panning. Such modifications and optimisations as 
suggested in the plate-binding approach could potentially select phage with the binding specificity for 
FCV or MNV VPg. Thereafter, the selected peptide could then be examined for its inhibitory effect on 
the activity of VPg by in vitro translation, or its interaction of eIF4E and VPg using a competitive ELISA 
assay. Subsequently, the identified VPg-binding sequences could be chemically synthesised and their 
effect on the function of VPg could be determined in vitro. Once the synthesised peptide was found to 
inhibit the function of VPg, it could be coupled with some molecules, i.e. cholesterol or another peptide, 
i.e. penetratin, to enable the uptake of peptide drugs into the permissive cells and animals in order to 
examine their effect on a virus infection, particularly on viral translation and replication. Since VPg is 
vital for viral infectivity, and plays an important role in viral translation and replication, compounds that 
interfere with the activity of VPg are promising drug candidates to eliminate the rapid dissemination 
norovirus disease. 
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4 Introduction 
Human noroviruses are not cultivatable in vitro, therefore most molecular studies have been based on 
cell culture-adapted MNV, a close genetically related virus. MNV shares a similar genomic organisation 
and displays a variety of other similar characteristics with human noroviruses e.g. route of transmission, 
low infectious dosage and rapid onset of disease. The linkage of calicivirus VPg to the genomic RNA is 
crucial for virus infectivity, as the removal of VPg from calicivirus RNA results in the loss of infectivity 
(Burroughs and Brown, 1978). In contrast, the picornavirus VPg is not required for infectivity (Flanegan 
et al., 1977b; Nomoto et al., 1977) or viral translation (Fitzgerald and Semler, 2009). Calicivirus VPg 
functions as a ‘cap substitute’ that recruits translation initiation factors, potentially by interacting with 
eIF4E (Chaudhry et al., 2006; Goodfellow et al., 2005). In addition to the role in translation initiation, FCV 
VPg has been shown to interact with VP1 and NS7 by yeast-two hybrid analysis. VPg serves as a primer 
for the viral RdRp (NS7) (Belliot et al., 2008; Machin et al., 2001; Mitra et al., 2004) and possibly plays a 
functional role in encapsidation (Kaiser et al., 2006). 
The VPg proteins of both MNV and NV (prototype strain of the genus Norovirus) share 54% amino acid 
identity and both have been shown to bind cellular translation initiation factors such as eIF4E (Chaudhry 
et al., 2006; Daughenbaugh et al., 2006). In this chapter, mutational analysis of MNV VPg was used to 
identify the regions of the protein involved in translation initiation. Based on the high levels of similarity 
between mouse and human noroviruses, we also aimed to determine if NV VPg can functionally 
substitute the MNV VPg during virus replication in cell culture, in order to perform a similar type of 
mutational analysis on the human norovirus VPg.  
4.1 Characterising the functional residues of NV VPg using two different cell-
based approaches 
4.1.1 Generation of a MNV chimeric clone expressing NV VPg 
Since MNV and NV are closely related noroviruses, they are likely to share the same conserved 
mechanism of VPg-dependent translation initiation. To date, it has not yet been determined whether 
they truly share the same requirement for translation initiation. In addition, the roles of individual 
amino acids within VPg, which are required in NV translation and replication, have not been dissected. 
In order to generate a system to allow the identification of residues within the NV VPg that play a role in 
NV translation, NV VPg was introduced into a full-length infectious cDNA clone (pT7: MNV 3’RZ) of MNV 
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(Chaudhry et al., 2007). In this way, a MNV/NV chimera could be generated that expressed all the MNV 
non-structural and structural protein, with VPg however being replaced by human norovirus VPg.  
To construct a full length MNV/NV cDNA chimera, site-directed mutagenesis using overlap extension 
PCR  was used to generate 2 silent mutations in the two regions flanking the MNV VPg coding region (as 
described in methods and materials). The resultant cDNA clone is henceforth referred to as pT7:MNV 
3’RZ NS5*. It has two inserted mutations generating unique restriction sites, which were then used to 
insert the NV VPg into the region encoding the MNV VPg. Prior to insertion of the NV VPg coding region, 
2 clones of pT7:MNV 3’RZ NS5* (parental clone 1 and 2) were sequenced for the presence of the 
required restriction sites and reverse genetics was preformed to examine if the introduced silent 
mutations affected virus recovery. The yields of viruses recovered from pT7:MNV 3’RZ NS5* (clone 1 and 
2) were identical to the virus titre obtained from the wild type (WT) MNV infectious cDNA clone (data 
not shown) confirming that the introduced silent mutations did not disrupt any RNA sequence or 
structures essential for virus replication. Next, four MNV/NV chimeras were made: with clone a and b 
being derived from the parental clone 1, while clone c and d used the parental clone 2 as the backbone. 
All chimera clones were sequenced to confirm the presence of NV VPg insert. 
To examine the effect of the replacement of MNV VPg with NV VPg, a RNA-based reverse genetics 
system was developed. The system relied on the transfection of the post-transcriptionally capped MNV 
RNA from the full-length MNV cDNA clone into cells (Yunus et al., 2010). Briefly, full length MNV RNA 
was generated by in vitro transcription, and subsequent capping was performed using the ScriptCap 
enzymatic capping system, as described in methods and materials. The effect of NV VPg substitution on 
virus recovery from synthetic capped MNV RNA into BSRT7 cells was then examined 24 hours post-
transfection, by TCID50 of infected lysate in MNV permissive RAW264.7 mouse macrophages.  The 
parental clone 1 and clone 2 bearing unique restriction sites and the original full length infectious clone 
of MNV (WT) were used as positive controls. The replication defective derivative of the WT clone, pT7: 
MNV-3’RZFS (FS) encoding a frame-shift mutation in the region coding for NS7 (Chaudhry et al., 2007) 
was used as a negative control. The results showed that none of the chimeric RNAs enabled the recovery 
of infectious virus compared to the positive controls (figure 4.1).  
To determine whether the coding region of NV VPg in the MNV clone had caused a change in 
polyprotein processing, the expression of viral non-structural proteins i.e. NS7 and VPg was determined 
by a western blot. Mature and precursor forms of NV VPg protein with a slightly higher molecular weight 
than MNV VPg were detected (figure 4.2A), suggesting that an authentic proteolytic processing of non-
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structural polyprotein mediated by protease occurred in cells bearing a chimeric clones. The western 
blot analysis demonstrated that the transfection efficiency was relatively similar in all the examined 
constructs and confirmed that polyprotein processing was not inadvertently affected when making the 
chimeric viruses.  
 
In an attempt to recover virus, three serial ‘blind’ passages of the chimera samples were preformed, 
however virus was not detected by TCID50 based on the absence of a visible cytopathic effect (figure 
4.1). To further confirm that virus was not recovered from chimeric RNA, total RNA was extracted from 
cells after passage three and reverse transcribed and amplified by PCR to detect the VP2-coding region. 
This analysis verified that virus was not recovered from the four chimeras in comparison to the WT MNV 
cDNA clone and both parental clones with unique restriction sites (figure 4.2B).  
 
Figure 4.1 Recovery of MNV chimera encoding NV VPg in cell culture using RNA based reverse 
genetics system. The capped RNAs transcribed from full-length cDNA constructs were 
transfected into BSRT7 cells to recover viruses. The yield of recovered virus was examined by 
TCID50 titration in RAW264.7 cells and compared to RNA transcribed from WT MNV cDNA and 
parental clones (1 and 2) with unique restriction sites. FS was an MNV mutant containing a 
frame-shift mutation in the region coding for NS7, which acted as a negative control for 
recovery. The limit of detection is indicated by a dotted line. Chimeric clones (a –d) did not 
recovered any virus from the RNA-based reverse genetics system based on the absence of 
visible cytopathic effect, and therefore were passaged three times in RAW264.7 cells in an 
attempt to recover an infectious virus. P0 to P3 represents the number of passage. After several 
passages, all chimeras failed to recover any viable virus.  
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4.1.2 Like MNV VPg, human norovirus VPg associates with translation initiation factors 
Given that we were unable to generate a MNV/NV chimera to identify the functional sites in human 
norovirus VPg, we instead chose to use one of the only systems currently available to study human 
norovirus replication, namely the NV replicon system (Chang et al., 2006). Essentially a cDNA sequence 
of the NV RNA genome (pNV101), pNV-Neo, has been engineered to contain a neomycin resistance gene 
replacing most of the VP1 sequence in ORF2 (Chang et al., 2006). This construct was in vitro transcribed 
and the transcripts were capped and transfected into BHK-21 cells. The replicon-bearing cells expressed 
NV proteins and RNA could be maintained in the presence of G418 and this system circumvents the 
 
Figure 4.2  Detecting MNV chimeras encoding NV VPg by RT-PCR and western blot. In vitro 
capped chimera RNAs were transfected into BSRT7 cells to recover viruses. None of the in vitro 
capped chimera RNAs recovered any infectious virus from the RNA-based reverse genetics 
system. A) Western blot analysis was performed on lysates of transfected BSRT7 cells to measure 
translation of NS7, VPg and GAPDH as a control. NI refers to mocked cell control. B) Screening by 
RT-PCR. The chimeras were passaged three times in RAW264.7 cells in an attempt to amplify 
infectious virus. RT-PCR was performed to confirm that virus had not been recovered from the 
chimera RNAs after multiple passages. RT negative represents samples were amplified in the 
absence of reverse transcriptase; RT positive represents that samples were amplified in the 
presence of a reverse transcriptase.  
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need for a helper virus. In this study, a cell clone (G6) expressing self-replicating NV RNA, which 
expresses NV proteins and supports authentic proteolytic processing and virus replication was selected 
(Chang et al., 2006). Furthermore, treatment of the RNA replicon with proteinase K prior to transfection 
abolished the ‘infectivity’ of replicon RNA, suggesting the presence of VPg enhances the infectivity of the 
RNA replicon (Chang et al., 2006). The availability of helper virus-free NV replicon-bearing BHK-21 cells 
allows the study of virus replication monitored by RT-PCR, qRT-PCR, northern or western blot analysis 
for the presence of viral protein. Furthermore, it allows molecular manipulation to the viral genome by 
mutagenesis. Based on the fact that presence of VPg is essential for the ‘infectivity’ of the RNA replicon, 
another application of the NV replicon system could be used to examine the distinctive VPg-dependent 
translation initiation such as identify the functional residue of VPg by mutagenesis study or characterise 
the functional role of the NV VPg binding protein in translation initiation. 
To examine whether the NV replicon system enables an analysis of VPg-dependent translation, lysates 
from BHK cells and NV replicon-bearing BHK-21 cells were examined using cap affinity chromatography. 
Cap sepharose chromatography is a useful method for isolating proteins associated with the eIF4F 
complex, as one of its major components, namely the eIF4E protein, is readily purified from cells on m7-
GTP (cap) sepharose (figure 4.3). Our previous work has showed that the interaction of MNV or FCV VPg 
with eIF4E did not affect binding and can be purified using cap sepharose. Based on our previous work, it 
was expected that the interaction of NV VPg with eIF4E would not affect binding to the cap structure. 
Hence, cap affinity chromatography was used to quickly address whether NV VPg associates with eIF4E 
and/or other components of the eIF4F complex. As can be observed in figure 4.4, the eIF4F complex and 
PABP were isolated from both the parental BHK and NV-replicon bearing cell lines using cap-sepharose. 
Most importantly, NV VPg was co-purified with eIF4E from NV-replicon bearing cell lines using cap 
sepharose. To prove only protein that bound to translation initiation factors could be purified using the 
cap-sepharose, the samples were probed for the presence of NS3 as another negative control, since NS3 
is unlikely to be involved directly in viral translation or associated with translation factors. The western 
blot analysis showed that NS3 was detected in lysates of cells bearing the replicon, but was not isolated 
using cap-sephaorse (figure 4.4). This collective data illustrated, as observed for MNV, the mature NV 
VPg bound to cap-sepharose via an interaction with the translation initiation factors. In addition, the 
precursor forms of VPg were also associated with the canonical translation initiation factors. The 
experiment confirmed that the eIF4F complex together with PABP were components of the translation 
initiation complex associated with NV VPg using NV replicon system.  
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Our initial aim to examine the replicon system was to introduce VPg mutations into the NV replicon and 
try to determine which enable the generation of replicon containing cell lines, but due to time 
constraints, further work was not possible. However this work provides the first evidence for an 
interaction between the human norovirus VPg protein and translation initiation factors during virus 
replication, albeit using a somewhat artificial replicon system. 
 
 
Figure 4.3  Diagrammatic Illustration of cap-sepharose affinity chromatography. The MNV 
infectious cDNA construct encoding MNV proteins was transfected into FPV-infected BSRT7 cells, 
and the expression of viral proteins was driven by T7 RNA polymerase supplied by helper FPV. 
One day post-transfection, the cells were lysed with a standard CAP buffer and incubated with 
cap-sepharose to assess the effect of mutations on translation factor binding. Through the 
interaction of the cap-binding protein eIF4E (labelled as 4E), its associated translation initiation 
factors, such as eIF4G (labelled as 4G) and eIF4A (labelled as 4A) could be isolated using cap 
sepharose. Since the VPg-eIF4E interaction did not interfere with the binding of eIF4E to the cap 
structure on cellular mRNA, VPg bound to eIF4E could be readily isolated from the translation 
initiation factors using cap-sepharose as illustrated. The resulting protein complex was 
precipitated with cap-sepharose and washed with CAP buffer three times to remove any non-
specific associated proteins. The purified proteins were then resolved on an SDS-PAGE gel and 
analysed by western blot to detect the presence of VPg and translation factors such as eIF4E.  
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Figure 4.4 NV VPg interacts with translation initiation factors in vitro. Lysate from BHK cells and 
NV replicon-bearing BHK-21 cells were subjected to cap sepharose affinity chromatography.  A 
western blot was performed to detect the presence of eIF4A, eIF4E, eIF4G, PABP, NS3 and NS5 
from lysates (L) and from the samples after purified using cap-sepharose (m7). The expression of 
non-specific protein is indicated by an asterisk. The number on the left of the figure is the size of 
the molecular weight protein marker. A black triangle () represents NS3. Notes: Four VPg 
precursors (NS4/5, NS4/5/6, NS5/6/7, NS4/5/6/7) and a mature VPg (NS5) were expressed and 
co-purified.  
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4.2 The C-terminus of VPg is required for initiation factor binding and virus 
viability 
As an approach to characterise the functional residues of VPg required for translation initiation, a large 
number of mutations in MNV VPg were constructed by members of our laboratory prior to starting of 
this project. These mutations primarily focused on amino acids conserved in the VPg proteins from 
different caliciviruses (figure 4.5). The mutations were built into the infectious MNV-1 cDNA construct 
(Chaudhry et al., 2007), which expresses MNV-1 under the control of T7 polymerase promoter. A 
reverse genetics system previously established in our laboratory (Chaudhry et al., 2007) which relies on 
the transfection of a cDNA construct into BSRT7 cells infected with the recombinant FPV expressing T7 
polymerase (FPV) for the recovery of genetically defined noroviruses was then used in an attempt to 
recover the VPg mutants. The effect of mutations in VPg on virus viability was examined by TCID50 
assay. Work in our lab had examined the effect of the various mutations on virus viability and the data is 
summarised in table 4.1.  
 
Using the reverse genetics system, the majority of VPg mutants did not produce infectious virus or 
enable the recovery of infectious virus with variable degrees of reduction in the virus yield. Only two 
mutants recovered similarly to WT, namely S41A and D43A.  This suggested that the S41 and D43 
residues do not contribute to the function of VPg and do not affect the virus lifecycle. In contrast, seven 
Figure 4.5  Alignment of VPg proteins from different caliciviruses. The amino acid sequence of 
VPg from LDV, MNV and FCV were aligned. The asterisks indicate the conserved amino acid 
residue among the caliciviruses which were used for the mutagenesis study. The colons indicate 
conservation between groups of strongly similar properties; the dots indicate the columns where 
there is conservation between groups of weakly similar properties i.e. conserved biochemical 
character of the side chain. 
NV              GKNKGKTKKGRGRKNNYNAFSRRGLSDEEYEEYKKIREEKNGNYSIQEYLEDRQRYEEEL 
MNV             -GKKGKNKKGRGRP---GVFRTRGLTDEEYDEFKKRRESRGGKYSIDDYLADREREEELL 
FCV             --AKGKTKSKVGP----YRGRGVALTDDEYDEWREHNATRKLDLSVEDFLMLRHRAALGA 
                   ***.*.  *           .*:*:**:*::: .  :  . *::::*  *.*      
 
NV              AEVQAGGDGGIGETEMEIRHRVFYKSKSKKHQQEQRRQLGLVTGSDIRKRKPIDWTPPKN 
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FCV             DDADA---------------VKFRSWWNSRSRLADDYEDVTVIGKGGVKHEKIRTN---- 
                   :                  *    . : :  :  :   * * .   :: *  .     
 
NV              EWADDDREVDYNEKINFE-- 
MNV             SWADDDRQVDYGEKINFE-- 
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                      * ** . .:.*   
NV              GKNKGKTKKGRGRKNNYNAFSRRGLSDEEYEEYKKIREEKNGNYSIQEYLEDRQRYEEEL 
MNV             -GKKGKNKKGRGRP---GVFRTRGLTDEEYDEFKKRRESRGGKYSIDDYLADREREEELL 
FCV             --AKGKTKSKVGP----YRGRGVALTDDEYDEWREHNATRKLDLSVEDFLMLRHRAALGA 
                   ***.*.  *           .*:*:**:*::: .  :  . *::::*  *.*      
 
NV              AEVQAGGDGGIGETEMEIRHRVFYKSKSKKHQQEQRRQLGLVTGSDIRKRKPIDWTPPKN 
MNV             ERDEEE----------AIFGDGFGLKATRRSRKAERAKLGLVSGGDIRARKPIDWNVVGP 
FCV             DDADA---------------VKFRSWWNSRSRLADDYEDVTVIGKGGVKHEKIRTN---- 
                   :                  *    . : :  :  :   * * .   :: *  .     
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clones containing the mutations K3A, L21A, D23A, E25A, Y26F, E28A and F123A could not recover viable 
virus from the reverse genetics system (table 4.1).  
 
These non-viable mutants were blind-passed 5 times in RAW264.7 cells, and the appearance of a virus-
induced cytopathic effect and infectious viruses were subsequently examined by TCID50 titration in 
RAW264.7 cells. However even after serial blind passages, the seven non-recovered mutants, K3A, L21A, 
D23A, E25A, Y26F, E28A and F123A, did not produce any infectious virus, thus confirming their lethal 
phenotype (table 4.1, highlighted in grey). The viable viruses were repeatedly passaged 7 times in 
RAW264.7 and the mutated position was sequenced to examine sequence stability. Sequencing the 
 
Table 4.1 Summary of MNV VPg mutagenesis analysis. Recovery is expressed as the yield of 
infectious virus 24 hours post-transfection of MNV cDNA clones into BSRT7 cells relative to wild-
type (++++) as assayed by 5 independent experiments. Typical yields of the wild-type virus were 
1.5 x 104 TCID50 units per 35mM dish. The detection limit is ~50 TCID50 units. The 
corresponding mutant showing (-) from the recovery indicates that no infectious virus was 
recovered. The mutants showing (+) indicate that a relatively low levels of infectious virus was 
recovered compared to the yield of virus from WT. The recovery samples in which the virus was 
not detected were blind-passaged 5 times in RAW264.7 cells and are highlighted in grey. The 
appearance of virus induced cytopathic effect and infectious virus was examined by subsequent 
TCID50 titration in RAW264.7 cells, but no virus was isolated after bind passage. The white box 
under the recovery column indicates the recovery samples in which the mutated position of the 
virus was sequenced after 7 repeat passages in RAW264.7 cells, and the mutation originally 
introduced was the major dominating sequence identified by sequencing of the viral population 
at passage 7. V115A was the only recovered virus in which the mutated position 115 had 
reverted to WT, highlighted in a black box. (Note: The recovery of all these mutants were 
preformed by Ian and Yasmin Goodfellow) 
Mutation Recovery Notes 
K3A - Processing defect 
K5A +++ 
K7A +++ 
L21A - 
D23A - 
E25A - 
Y26F - Defective in 
nucleotidylation 
D27A + 
E28A - 
S41A ++++ 
D43A ++++ 
V115A +++ Small plaque phenotype 
D116A +++ 
F123A - 
++++ 
+++ 
++
+
-
Increasing severity 
of phenotype
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mutated position in the K5A, K7A, D27A, S41A, D43A, and D116A mutants revealed that the mutation 
originally introduced remained and was stable (table 4.1). However, the virus carrying the V115A 
mutation had reverted to WT after 7 passages (table 4.1, highlighted in black box). The mutation of 
V115A conferred a smaller plaque phenotype (data not shown), and reduced virus recovery rate 
compared with WT. This indicated a growth defect, and therefore there was sufficient pressure on the 
virus to restore the original WT sequence upon passage in cell culture. This revertant virus that had 
repaired the mutation suggests the amino acid at position 115 could be important to the virus lifecycle. 
Cap affinity chromatography was conducted to investigate whether or not any of the mutations that 
affected the recovery of the infectious virus were the result of defects in the ability of VPg to interact 
with the translation initiation factors. The MNV infectious cDNA constructs of the various mutants were 
transfected into FPV-infected BSRT7 to drive the expression of the viral proteins by T7 RNA polymerase 
supplied by the FPV helper virus. One day after transfection, the cells were lysed and incubated with 
cap-sepharose to assess the effect of the mutations on translation factor binding. As previously 
mentioned, the interaction of VPg with eIF4E does not affect the ability of eIF4E to interact with a cap 
structure, therefore cap sepharose chromatography can be used to quickly address whether mutations 
affect the ability of VPg to associate with eIF4E and/or other components of the eIF4F complex. Our 
data indicated that the WT forms of VPg were successfully isolated from the eIF4E-containing complexes 
via cap-sepharose. As expected, the mature and precursor forms of VPg were enriched (Chaudhry et al., 
2006) from cells transfected with a WT MNV clone (figure 4.6). The data from western blot showed that 
a total of ten mutants, K5A, K7A, L21A, D23A, E25A, Y26F, D27A, E28A, S41A and D43 retained their 
ability to bind translation initiation factors, since a relatively similar level of VPg was isolated using cap-
sepharose from those mutants compared to those isolated from the WT (figure 4.6). Among these 
mutants, L21A, D23A, E25A, Y26F and E28A did not allow the recovery of infectious virus using the 
reverse genetics system. Therefore, the effect of mutations at positions 21, 23, 25, 26 and 28 which 
resulted in defects in virus growth, was not a result of inability to bind the translation initiation factors. 
Hence, those mutants which conferred a lethal phenotype could be losing their function in RNA 
synthesis or encapsidation i.e. defects in binding to a major capsid protein VP1, or viral RNA polymerase, 
NS7, as FCV VPg bound to VP1 and NS7 from the yeast-two hybrid analysis (Kaiser et al., 2006). The 
other VPg mutant K3A displayed defects in polyprotein processing, and this resulted in the isolation of a 
VPg with a larger molecular weight than its processed size, which is indicated by an asterisks in figure 
4.6. This explains why the K3A mutant, which expressed a defective VPg, was not recovered from the 
reverse genetics system. In contrast, the VPg protein of the F123A mutant which was not recovered 
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using the reverse genetics system, had a significantly reduced ability to bind translation factors 
compared to others in cap-sepharose pull-downs assay (figure 4.6). This highlights that the amino acid at 
position F123 in VPg is essential for translation initiation factor binding. The V115A and D116A mutants 
had a reduced amount of VPg being isolated from cap-sepharose which can be the result of a reduced 
capacity to bind the translation initiation factors (figure 4.6). The data from the mutagenesis study 
suggests that the residues V115 and D116 of VPg protein could help to stabilise the translation initiation 
complex, since less VPg was co-purified, while the position at F123 in VPg was critical for establishing an 
interaction with the translation initiation factors. Furthermore, although the V115A mutation was 
restored upon repeated in vitro passage, the mutation D116A, which also independently reduced the 
ability to bind translation factors, was stable during multiple passages. In addition, both mutations 
resulted from a single nucleotide change in VPg. Thus, V115 could be a second important residue of VPg 
required to establish translation initiation factor binding, while D116 could be less essential. To 
summarise the combined data from the reverse genetics analysis and cap sepharose pull-down assay, 
the defects in viral growth exhibited in the mutations of V115A, D116A and F123A could be the result of 
a reduced ability to bind the translation initiation factors. In conclusion, the residues at the C-terminus 
of VPg are essential for the interaction with the components of the eIF4F complex. 
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Figure 4.6 Mutations in the residues of the C-terminus of VPg affect its ability to bind to 
translation initiation factors. BSRT7 cells transfected with either wild type (WT) or various VPg 
mutants were lysed, and the resulting lysate (L) was then subjected to cap-sepharose affinity 
chromatography. After purification, the proteins (m7) associated with cap-sepharose beads 
were detected by western blotting with antisera to MNV VPg and eIF4E. VPg precursors with a 
larger molecular weight are indicated by an asterisk. The effect of VPg mutations on virus 
replication was also summarised in this figure. Recovery is expressed as the yield of infectious 
virus 24 hours post-transfection of the cDNA clones into BSRT7 cells relative to WT (++++) as 
assayed by >5 independent experiments. Typical yields of WT virus were 1-5 x 104 TCID50 units 
per 35mM dish. The corresponding mutant showing (-) from the recovery indicates that no 
infectious virus was recovered (The viral titre was measured by Yasmin Goodfellow).  
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4.3 Identification of structural residue in MNV VPg required to stabilise its 
core using mutagenesis 
 
The structural residues of MNV VPg have been recently reconstituted by our collaborators, Eoin Leen 
and Stephen Curry (unpublished data), and nuclear magnetic resonance (NMR) analysis suggests that 
MNV VPg has a stable helical structural core domain with two flexible termini (figure 4.7). Within the 
structure of MNV VPg are two important alpha helices; with the first helix being similar to that of FCV 
VPg, whilst the second helix ends with the EEELL motif. The helical structural core of MNV VPg stretches 
from amino acid position 14 to 55, and appears to be stabilised through salt-bridges and hydrophobic 
interactions (figure 4.7). Based on this NMR prediction, the mutations F29A, Y40A, Y45A resulted in a 
loss of core structure, which suggests the hydrophobic core of MNV VPg may make a greater 
contribution to stabilising the structural core domain, while disrupting some of the salt-bridges had less 
of an alteration effect on the core structure (figure 4.7). For example, the mutation R49E appeared to 
have a minor effect on the core of VPg (Eoin Leen, personal communication).  
Figure 4.7 The structure of the MNV VPg by NMR analysis. The structure of MNV VPg is 
highlighted in pink with two alpha helices (represented by pink ribbons) and two flexible termini. 
The helical structural core of MNV VPg stretches from amino acid position 14 to 55. Based on 
NMR prediction, the core is stabilised through salt-bridges and hydrophobic interactions. The 
three aromatics residues (F29, Y40 and Y45) of the MNV VPg core are highlighted in green. The 
positively charged residues R32 and R36 and the negatively charged residue D48 are predicted to 
form salt bridges (the residues are highlighted in red). For instance, the OH group of Y45 appears 
to interact with a side chain amino group of R49 (NH epsilon group). R49 in turn forms a 
hydrogen bond with the D48 side chain, while D48 in turn forms a salt bridge with R32.  Y26 is 
thought to interact with NS7 for nucleotidylation is highlighted in yellow. The D43 residues are 
solvent-exposed residue and predicted to have no effect on the structure (not shown). In 
addition, R49 that forms a salt-bridge with E25 is highlighted in grey. Diagram was provided by 
Eoin Leen (Imperial College London).  
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Based on the predicted assumption of the NMR, a panel of MNV VPg mutants was generated by Ian 
Goodfellow and characterised with the aim of identifying amino acid residues that could be involved in 
core stabilisation through salt bridges or hydrogen bonds. As previously described, the mutations were 
engineered into the MNV cDNA construct, which expressed MNV proteins under the control of a T7 
polymerase promoter. BSRT7 cells were infected with FPV expressing the T7 RNA polymerase and 
subsequently transfected with constructs containing the specified mutation in VPg. The level of NS7 was 
determined by western blot to determine whether mutations affected the polyprotein processing and 
transfection efficiency. A relatively similar level of NS7 was observed (figure 4.8B), suggesting authentic 
polyprotein processing of non-structural proteins occurred in cells. The effect of mutations on virus 
recovery was determined in RAW264.7 by TCID50 titration (figure 4.8A). It has previously been shown 
  
Figure 4.8  Recovery of MNV VPg mutants. BSRT7 cells were infected with FPV expressing the T7 
RNA polymerase and subsequently transfected with plasmids containing the specified mutation 
in VPg, where the expression of the genome is under control of a T7 promoter. Recovery is 
expressed as the yield of infectious virus 24 hours post-transfection of cDNA clones into BSRT7 
cells and assayed by 3 independent experiments. A) The virus yield obtained 24 hours post-
transfection was examined by TCID50 titration in RAW264.7 cells and compared to WT. None of 
the chimera allowed recovery of an infectious virus. The limit of detection is indicated as a 
dotted line. Error bars represent the standard error of the mean. B) Western blot analysis was 
performed on lysates of transfected BSRT7 cells to evaluate the effect of mutation on 
polyprotein processing and transfection efficiency. Expression of NS7 was detected by anti-NS7 
antibody.  
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that the Y26F mutation could not recover any infectious virus from the reverse genetics system (table 
4.1), and therefore this mutant served as a negative control in this experiment. D43A served as a 
positive control, since it was predicted to have no effect on virus viability, given it is a solvent exposed 
residue. Our result showed that the D43A mutant recovered with similar virus yield as the WT. No 
infectious virus was recovered from the F29, Y40 and Y45 mutants, in which the three aromatic residues 
of VPg had been substituted with a non-reactive alanine. This suggested the hydrophobic aromatic 
residue of F29, Y40 and Y45 are involved in a stacking interaction with other aromatic side chains and 
are important to form the hydrophobic core of VPg. Furthermore, an aromatic substitution to another 
aromatic residue at position 40 (Y40F) recovered a similar virus yield as the WT, which appeared that the 
stacking interaction with other aromatic side chains is required to stabilise the core of VPg. In contrast, 
Y45F conferred a lethal phenotype, in which no virus was recovered from the reverse genetics system. 
The only difference between tyrosine (Y) and phenylalanine (F) is that the latter amino acid does not 
have a hydroxyl group in the ortho position on the benzene ring. Therefore, having a reactive hydroxyl 
group at Y45 appeared to be essential for stabilising the core structure of VPg. Consistent with the NMR 
analysis, the data indicated that F29, Y40 and Y45 of VPg are important in stabilising the structural core 
of the VPg. 
From the NMR data, R32, R36 and D48 were found to be stabilising the VPg core structure through the 
salt bridges (figure 4.7). Substitution of a positively charged arginine at position 32 or position 36 for a 
negatively charged aspartate (R32D and R36D respectively) displayed only a slight reduction in virus 
yield compared to the WT, while the substitution D48R recovered with the same virus yield as WT. Even 
the double substitution at D48R/R32D displayed only a slightly reduction in virus yield. This suggested 
that the salt bridge has only a small effect on the stability of the VPg core, whereas disrupting the 
hydrophobic core of VPg could be devastating to its stability.  
 
4.4 Discussion 
A growing interest in studying human NV has been hampered by the lack of suitable cell culture to study 
their replication cycle; hence, reverse genetics and replicon systems have become important tools to 
examine calicivirus replication. Currently, reverse genetic system are available for FCV (Sosnovtsev and 
Green, 1995), RHDV (Liu et al., 2006) and MNV (Chaudhry et al., 2007). The availability of the MNV 
reverse genetics system has in fact made a significant impact on the progression of norovirus research. 
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Given that this system relies on the transfection of an MNV cDNA clone into BSRT7 cells with the help of 
T7 expressing FPV to recover virus, the cDNA clone can be easily manipulated by mutagenesis to 
investigate various aspects of the MNV replication cycle. Although MNV and NV share significant genetic 
similarity, it is not proven whether they share the mechanism of translation initiation mediated by VPg, 
or share a conserved functional residue in terms of translation and replication, or indeed share the same 
requirements for translation initiation. A cell-based replicon system was established to investigate NV 
replication. This NV RNA replicon (pNV-Neo) contains a consensus cDNA sequence of the NV RNA 
genome. It has a neomycin resistance gene as selective marker inserted into the VP1-encoding region, 
disrupting the expression of VP1, but leaving an intact ORF3 and 3’ genomic end. The transfection of 
RNA transcribed from pNV-Neo expresses NV proteins and RNA without the need of a helper virus and 
can support authentic polyprotein processing. Importantly, treatment with proteinase K affects the 
‘infectivity’ of the replicon RNA isolated from replicon containing cells, indicating the presence of VPg is 
required for replicon infectivity. Despite the fact that the RNA replicon-bearing cell line has now been 
available for several years, most studies have been focused on RNA replication and not much work has 
been done on translation. This led us to investigate the potential uses of this system in terms of 
translation and examine the functional role of the amino residues in both norovirus VPg using the MNV 
reverse genetic system and NV replicon-bearing cell system. 
4.4.1 Two cell-based systems for studying NV translation 
In an attempt to determine the functional role of the residues in the NV VPg, we tried to construct a 
MNV/NV chimera, whereby the coding region of MNV VPg in the full length infectious MNV clone was 
replaced by the corresponding region of NV VPg. Four cDNA clones of a MNV/NV chimera yielded full-
length RNA transcripts that were not infectious when transfected into permissive cells. A western blot 
was performed showing the transfection efficiency was not affected due to poor stability of RNA or 
inability of cellular translation machinery to translate capped RNA or wrongly capped RNA. In addition, 
the coding region NV VPg in the MNV cDNA clone resulted in the full polyprotein expression, including 
production of mature NV VPg. After three ‘blind’ passages, virus could not be recovered from the full 
length chimera. Given that VPg has been shown to bind NS7, VP1 and translation factors, there are 
several hypotheses regarding the inability to recover virus by the RNA-based reverse genetics system. 
First, NV VPg might bind to translation factors that are different from those which bind to MNV VPg; 
secondly, NV VPg might not recognise MNV VP1 and therefore encapsidation is possibly affected; 
thirdly, NV VPg might not be recognised by MNV NS7, and may therefore not function as a template for 
MNV NS7 to initiate RNA synthesis. Subsequent to this study, published work has highlighted that MNV 
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VPg cannot be recognised by the human norovirus GII.4 NS7 and vice versa (Subba-Reddy et al., 2011), 
hence this hypothesis that lack of recovery was due to some type of species specific interaction between 
VPg and NS7 was correct. Based on this published data, NV VPg was not recognised by the NS7, MNV 
RNA polymerase for nucleotidylation; hence the MNV genomic RNA without VPg attached at its 5’ end 
was not infectious. Since replacing a full length MNV NS5 gene with NV NS5 was not tolerated within the 
genome of MNV, manipulating chimera encoded with a hybrid structure of MNV and NV VPg could 
possibly enable the recovery of a viable virus with less global effect compared to replacing a full length 
coding region of NV VPg. For instance, a small coding region of MNV VPg (i.e. C-terminus domain) in the 
MNV cDNA clone could be replaced by the corresponding region of NV VPg, without affecting the NS7 
interaction for nucleotidylation, while the core and N-terminal region of MNV VPg remain in the cDNA 
clone. By generating this chimera, it should provide useful information whether the replaced 
corresponding region is conserved in noroviruses for translation factor binding and it would enable us to 
further elucidate the corresponding functional residues required for vial translation by performing a 
mutagenesis study. 
To date, the NV replicon system has only been used as a tool to study viral replication, but not viral 
translation. As an alternative approach to elucidate the functional feature of NV VPg required for 
translation initiation, the NV replicon system was examined. To determine whether or not translation 
initiation factors were isolated from the replicon system, similar to the MNV reverse genetics system, 
cap affinity chromatography was performed. Our result indicated that NV VPg could be isolated along 
with eIF4E and other associated translation initiation factors from NV-replicon bearing cell extracts. This 
suggested that similar to MNV and FCV VPg (Chaudhry et al., 2006; Goodfellow et al., 2005), the 
interaction of NV VPg and eIF4E does not interfere with the cap binding ability of the eIF4E protein. This 
experiment showed that the NV replicon cell line could be used as an experimental system to examine 
the effect of NV VPg mutations on their generation of replicon containing cell line, although further 
investigation was not possible due to time constraints. Nonetheless, this work provides the first data for 
the interaction between human norovirus VPg and translation initiation factors during virus replication. 
In addition, the NV replicon system can be used to study the functional role of translation initiation 
factors involved in NV translation using RNA interference, and the effect of gene silencing approaches 
on NV could be examined by quantifying copies of genomic RNA by qPCR. Given that NV replicon 
bearing cells could be a good tool in the elucidation of NV VPg-dependent translation initiation, a 
comparative mutagenic analysis of MNV and NV VPg could be performed on the basis of its role in 
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translation factor binding. In conclusion, future studies on the NV replicon system could provide 
fundamental information for vaccine and antiviral development. 
4.4.2 Analysis of the functional residues in MNV VPg essential for translation initiation 
factor binding 
From our mutagenic study of MNV VPg, seven substitutions (K3A, L21A, D23A, E25A, Y26F, E28A and 
F123A) in MNV VPg did not recover any virus based on the absence of a visible cytopathic effect by 
TCID50 assay. This might indicate that those conserved amino acid residues at the corresponding 
positions of MNV VPg are critical determinants for MNV infectivity. F123A displayed a lethal phenotype 
i.e. no virus was recovered, even after serial bind passage, which was likely the result of its reduced 
ability to bind translation initiation factors, as seen by the cap affinity chromatography assay. Thus, the 
F123A mutant was further characterised in chapter 5, in order to analyse the functional role of MNV VPg 
involved in translation initiation through its F123 residue. Other residues, such as V115 and D116, may 
also play a role in aiding or stabilising the translation initiation factors binding to VPg from the analysis 
of cap affinity chromatography. The substitution of valine with alanine 115 reverted to WT after 7 
passages, implying that position 115 may also be important for viral translation. In contrast to the V115A 
mutation which was restored during passage in vitro, the mutation D116A was stable after multiple 
passages in tissue culture. It is possible that changing from a more hydrophobic valine to a less 
hydrophobic alanine at position 115 affected the structure of the VPg to some extent; therefore, the 
mutation was restored after several passages in tissue culture. Nevertheless, V115 appeared to be a 
more important residue of VPg required to establish translation initiation factor binding, while D116 
could be less essential. In general, analysis of the MNV VPg mutagenic study has demonstrated that the 
residues in the C-terminus of VPg are essential for the interaction of VPg with the components of the 
eIF4F complex. The relative order of importance of VPg residues for translation initiation factor binding 
can be categorised as F123> V115> D116. Based on the fact that VPg F123, V115 and D116 are the 
binding sites for translation initiation factors, it would be exciting to screen for a peptide-based drug 
from peptide library, which may target one these three conserved residues on VPg to test if they inhibit 
the translation initiation binding. This constitutes an interesting field of study in order to find strategies 
to control noroviruses from a peptide library. 
Our mutagenesis study also showed that the K3A mutant could not be recovered by reverse genetics, 
which was largely due to defects in polyprotein processing; thus, the VPg precursors bearing a larger 
molecular weight were being isolated from the cap sepharose. Of those VPg mutants, the mutations 
                                                             P a g e  | 120 
 
L21A, D23A, E25A, Y26F and E28A also conferred a lethal phenotype and no infectious virus could be 
recovered by the reverse genetics, even after a series of blind passages. Given that VPg plays a role in 
RNA synthesis and potentially encapsidation, the mutations at positions 21,23,25,26 and 28, which did 
not appear to affect translation initiation factor binding from the cap-sepharose pull down assay may 
affect RNA polymerase or major capsid protein binding. It has been shown that NS7 is required for the 
successful nucleotidylation of calicivirus VPg in which VPg could serve as a primer for RNA synthesis in a 
template-dependent manner. For instance, RHDV VPg could be uridylylated by viral polymerase at a 
tyrosine residue located at position 21 (Machin et al., 2001), which is the first evidence to suggest VPg 
may serve as a primer during replication. Mutagenesis studies of VPg have found the corresponding 
conserved tyrosine at position 24 in FCV VPg (Mitra et al., 2004) and tyrosine at position 27 in the 
human MD145 norovirus, VPg protein (Belliot et al., 2008) to be the site of nucleotidylation. Based on 
the amino acid sequence alignment, the homologue conserved tyrosine in MNV VPg is at position 26. 
From the mutagenesis study, although Y26F retained the capacity to bind translation factors, no virus 
was recovered from the reverse genetics system, and therefore the VPg appeared to be defective in 
nucleotidylation. Yet, a recent in vitro mutagenesis study suggests that the mutation of MNV VPg at 
position 117 also diminishes its nucleotidylation (Han et al., 2010). The ability of VPg containing Y26A 
and Y117A to stimulate the activity and function as a target for NS7-mediated nucleotidylation were 
examined using a cell based reporter assay. This assay relied on RNAs synthesised by transiently 
expressed RdRp that stimulates retinoic acid-inducible gene I (RIG-I)-dependent reporter luciferase 
production via the beta interferon promoter. The result showed that the presence of WT and Y117A did 
not affect the ability of NS7 to generate VPg-linked RNA that was sensed by RIG-I and subsequently lead 
to the induction of luciferase under the control of the IFN beta promoter. In contrast, Y26A showed a 
reduction in luciferase expression compared with WT (Subba-Reddy et al., 2011). This study indicates 
that Y26 interacts with NS7 for nucleotidylation. Moreover, the effect of the Y26A and F117A mutation 
have further been examined by introducing these mutations into the MNV infectious clone. Similar to 
what we observed, it was shown that the Y26A mutation could not recover any virus, whereas Y117 
mutation recovered with a similar virus yield and exhibited similar plaque morphology as WT. This 
confirms that the linkage of VPg to viral RNA is likely through Y26 rather than Y117 (Subba-Reddy et al., 
2011). As for the remaining mutants (L21A, D23A, E25A and E28A), additional studies are required to 
determine the mutation effect and their functional role in the virus life cycle.  
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4.4.3 Conserved feature of structural core of VPg 
NMR analysis has revealed that MNV VPg possesses a stable helical structural core domain with two 
flexible termini. The helical structural core of MNV VPg stretches between amino acid positions 14 and 
55, which appeared to be stabilised through salt-bridges and hydrophobic interaction. Based on an 
analysis of NMR and mutagenic data, it is concluded that the stabilisation of VPg core largely depends on 
hydrophobic interactions rather than salt bridges, since disrupting the hydrophobic interaction resulted 
in the loss of core structure and significant defects in virus yield. Furthermore, the results concluded 
that hydrophobic aromatic residues at F29, Y40 and Y45 of VPg are important for the stabilisation of the 
structural core of the VPg. 
Another interesting finding from the NMR analysis is that both the N- and C-termini of MNV VPg are 
flexible and not well-structured, the so-called intrinsic disorder region. It has been suggested that these 
intrinsic disorder regions are often involved in protein function, such as specificity and binding affinity. It 
has been proposed that the transition from a disordered to an ordered structure occurs upon binding to 
its interacting partner (Fong et al., 2009). Thus, the conserved F123, V115 and D116 of VPg which lie 
within the intrinsic disorder region may orientate upon being cooperatively bound to various translation 
factors which favour viral translation initiation. HA proteins of virulent influenza virus strains (H1N1 
1918, H5N1) have also been predicted to have intrinsic disordered regions at the helical tip of the 
protein, but not in avirulent strains which contain a more ordered region in the HA protein (Goh et al., 
2009). It was proposed that the increasing disorder structure of the HA protein correlates with increased 
fitness of influenza, and serves as a predictor of virulence.  Therefore this knowledge can also be used in 
alternative strategies for vaccine development against pathogenic influenza viruses. Alternatively, 
knowing the structure of MNV VPg will allow us to search for a new drug specifically targeted to 
conserved functional properties of VPg (i.e. F123 or Y26) using NMR-based screening technology.  
This work highlights that the efficiency of translation is dependent on VPg, which might be a major 
determinant of virulence. In vitro mutagenesis showed that F123, V115 and D116 are conserved 
residues within the disordered region, which are involved in translation initiation binding, and in 
addition to that F123 is the key residue responsible for translation initiation factor binding. This study 
has also discovered other functional features of VPg which may be involved in other aspect of the MNV 
life cycle, such as nucleotidylation, viral RNA synthesis or encapsidation. These functional residues found 
in MNV VPg are potentially a good target for drug design. As a target approach of disrupting the 
interaction of VPg with translation factors, information on translation initiation binding sites in MNV VPg 
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and direct interacting partners of MNV VPg (see chapter 6) could be needed. In summary, our data from 
the mutagenesis study and NMR have provided new strategies for the discovery of drugs and possibly 
vaccines to combat human and murine norovirus infection.  
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5 Introduction 
Members of Caliciviridae differ in their requirements for components of the eIF4F complex (Chaudhry et 
al., 2006; Goodfellow et al., 2005), but the requirement of other cellular factors in VPg-dependent 
translation is unknown. Therefore, a full-scale proteomic analysis of calicivirus translation initiation 
complexes may provide a better insight into the mechanism of calicivirus translation initiation in a 
broader context and enable a more in-depth comparative analysis of members of the Caliciviridae.  
A common tool used to identify protein partners is co-immunoprecipitation (Co-IP). This is a single-step 
method used to purify target proteins and their interacting partners, however it requires good quality 
antibodies with high affinity and specificity against the target protein. While this approach limits the 
recovery of low abundance proteins present in the starting material, tandem affinity purification (TAP) 
enables a rapid purification of fusion protein complexes from crude extracts in native conditions, using a 
two-step process (Burckstummer et al., 2006). The advantages of two-step purification are that it 
reduces background contamination by abundant proteins and can even isolate protein targets that are 
present at low concentrations. In this study, TAP was used to isolate the VPg-associated translation 
initiation complex to gain further insights into this novel mechanism of viral genome translation. 
 
5.1 Tandem affinity purification 
The TAP system was based on a modified version developed by Burckstummer et al (Burckstummer et 
al., 2006) in which the fusion tag contained two units of protein G and a streptavidin-binding peptide 
(SBP), separated by a tobacco etch virus (TEV) protease cleavage sequence (referred  to as a TAP tag, 
figure 5.1A). In this study, the TAP tagged VPg was expressed using two expression systems, a cadmium 
chloride (CdCl2) (figure 5.1B) and the tetracycline (figure 5.1C) inducible systems. For the CdCl2 inducible 
system, the pMEP4 plasmid was engineered to contain a TAP tag at the N-terminus of the target protein, 
which was driven by a metallothionein inducible promoter, and expressed in human 293T cells. This 
construct also encoded the Epstein Barr virus EBNA1 protein, which enables the stable episomal 
maintenance of the plasmid. Once induced with CdCl2, the target protein, expressed as a fusion protein 
with two protein G domains, is readily detected by immunoblotting with IgG containing antiserum. For 
the tetracycline inducible system, a parental 293TREX cell line expressing the tetracycline repressor was 
transfected with a pCDNA4:TO:NTAP constructs that encoded TAP tag derivatives of VPg tagged at the 
N-terminus (NTAP). When the cells were induced with a stable derivative of tetracycline, doxycycline, 
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the TAP-tagged fusion proteins were expressed, which again could be detected by immunoblotting with 
IgG containing antiserum. The induced cell lines expressing the NTAP-target proteins were then 
subjected to tandem affinity purification to co-purify the cellular proteins that bound to the target 
proteins.  
The TAP process consisted of several main steps, as highlighted in figure 5.2. Briefly, the lysates 
containing the TAP-tagged proteins were immunoprecipitated by binding of the protein G domains to 
IgG-coupled to agarose resin. The protein G domains were then cleaved off by TEV protease and 
removed. As such, the SBP-tagged proteins in a complex with any associated host cell factors were 
released into the supernatant and were subsequently isolated using streptavidin agarose. Finally, the co-
purified proteins were eluted with biotin, resolved by SDS-PAGE gel, and identified using mass 
spectrometry.  
 
 
Figure 5.1  Overview of the TAP expression systems. A) Schematic diagram of an N-terminal TAP 
tag fused with a target protein. The TAP tag contains two units of protein G domain, followed by 
a TEV protease cleavage site and a streptavidin binding peptide. Such a TAP tag was engineered 
into a construct and expressed under different inducible systems; B) the CdCl inducible system 
and C) the tetracycline inducible system.  
A.
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Figure 5.2  Overview of the process of the tandem affinity purification. After induction, cells were 
harvested, lysed with a TAP buffer, and centrifuged to remove any cell debris (1). The cleared 
lysates then were subjected to the first Co-IP by incubation with IgG agarose resins (2). The protein 
G units from the NTAP protein have an affinity with the IgG-coupled agarose, co-purifying the 
cellular proteins associated with the NTAP-target protein under mild buffer conditions. After 
incubation, any unbound and non-specific proteins were removed by washing (3). Subsequently, the 
protein G domains were cleaved off by TEV protease (4) and removed. The SBP-tagged proteins 
were released into the supernatant, along with any associated host cell factors, which were then 
isolated by binding to streptavidin agarose (5). This was the second co-IP, which improved the 
specificity of the purification procedure and reduced the possibility of a false positive result. Finally, 
any proteins associated with the SBP-tagged proteins were eluted with biotin (7) after washing (6).  
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5.2 Expression of NTAP-VPg 
At the beginning of this study, a pMEP4 construct encoding the MNV VPg fused to an N-terminal TAP tag 
(NTAP-MNV VPg) was transfected into 293T cells and cells episomally replicating the plasmid were 
selected. The expression of NTAP-MNV VPg was induced with CdCl2 for 16 hours and analysed by 
western blot. Since the NTAP contained the protein G units, the NTAP fusion proteins could be readily 
detected by immunoblotting with rabbit anti-serum containing IgG. The NTAP-MNV VPg with the 
molecular weight of 35kDa was detected by western blot, while the NTAP protein alone was about 
20kDa in size (figure 5.3A). The cell line expressing NTAP alone was used as a negative control for the 
experiment to identify proteins that bound to the TAP tag non-specifically.  
 
Using this CdCl2 inducible system, under conditions where cell density was low, the cells containing the 
episomally maintained TAP expression plasmid displayed significant signs of apoptosis after induction 
 
Figure 5.3 Expression of NTAP-tagged derivatives. Various NTAP-tagged derivatives were expressed 
using a CdCl inducible system (A) and a tetracycline inducible system (B). A) The HEK 293 cell line 
expressing TAP alone or NTAP-MNV VPg was induced with CdCl and the lysate was resolved in SDS-
PAGE gel. The expression of the NTAP or NTAP-MNV VPg proteins was determined by immuno-
blotting with rabbit anti-serum containing IgG. B) The selected stable 293TREX cell line expressing 
NTAP or its derivatives of MNV VPg, RHDV VPg and FCV VPg was induced with doxycycline. The 
presence of NTAP fusion protein was detected by immuno-blotting with normal IgG containing 
rabbit serum. The sample that was prepared from cells had not been induced are labelled as ‘NI’, 
and those was prepared from induced cells are labelled as ‘I’.  
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(data not shown). Previous studies have supported our observation that the heavy metal CdCl2 is toxic to 
cells (Watjen et al., 2002a; Watjen et al., 2002b), thus, a tetracycline inducible system was also used as 
an alternative protein expression system because tetracycline is non-toxic to cells. A pcDNA4 construct 
encoding the MNV VPg fused with an NTAP tag was transfected into 293TREX cell and stable cell lines 
selected. After being induced with tetracycline derivative, doxycycline, NTAP and NTAP-MNV VPg were 
readily detected (figure 5.3B). It is worth noting that the inducibility of the tetracycline system appeared 
to be better than that of the CdCl2 system. As previously mentioned, a comparative proteomic analysis 
between members of the Caliciviridae would be a good approach to understand the requirement for 
translation initiation factors among caliciviruses. Hence, several constructs encoding the VPg from 
representative members of a number of Caliciviridae genera were also made; this included FCV VPg 
from Vesivirus and RHDV VPg from Lagovirus. They represent the best-studied member of the genus and 
could provide a framework for understanding the biology of other caliciviruses. These NTAP-VPg 
derivatives were transfected into 293TREX cells and their stable integrants were selected. Upon 
tetracycline induction, the cells expressed the NTAP derivatives of RHDV VPg and FCV VPg with 
approximate sizes of 35kDa and 32kDa respectively (figure 5.3B).  
5.3 NTAP tag does not interfere with the translation factor binding to MNV or 
RHDV VPg 
The NTAP-VPg fusion proteins were first examined to determine if they had retained the ability to 
interact with the translation initiation factors. Cap sepharose affinity chromatography was used to 
isolate the cellular translation initiation complex and the associated VPg protein through the interaction 
of a cap-binding protein, eIF4E (Chaudhry et al., 2006). A cap-sepharose purification of lysates from the 
cells was performed following induction, and the resulting eluates were analysed by western blot. As 
expected, eIF4E was clearly isolated from all cell lines (bottom panel, figure 5.4). The NTAP-MNV VPg 
and NTAP-RHDV VPg fusion proteins were co-purified with eIF4E and the eIF4F complex using cap-
sepharose (top panel, figure 5.4), confirming that the expressed NTAP derivatives of the MNV and RHDV 
VPg protein were able to interact with the translation initiation factors. In contrast, the NTAP-FCV VPg 
was not co-purified with translation initiation factors using cap-sepharose (figure 5.4), indicating that 
the NTAP-FCV VPg may have been incorrectly folded. Furthermore, preliminary data from our 
collaborator, Stephen Curry (Imperial College), has suggested that the N-terminus of the FCV VPg might 
be important for eIF4E binding (data not shown). Therefore, it is not surprising that the N-terminal tag 
on FCV VPg affected the ability of FCV VPg to be co-purified with the initiation factors. 
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Having confirmed their binding abilities of the NTAP-VPg, the cell lines expressing the NTAP-MNV VPg 
and NTAP-RHDV VPg fusion proteins, as well as the NTAP tag alone as a negative control, were induced 
with either CdCl2 or doxycycline and subsequently subjected to tandem affinity purification on a large 
scale. Following purification, 15% of the total eluted protein from each sample was fractionated by SDS-
PAGE gel, which was then silver-stained for protein analysis. The remaining eluted protein was then run 
on a 1D gradient SDS-PAGE gel, and protein bands were excised and sent for mass spectrometry 
analysis.  
 
5.4 Proteomic analysis of RHDV VPg-translation initiation factor complex 
As described above, an attempt was made to co-purify the translation initiation factors using NTAP-
RHDV VPg with the same procedure used for NTAP-MNV VPg, however no host factors were co-purified 
except those found to non-specifically associate with the tag (figure 5.5). The most likely explanation for 
this is that NTAP-RHDV VPg may be only loosely associated with the canonical translation initiation 
factors at the ionic strength of a washing buffer, i.e. the salt concentration used in the TAP buffer. 
Furthermore, the NTAP tag on the VPg structure may affect the binding of translation initiation factors 
under the conditions used during the tandem affinity purification. Although the NTAP-RHDV VPg could 
be isolated from the cap sepharose through interaction with the translation initiation factors (figure 
5.5), the buffer conditions used in the cap sepharose pull-down assay and in the tandem affinity 
  
Figure 5.4 Isolation of the NTAP-calicivirus VPg proteins using cap sepharose. The NTAP derivatives 
of MNV, FCV and RHDV VPg were expressed in 293 TREX cell lines and the lysates (L) were incubated 
with cap sepharose as described in methods and materials. The proteins remaining bound to the 
cap sepharose after washing were eluted in SDS-PAGE sample buffer and analysed by western 
blotting to probe for the presence of NTAP tagged protein and eIF4E. These purified proteins are 
referred as ‘m7’. 
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purification differed slightly, which may have affected the stability of the interaction between cellular 
factors and RHDV VPg. In this case, samples which were taken at different stages of the purification 
procedure were analysed by western blot to probe for eIF4A and eIF4E, in order to determine the 
efficiency of purification and determine at which step the initiation factors were removed. eIF4A and 
eIF4E were only detected in clear lysate and supernatant obtained after incubation with IgG agarose 
resin, indicating that eIF4A and eIF4E were simply not purified with the RHDV VPg after 
immunoprecipitating the cleared lysate with IgG-coupled resin (data not shown). However, it is clear 
that the tagged-RHDV was present in the final elution (figure 5.5), confirming the NTAP-RHDV VPg 
purification was sucessful, while the translation initiation factors that were associated with the NTAP-
RHDV VPg were lost during the purification procedure. Further studies using TAP tagged derivative of 
RHDV VPg would require optimization of the buffer conditions and unfortunately I was unable to 
perform this additional work due to time constraints. 
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Figure 5.5 Tandem affinity purification of VPg-
associated translation initiation factors from the HEK 
293 TREX cell, which expressed NTAP-RHDV VPg. The 
stable 293 TREX cell lines, expressing either NTAP 
alone or NTAP fused to RHDV VPg, were generated 
and tandem affinity purified. The eluted proteins 
were subsequently resolved by gradient SDS-PAGE 
and silver-stained. The NTAP RHDV VPg protein is 
indicated by a white triangle (). The NTAP alone is 
indicated by a black triangle ().  
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5.5 Comparative analysis of NTAP-MNV VPg expressed from two inducible 
systems  
 
 
 
Figure 5.6 Comparative purification of NTAP-MNV VPg expressed using two different inducible 
systems, A) CdCl and B) tetracycline inducible system. A) The purified proteins expressed in a CdCl2 
inducible system were resolved in SDS-PAGE gel and silver-stained as shown. B) The purified proteins 
that expressed in a tetracycline inducible system were treated in the presence (+RNase) or absence 
(-RNase) of the nuclease during the purification process, and were subsequently resolved in SDS-
PAGE gel and silver-stained. The left panel indicates the pre-stained marker with the corresponding 
molecular weight. The TAP tag protein that acts as a negative control is indicated by a black triangle 
(). The protein bands observed in the sample of NTAP alone are non-specific proteins associated 
with the TAP tag. The NTAP-MNV VPg is indicated by an asterisk.  
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The NTAP-MNV VPg proteins that were purified using the CdCl2 and tetracycline inducible systems were 
compared, as shown in figure 5.6. As demonstrated by silver staining analysis, the tetracycline inducible 
system resulted in co-purification of fewer proteins in comparison to the CdCl2 inducible system. Given 
that CdCl2 metal caused significant cellular stress (Watjen et al., 2002a; Watjen et al., 2002b), it is 
possible that using CdCl2 as an inducer for protein expression resulted in increased isolation of non-
specific and irrelevant proteins. This explains why a tetracycline inducible system was used as an 
alternative for protein expression in the subsequent investigation. However, the profile of proteins 
isolated with NTAP-MNV VPg via either the CdCl2 or tetracycline inducible systems were largely similar. 
NTAP acted as a control for the experiment and the proteins that were isolated from NTAP tag were 
considered non-specific binding proteins (figure 5.6). Previous work in our lab has indicated that VPg 
may possess RNA binding activity by virtue of a highly K/R rich sequence at its N terminus (data not 
shown); therefore, VPg may bind and co-purify cellular RNA along with any associated host cell factors. 
To overcome this problem, cell lysates prepared from the tetracycline inducible system were also 
treated with RNase and DNase during the course of the purification process to ensure the isolated 
proteins were RNA-independent and specifically bound to VPg.  Figure 5.6B showed that the treatment 
of the samples with nucleases had no effect on the profile of the proteins isolated; hence, it can be 
concluded that the isolated proteins are likely to interact with VPg in an RNA-independent manner.  
 
5.6 Co-purification of canonical translation initiation factors using NTAP-
MNV VPg 
The proteins co-purified with the NTAP-MNV VPg expressed in the two different inducible systems were 
sent for mass spectrometry analysis performed at the proteomics facility of McGill University and 
Quebec Innovation Centre in Canada. The mass spectrometry data was analysed against human and 
MNV protein databases, and the identified proteins were screened against the list of proteins found in 
the non-specific NTAP purification control, using proteomic software, Scaffold 2. The final data is 
summarised in table 5.1, which is organised based on the number of unique peptides. A variety of 
cellular proteins were purified using the NTAP-MNV VPg protein, which were not found using  the NTAP 
tag alone, and as such these were considered to be specific interaction partners of VPg.  Conversely, any 
proteins that were also found in the NTAP control were considered as non-specific binding proteins and 
filtered out. It is worth noting that the NTAP-VPg sample from the tetracycline expression system had 
been nuclease treated, therefore the proteins identified must form protein-dependent interactions with 
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NTAP-VPg. The majority of the canonical translation initiation factors, isolated using the NTAP-MNV VPg 
from the CdCl2 expression system, were also isolated with the NTAP-MNV VPg expressed in the 
tetracycline inducible system. These canonical factors included two isoforms of the PABP protein, 
components of the eIF3 complex and the entire eIF4F complex including eIF4E, eIF4A and eIF4G. It is not 
surprising that these canonical translation initiation factors were isolated using NTAP-MNV VPg, since 
previous studies have already shown MNV VPg possibly interacts with eIF3, eIF4GI and eIF4E (Chaudhry 
et al., 2006; Daughenbaugh et al., 2003; Daughenbaugh et al., 2006). However, this is the first report 
showing MNV VPg co-purified a large range of canonical translation factors in a complex. From table 5.1, 
the eIF4G isoforms eIF4GI and eIF4GII, isolated from both expression systems, clearly had the highest 
number of unique peptides. This data is likely to indicate that these proteins were the most abundant 
proteins in the purified complex. Further experiments were carried out (see chapter 6) to determine 
which canonical translation initiation component was the direct binding partner of the MNV VPg protein 
and the interaction most likely to play a functional role in viral translation.  
As a member of the DEAD box family of putative ATPase/helicases, elF4A is required for MNV translation 
(Chaudhry et al., 2006). Not surprisingly, eIF4A (including eIF4AI and eIF4AII) had the second highest 
number of isolated unique peptides (table 5.1). In addition, the eIF4AII isoform appears to have a much 
lower number of unique peptides than eIF4AI. Although it is possible that eIF4AII is less abundant in the 
starting extract, a more appealing explanation is that MNV translation may have a greater dependence 
on the eIF4AI function than the eIF4AII, however future experiments are needed to address this 
question. PABP was also co-purified with NTAP-MNV VPg. PABP1 is one of the PABP isoforms, which 
represents the third highest number of isolated unique peptides (table 5.1). In addition, PABP4 was also 
co-purified with NTAP-MNV VPg, although fewer unique peptides were identified compared with PABP1, 
suggesting it was less abundant in the co-purified complex. As previously mentioned in the introduction, 
the translation of MNV RNA is insensitive to the depletion of eIF4E or the addition of 4E-BP1, which 
prevents the eIF4E-eIF4G interaction in the in vitro translation system (Chaudhry et al., 2006). This 
suggests that eIF4E may not be required for MNV translation and explains why a relatively low number 
of unique peptides of eIF4E were isolated.  
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The eIF3 complex is responsible for the 48S complex assembly via interacting with eIF4G. It consists of 
13 non-identical sub-units, which are designated eIF3a to eIF3m (Masutani et al., 2007; Zhou et al., 
2008). Yet, the data obtained here demonstrated that NTAP-MNV VPg isolated 12 of the total 13 
subunits of the eIF3 complex from the CdCl2 expression system (table 5.1A). The eIF3j subunit was the 
only subunit which was not found in the purified eIF3 complex. In contrast, only five subunits of eIF3 
(subunits a, b, c, e, l and k) were isolated using the tetracycline inducible system (table 5.1B), while the 
remaining subunits (d, f, g, h, i and m) may have been lost during purification. Further studies are 
warranted to examine which subunits form part of the VPg-associated translation initiation complex and 
their functional role in viral protein synthesis. 
NTAP-MNV VPg expressed from the CdCl2 expression system also co-purified the 40S ribosomal proteins 
(S12, S15A and S25) and the 60S ribosomal protein P2 (table 5.1A), since they are key apparatus for 
protein synthesis (Agalarov et al., 2000; Alksne et al., 1993). In contrast, the sample of NTAP-MNV VPg 
expressed from a tetracycline inducible system that had been treated with nuclease did not isolate any 
ribosomal protein. Therefore, the ribosomal subunits were probably isolated due to their association 
with RNA, which stabilise their interaction with VPg through interaction with the eIF3 complex. 
Elongation factor 1 alpha (EFIα) was identified in the NTAP-MNV VPg containing complex from the CdCl2 
expression system. As its name suggests, it is involved in elongation of the polypeptide chain, and 
transporting aminoacyl-tRNAs to a free site of the ribosome. Apart from its function in translation 
elongation, it has been implicated in virus replication. The multifunctional EFIα protein also interacts 
with tubulin beta to initiate assembly of the microtubules in the presence of tubulin beta (Gillardon, 
2009). Interestingly, tubulin beta was also isolated using the NTAP-MNV VPg from the CdCl2 expression 
system, however the peptide hit obtained from mass spectrometry was also relatively low (figure 5.1A). 
Since tubulin is the building block of microtubules and highly abundant in cells, it may simply be co-
purified due to the high levels of this protein expressed in cells. 
NTAP-MNV VPg also isolated some non-canonical translation initiation factors from the CdCl2 expression 
system (table 5.1a). These proteins included RNA helicase A (DDX9), ATP-binding cassette sub-family E 
member 1 (ABCE1), tubulin beta 2C, La-related protein (LARP) and insulin-like growth factor 2 mRNA 
binding protein (IGF2-BP1). Interestingly, these non-canonical translation initiation factors were isolated 
with NTAP-MNV VPg from the CdCl2 expression system but not from the tetracycline expression system. 
Given that the proteins purified from the CdCl2 expression system were not nuclease treated during the 
purification and that VPg has an RNA-binding activity, many of these non-canonical translation initiation 
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factors could be RNA-associated proteins; hence they were possibly co-purified with RNA rather than 
associated with the VPg-containing complex. Alternatively, the presence of non-canonical factors from 
the CdCl2 expression system could be a simple reflection of the higher expression levels of the NTAP-VPg 
fusion protein expressed in this system hence, more non-canonical translation factors were isolated. 
Another possibility is that they were co-purified with NTAP-MNV VPg from the CdCl2-induced cells when 
the cells are under stress. Finally, actin was also isolated from tetracycline expression system using 
NTAP-MNV VPg, which has been implicated to play a role in virus assembly (Han and Harty, 2005) and 
virus spread (Ward and Moss, 2001). Moreover, it can associate with and EF1α, that in turn mediates 
cellular RNA-cytoskeleton interaction (Zeenko et al., 2002). 
 
5.7 Confirming the presence of VPg-associated translation initiation factors 
To confirm the presence of translation initiation factors associated with NTAP-MNV VPg, the eluted 
proteins isolated from the tetracycline expression system were analysed using western blot. The 
presence of the eIF4A, eIF4E, eIF4G and PABP proteins in the MNV VPg-containg complex was confirmed 
(figure 5.7A), supporting the data from the mass spectrometry analysis. It is worth noting that the level 
of eIF4E in the input lysate of the TAP procedure was not detectable at low exposure despite a high level 
of eIF4E being purified from the NTAP-MNV VPg (figure 5.7A, lane 3).  This could have been because the 
signal indicating the presence of eIF4E in the lysate sample was partially masked by the signal from the 
protein G domains in TAP fusion tag binding to the eIF4E antisera. To confirm that eIF4E was present in 
the NTAP-MNV VPg-containing complex, the eluted proteins were run along with lysates from RAW 
cells. The result indicated eIF4E was co-purified with NTAP-MNV VPg (figure 5.7B), which suggested 
eIF4E was enriched during the purification and enabled it to be readily detected in the final eluted 
sample. 
The presence of non-canonical translation initiation factors, such as DDX9 and ABCE1 was also 
examined. Whilst the western blot analysis demonstrated that NTAP-MNV VPg isolated various 
canonical translation initiation factors from the tetracycline inducible system, the non-canonical 
translation initiation factors such as ABCE1 and DDX9, were not detected (figure 5.7A), which is 
consistent with the result of the mass spectrometry analysis. In conclusion, the canonical initiation 
factors (eIF4A, eIF4E, eIF4G and PABP) appeared to form a translation initiation factor complex 
associated with MNV VPg. 
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Figure 5.7 The translation initiation factors that were co-purified with NTAP-MNV VPg were 
confirmed by western blot. A) The whole cell lysates (L) from the sample of TAP tag protein alone 
and the NTAP-tagged derivative of MNV VPg were tandem affinity purified. The elutes prior to 
nuclease treatment (E+) or without nuclease treatment (E) were analysed by western blot to probe 
for the presence of eIF4E, eIF4G, eIF4A, PABP, DDX9 and ABCE1 in the purified sample of NTAP-MNV 
VPg. B) The presence of eIF4E protein from the purified sample of NTAP-MNV VPg was further 
confirmed. The RAW cell lysate (as the control) and the elute were analysed by western blot. The 
data confirms that eIF4E was present in purified samples. (E+ indicates the purified samples that 
were previously treated with nuclease; E indicates purified samples without treated with nuclease; 
The TAP tag protein is indicated by (◄); the asterisk represents the NTAP-MNV VPg protein. 
L        E      E+        L        E        E+
NTAP
NTAP- MNV 
VPg
HEK 293 TREX
PABP
eIF4A
*
eIF4G
eIF4E
◄
A
L         E      E+  
eIF4E (30kDa)
B
46
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220
175
80
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73
ABCE1
DDX9150
68
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5.8 4E-BP was co-purified with NTAP-eIF4E, but not NTAP-MNV VPg  
 
As a control and for a comparative analysis, a cell line expressing NTAP-eIF4E in the tetracycline 
inducible system was tandem affinity purified by our lab members (Bailey et al., 2012). The samples 
were also sent for mass spectrometry analysis to identify cellular proteins associated with eIF4E 
(appendix 1). The identified canonical translation initiation factors were then compared with those 
purified using NTAP-MNV VPg (table 5.2). As a component of the eIF4F complex, eIF4E can bind to the N-
terminus of eIF4G that in turn co-operatively interacts with PABP, eIF3 and eIF4A; therefore, it is not 
surprising that the entire eIF4F complex, PABPs and eIF3 complex were isolated with NTAP-eIF4E. These 
canonical translation initiation factors (eIF4A, eIF4G and PABP) were also co-purified with NTAP-MNV 
 
Table 5.2 Comparative analysis of NTAP-eIF4E and NTAP-MNV VPg. The table shows various 
canonical translation initiation factors which had been isolated using NTAP-eIF4E and NTAP-MNV 
VPg from two expression systems. The grey box indicates the presence of corresponding protein 
from the sample; the white box indicates the absence of corresponding protein from the sample.  
NTAP-eIF4E 
Identified 
protein
CdCl expression 
system
Tetracycline 
expression 
system
Tetracycline 
expression 
system
eIF4A I
eIF4A II
eIF4E 
eIF4G I
eIF4G II
PABP 1
PABP 4
4E-BP1/ 4E-BP2
eIF3a
eIF3b
eIF3c
eIF3d
eIF3e
eIF3f
eIF3g
eIF3h
eIF3i
eIF3j 
eIF3k
eIF3l
eIF3m
NTAP-MNV VPg
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VPg. It is worth noting that NTAP-eIF4E co-purified the entire eIF3 complex (table 5.2), whilst NTAP-MNV 
VPg resulted in co-purification of the whole complex except eIF3j in the CdCl2 expression system but 
only a small number of subunits with the tetracycline expression system (table 5.2). These results may 
suggest that the interaction of NTAP-eIF4E with the eIF3 components are more stable compared with 
the NTAP-MNV VPg. 
4E-BP1 and 4E-BP2, which are known to compete with eIF4G for binding to eIF4E, were purified with 
NTAP-eIF4E, but were not isolated from the NTAP-MNV VPg (table 5.2). The interaction of 4E-BP and 
eIF4E prevents eIF4E from binding to eIF4G to form an active eIF4F complex, which in turn results in the 
inhibition of a cap-dependent translation (Hughes et al., 1999). This suggests that eIF4E isolated with 
NTAP-MNV VPg appears to be within the eIF4F complex, but not as a “free” eIF4E. The non-canonical 
translation initiation factors such as DDX9, ABCE1, LARP, IGF-2 and EFIα, purified with NTAP-MNV VPg 
were not isolated using the NTAP-eIF4E, whilst other factors such as eIF4E transporter and 
heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) isolated with NTAP-eIF4E were not found in the 
purification of NTAP-MNV VPg (see appendix 1). 
5.9 Expression of VPg-associated proteins during MNV infection  
Viruses often modify the expression of cellular proteins which are involved in their lifecycle. To 
determine the role of the factors identified in the VPg-translation initiation factor complex and to 
examine whether or not virus infection modifies their expression, their levels of expression were 
examined by western blot. The levels of eIF4E, eIF4A, eIF4G and eIF3 proteins were expressed at the 
same level throughout the MNV infection (figure 5.8), suggesting that the MNV does not modify their 
gene expression during infection. Interestingly, eIF4G was shown be cleaved during FCV infection 
(Willcocks et al., 2004), whereas no cleavage products were seen at the bottom of the gels throughout 
the MNV infection by the western blot analysis (data not shown). The eIF4G cleavage does not occur 
during MNV infection, indicating that MNV and FCV employ different strategies to gain control of 
cellular mRNA translation. 
In contrast, PABP was cleaved at around 9 hours post-infection respectively (right panel, figure 5.8), 
which suggests that MNV modifed the expression of PABP. It has been reported that PABP cleavage, 
which is mediated by viral proteases in PV-infected cells, contributes to the host translational shutoff. 
During FCV infections, the PABP proteins had been cleaved at various sites by the FCV protease, similar 
to the observation in PV- infected cells (Kuyumcu-Martinez et al., 2004b). The PABP cleavage product 
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detected in FCV-infected feline kidney (CRFK) cells was approximately 50kDa, whereas three PABP 
cleavage products (61kDa, 46kDa and 55kDa) were generated by PV 3C and 2A proteases in HeLa cells 
(Kuyumcu-Martinez et al., 2004b). Similar to the PV 3C protease, human NV NS6 protease preferentially 
cleaves the PABP associated with the translation apparatus, which yields cleavage products of about 
61kDa and 46kDa. From our western blot analysis, PABP was cleaved to produce a product of 30kDa in 
size during MNV infection. A possible explanation for the differentially sized cleavage products could be 
the variation of the amino acid sequences of the PABP between two species, i.e. humans and mice, 
however a comparative study between the cleavage products mediated by both proteases would be 
required to confirm this observation.  
 
 
Figure 5.8  Effects of MNV on protein expression. RAW cells were infected with MNV at an m.o.i of 
4 for 24 hours and were harvested at various time points. The cells were lysed and resolved by SDS-
PAGE gel and immuno-probed for the presence of eIF4E, eIF4G, eIF4A, PABP, eIF3, NS7 and GAPDH. 
The mock lysate (M) from non-infected cells was a control for the experiment. (Note: No cleavage 
product was observed where the cropped images are shown.) 
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5.10 Phenylalanine at position 123 in VPg is critical for translation initiation 
factors binding 
The F123A VPg mutant was previously described in chapter 4, conferred a lethal phenotype and was 
unable to produce a viable virus after the serial bind passage. In addition, F123A mutation reduced the 
ability to bind translation initiation factors in the cap sepharose pull-down assay, therefore F123A 
mutant was further characterised to examine the effect of mutation in the VPg protein on the 
translation initiation factor binding. Constructs encoding the WT or the mutant F123A form of NTAP-
MNV VPg were transiently expressed and tandem affinity purified. Subsequently, the samples were 
subjected to SDS-PAGE electrophoresis and analysed by western blot. The data indicated that eIF4A, 
eIF4G and PABP were co-purified with NTAP-WT MNV VPg, whereas the purification of NTAP-VPg F123A 
could not detect these proteins (figure 5.9A), correlating with the results from the cap-sepharose pull-
down assay. Interestingly, eIF4E was co-purified with both NTAP-WT VPg and NTAP-F123A VPg (figure 
5.9A).  
To confirm whether the interaction existed between eIF4E and F123A VPg, similar to the WT VPg, a 
capture ELISA was preformed. In this experiment, the Cherry-ORF4-HIS protein that does not contribute 
to viral translation was a negative control. The WT and F123A forms of VPg containing a Cherry and HIS 
tag at its N and C-terminus respectively supplied from our laboratory were used. These proteins have a 
Cherry tag, consisting of a 11kDa heme binding domain of cytochrome. This tag gives the expressed 
fusion protein a red colour and is convenient for rapid screening and optimisation of protein solubility. 
Essentially, the recombinant Cherry-HIS tagged proteins were immobilised on a plate to examine its 
interaction with HIS-eIF4E. Their interactions were then detected by anti-eIF4E antibodies. Our data 
showed the recombinant HIS-eIF4E was retained by both WT and mutant F123A form of MNV VPg, 
whereas a control protein Cherry-ORF4-HIS failed to bind eIF4E (figure 5.9B). These observations 
suggested that eIF4E is unlikely to be important in MNV translation, since F123A that displayed the 
lethal phenotype retained ability to bind eIF4E. In general, the phenylalanine at position 123 in VPg 
protein is essential to mediate interaction with translation initiation factors, i.e. eIF4A, eIF4G and PABP, 
which is essential to establish a stable translation initiation complex for viral protein synthesis 
translation. 
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Figure 5.9 The amino acid position at 123 in VPg protein is critical for binding to eIF4A, eIF4G and 
PABP. A) HEK 293 cells transiently expressing either the WT or the mutated form (F123A) of NTAP-
MNV VPg proteins were tandem affinity purified. The clear lysate (L) and the purified eluted protein 
(E) were subjected to SDS PAGE gel and analysed by western blot for detecting eIF4A, eIF4G, eIF4E 
and PABP. The NTAP tag protein is indicated by a black triangle () and the NTAP-MNV VPg protein 
is represented by an asterisk. B) The interaction of eIF4E with the WT and F123A mutant form of 
Cherry-HIS-MNV VPg was assayed by capture ELISA. The ELISA plate were pre-coated with variable 
amounts of the WT or F123A form of recombinant Cherry-VPg-HIS. Cherry-ORF4-HIS was used as a 
negative control for the experiment respectively. Up to 4μg of the murine HIS-eIF4E protein was 
incubated with the immobilised proteins. Protein associated with eIF4E was detected using anti-
eIF4E antisera and was quantified at OD450nm. Error bars represent the standard error of the mean 
for two independent experiments. 
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5.11 Comparative analysis of the human and murine norovirus VPg-containing 
translation initiation complexes 
Following the successful identification of the translation initiation factors associated with NTAP-MNV 
VPg in a complex, we performed a similar type of analysis using human norovirus VPg to examine 
whether or not similar components will be co-purified with human NV VPg, as with MNV VPg. Constructs 
expressing the NTAP or CTAP derivatives of NV VPg (the prototype GI human norovirus VPg) in the 
tetracycline inducible expression system were generated and compared in parallel for analysis. Cells 
expressing VPg were lysed and tandem affinity purified as described in the standard protocol. Western 
blot was performed to confirm the presence of eIF4A, eIF4E, eIF4G and PABP. The entire eIF4F complex 
and PABP were co-purified with both NTAP- and CTAP-NV VPg as observed from NTAP- or CTAP-MNV 
VPg (figure 5.10). In conclusion, the supportive data provided extra evidence that murine and human 
noroviruses share the same, or highly similar, translation mechanisms.  
 
 
Figure 5.10 The entire eIF4F complex and PABP proteins were co-purified with NTAP or CTAP 
derivatives of MNV VPg and of NV VPg. The whole cell lysate (L) from the sample of NTAP tag 
protein and NTAP or CTAP tagged derivative of MNV VPg or NV VPg were tandem affinity purified. 
The purified proteins (S7) were analysed by western blot to determine the presence of the 
components of eIF4F complex and PABP. The TAP tag protein is indicated as a dark triangle (◄); the 
triangles coloured in white () represent the NTAP- or CTAP-NV VPg; the asterisks represent the 
NTAP or CTAP derivatives of the MNV VPg protein.  
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5.12 Discussion 
As a key component of translation initiation machinery, the eIF4F complex mediates the circularisation 
of the mRNA through an interaction with PABP bound to the 3’ poly(A) tail and functions as a bridge 
between the mRNA and the ribosome via binding to eIF3 (Pestova et al., 2001; Pestova et al., 2007). All 
these proteins work in a synergistic manner to promote cellular translation, therefore eIF4F complex 
assembly is important for initiation of cap-dependent translation. As for calicivirus translation, VPg 
mimics a cap structure to recruit the eIF4F for viral protein synthesis. Previous data have demonstrated 
eIF4E, eIF4GI and the components of the eIF3 complex (subunit a, b, c and d) were associated with GST-
NV VPg from cell lysate, while a direct interaction between eIF4E and MNV or FCV VPg has been 
described (Chaudhry et al., 2006). Undoubtedly, further studies into this novel paradigm of protein-
directed protein synthesis were warranted, therefore a full-scale proteomic analysis of the MNV 
translation initiation complex was performed, which indicated that numerous canonical and non-
canonical translation initiation factors were associated with VPg (table 5.1). These canonical translation 
initiation factors included the entire eIF4F complex, components of eIF3, PABP and some ribosomal 
subunits.  
Our proteomic data showed that eIF4G had the highest number of unique peptide isolated from two 
expression system (table 5.1), suggesting it interacts with NTAP-MNV VPg strongly, despite being the 
least abundant of the eIF4 factors (von der Haar and McCarthy, 2002). Two eIF4G isoforms were isolated 
and they were eIF4GI and eIF4GII. Both are 46% identical and functionally interchangeable (Gradi et al., 
1998a; Gradi et al., 1998b), but they are expressed differentially among various tissue. The role of these 
eIF4G homologues in MNV translation was characterised and this work is described in chapter 6. In 
addition, eIF4G has been a target for cleavage by a number of viral proteases. In the case of PV and HRV, 
both eIF4G isoforms are cleaved by the viral protease, however, eIF4GI cleavage occurred at an earlier 
time than that of eIF4GII. It has been suggested that the cleavage of eIF4GII correlates to host 
translation shutoff, not the eIF4GI cleavage (Gradi et al., 1998b; Svitkin et al., 1999). While FCV also 
caused an eIF4G cleavage in infected CRFK cells, host shutoff was apparent at the time when both eIF4G 
proteins were cleaved. The NS6 protease of FCV, which is responsible for eIF4G proteolysis, cleaved only 
a proportion of eIF4GI and the rate of eIF4GI processing was much slower than that of eIF4GII (Willcocks 
et al., 2004). In contrast to FCV infection, eIF4G was not cleaved during MNV infection suggesting eIF4G 
cleavage is not responsible for the impairment of cellular protein synthesis. 
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elF4A is thought to be the one of the most abundant eIFs across eukaryotes (von der Haar and 
McCarthy, 2002), followed by elF4E. As a key component of eIF4F complex, elF4A is functionally 
essential for MNV translation as indicated using in vitro translation studies (Chaudhry et al., 2006). Our 
data shows that eIF4A protein is the second highest purified protein within the VPg-translation initiation 
complex (table 5.1). Interestingly there is lesser eIF4AII isolated compared with eIF4AI, suggesting that 
MNV translation has a greater dependence on the eIF4AI function than the eIF4AII. Due to time 
constraint, further studies have not yet preformed to address the role of different homologues in MNV 
protein synthesis. 
Followed by eIF4A, PABP was the third highest number of isolated unique peptide being co-purified with 
NTAP-MNV VPg (table 5.1). PABP directly interacts with 3’ poly (A) tail. It also binds to eIF4G via its 
second RRM domain resulting in circularisation of the mRNA, in a ‘closed’ loop conformation. This aids 
the recruitment of 40S subunits and ribosome recycling on the mRNA, and allows eIF4F to remain 
anchored to the mRNA even when its contacts with the 5’ end of the mRNA are disrupted. From our 
data, two form of PABPs were isolated, PABP1 and PABP4. Possibly, they are purified via their 
association with eIF4G. This would provide a mechanism for genome circularisation via an additional 
interaction of PABP with the viral poly(A) tail. In addition, PABP4 had lower number of unique peptides 
compared with PABP1, suggesting it was less abundant in the co-purified complex. Both isoforms exhibit 
a conserved CTD linked to the remaining region of protein via a proline-rich sequence and are 
responsible for protein-protein interaction such as with PCBP (Mangus et al., 2003). Most functional 
studies were preformed with PABP1 and the functional relatedness between the isoforms are not well 
characterised, although recent studies have demonstrated that PABP4 cannot rescue morpholino-
mediated PABP1 depletion. This indicates PCBP4 is functionally distinct from PABP1, although both are 
important for embryonic development and share a conserved role in stimulating global translation 
(Gorgoni et al., 2011). The observation of PABP expression in MNV-infected cells revealed that PABP was 
cleaved at 9 hours post-infection. Published data has demonstrated that PABP cleavage mediated by the 
enteroviral protease is accompanied by host shutoff during virus infection, which separates the RRMs at 
the N-terminus from the CTD resulting in impairment of cellular protein synthesis (Kuyumcu-Martinez et 
al., 2004b; Lloyd, 2006; Rivera and Lloyd, 2008). CTD is responsible for binding to various cellular 
proteins including eRF3, eIF4B and PAIP1, and therefore removal of CTD diminishes cellular protein 
synthesis due to the disruption of the protein-protein interaction (Kuyumcu-Martinez et al., 2004b; 
Lloyd, 2006; Rivera and Lloyd, 2008). In addition, in vitro study has shown that PABP is preferentially 
cleaved by NV NS6 protease, which yields a cleavage product of about 61kDa and 46kDa in size. 
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However, our preliminary observation indicated that PABP was cleaved generating a 30kDa cleaved 
fragment. Although MNV and human NV lay within the same genus and their proteases exhibit the same 
preference for dipeptide cleavage sites, the size of PABP-cleaved products generated by MNV and NV 
NS6 appears to be different. Hence, it is necessary to compare the PABP processing mediated by the 
MNV and human norovirus 3CL proteases in a parallel analysis before confirming this observation. 
Moreover, a previous study has demonstrated that the cleavage of PABP correlates with the host 
translational shutoff in FCV-infected cells (Kuyumcu-Martinez et al., 2004a). The PABP cleavage that 
occurs during MNV infection is most likely to cause suppression of the host protein synthesis; thus, more 
cellular translation machinery is available to complete the virus lifecycle effectively. Apart from the fact 
that the cleavage of the PABP correlates to the host shutoff, it may also play a role in a switch from 
translation to replication. In general, a PABP cleavage may be the mechanism adopted by caliciviruses to 
control the host mRNA translation, and this may be important to the virus lifecycle. 
As a control, NTAP-eIF4E was purified and its associated proteins were compared with those purified 
using NTAP-MNV VPg. The result suggested all canonical initiation factors isolated with NTAP-MNV VPg 
were associated with NTAP-eIF4E, except 4E-BPs (4E-BP1 and 4E-BP2). It is known that when eIF4E binds 
4E-BP1, it can no longer associate with eIF4G. Disassociation of eIF4E with eIF4G prevents the formation 
of a functional eIF4F complex, which ultimately results in inhibition of translation initiation (Matsuo et 
al., 1997). This means eIF4E found in the NTAP-MNV VPg purification was most likely associated with 
eIF4G and formed an active eIF4F complex. In addition, F123A mutation that exhibited a lethal 
phenotype, reduced the ability of VPg to associate with cap- sepharose (section 4.2, figure 4.6) but it 
was not entirely ablated (ie. it was still detectable after longer exposure in the mutagenesis data). 
Further characterisation of the effect the F123A mutation indicated that the mutated VPg failed to 
interact with the canonical translation initiation factors eIF4G, eIF4A and PABP, but retained the ability 
to interact with eIF4E. Consistent with these results, the ELISA binding assay confirmed that eIF4E bound 
to the F123A VPg, relatively similar to that of the WT VPg (section 5.10). These collective data confirm 
that this mutation appears to affect the binding of VPg to eIF4G but not eIF4E. The reduced binding to 
cap-sepharose is probably because the mutant form binds the eIF4F complex with a lower efficiency 
than the WT as it can no longer bind eIF4G. This additional interaction with eIF4G probably plays a role 
in the stabilization of the VPg association with the eIF4F complex. Furthermore, a previous study 
demonstrates that depletion of eIF4E or the addition of 4E-BP1 had no effect on MNV translation in vitro 
(Chaudhry et al., 2006), suggesting eIF4E or the interaction between eIF4E and eIF4G is not essential for 
MNV translation. Together with our data, eIF4E might be not responsible for viral translation, although 
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our proteomic data indicated eIF4E was isolated at a relatively low level. This raises the question of why 
MNV VPg recruits eIF4E to the VPg-translation initiation complex. One appealing hypothesis could be 
that the interaction of VPg and eIF4E reduces the amount of eIF4E available for the cap protein structure 
on the 5’ end of cellular mRNA, thereby increasing the availability of the other cellular components 
required for MNV translation, and consequently more translation factors are available for viral 
translation. Further studies on the effect of eIF4E recruitment on cellular or viral translation could not  
be examined due to time constraints; however the functional role of the eIF4E-eIF4G interaction during 
MNV infection was examined as detailed in chapter 6. 
eIF3 is the largest initiation factor in mammalian cells and consists of 13 non-identical sub-units, which 
are designated eIF3a to eIF3m (Masutani et al., 2007; Zhou et al., 2008). Only five of the eIF3 
components (eIF3a, -b, -c, -g and –i) compose a conserved core of the eIF3 complex, which is essential 
for translation in vivo (Masutani et al., 2007; Zhou et al., 2008). Previous data has shown that native eIF3 
in mammalian cell lysates or purified eIF3 components were isolated using GST-VPg (MNV and NV VPg), 
but only eIF3a, eIF3b and eIF3c were identified in GST-VPg pull-down elutes (Daughenbaugh et al., 2003; 
Daughenbaugh et al., 2006). The yeast two-hybrid analysis indicated eIF3d subunit bound directly to NV 
VPg, suggesting it is responsible for the interaction between NV VPg and the eIF3 complex 
(Daughenbaugh et al., 2003). Furthermore, the C-terminal half of NV VPg protein (GST- VPg70-138) could 
be primarily the eIF3-binding domain (Daughenbaugh et al., 2003; Daughenbaugh et al., 2006). Similarly, 
our mutagenesis data also demonstrated that the C-terminus of MNV VPg (especially the F123 residue) 
is responsible for translation initiation binding. This indicated the MNV and NV VPg are relatively 
conserved, and hence, they are likely to share the same translation initiation factors to initiate norovirus 
translation. Our present proteomic analysis demonstrated that NTAP-MNV VPg isolated 12 of the total 
13 subunits of the eIF3 complex from the CdCl2 expression system. The eIF3j subunit that has previously 
found to be readily disassociated with the eIF3 complex during purification (Fraser et al., 2007) was not 
associated with NTAP-MNV VPg, although this subunit is important for stabilising the interaction 
between eIF3 and the 40S ribosomal protein (Fraser et al., 2004). Whilst almost entire eIF3 complex was 
isolated from the CdCl2 expression system, only five subunits of eIF3 were isolated using the NTAP from 
a tetracycline expression system, which included subunits a, b, c, e, l and k. The remaining subunits (d, f, 
g, h, I, j and m) were not present in the purification of NTAP-VPg expressed in a tetracycline expression 
system, which suggested that these subunits were disassociated from the VPg-translation initiation 
complex during purification. Looking back at table 5.1B, the numbers of unique peptides of eIF3 
components isolated from the tetracycline expression system were generally much lower than from the 
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CdCl2 expression system (table 5.1A). It is worth noting that the eIF3d protein that is thought to play a 
role in the VPg-eIF3 interaction (Daughenbaugh et al., 2003) was not isolated from the tetracycline 
system. It could be that the eIF3-VPg interaction was established by another higher affinity binder than 
eIF3d, and eIF3d might well be only an auxiliary factor of the eIF3-VPg interaction. Since the purified 
proteins isolated from the tetracycline expression system was nuclease treated, the eIF3 complex that is 
responsible for 40S ribosomal protein binding and ribosomal biogenesis (Zhou et al., 2008)could be less 
stable in the absence of RNA. Hence, those components of the eIF3 complex that loosely associate with 
the core eIF3 module could be readily removed prior to the nuclease treatment and subsequent round 
of purification steps. Although it is possible that an entire eIF3 complex may be required to establish a 
stable and functional complex associated with VPg, the current study could not reveal which subunit(s) 
are responsible for VPg interaction. By comparing the mass spectra of free eIF3 with that bound to VPg, 
it may provide a further insight into the interaction of VPg and eIF3. Nevertheless, the eIF3 subunits a, b, 
c, e, l and k were isolated from both expression system and collectively functions in recruiting 40S 
ribosomal subunit. For instance, eIF3a is responsible for binding eIF1 and eIF2β (LeFebvre et al., 2006); 
eIF3c is responsible for binding eIF1 and eIF5 (Asano et al., 2001; LeFebvre et al., 2006); eIF3b, a scaffold 
sub-unit within eIF3 is responsible for binding 40S ribosome via eIF3j (ElAntak et al., 2007); eIF3e which 
was bound to eIF4GI (LeFebvre et al., 2006); eIF3l and eIF3k which was bound to eIF3e (Zhou et al., 
2008). One might predict that the eIF3(a:b:c:e:l:k) may well be a core interacting module binding to VPg 
at the manipulated ionic strength of a complex-containing solution, but further studies are required to 
reach a conclusion.  
From the CdCl2 expression system, the 40S ribosomal proteins (S12, S15A and S25) and the 60S 
ribosomal protein (P2) were co-purified with NTAP-MNV VPg. Since protein synthesis takes place on 
ribosome, it is not surprising that large (60S) and small (40S) subunits of the ribosome were isolated. It 
has been shown that the ribosomal subunits S12, S15 and S21 are associated with the 16S rRNA for the 
human equivalent bacterial small ribosomal subunit, 30S (Agalarov et al., 2000; Alksne et al., 1993). In 
contrast, NTAP-MNV VPg expressed from a tetracycline inducible system that had been treated with 
nuclease did not isolate any ribosomal protein. Given that VPg may have RNA binding activity by virtue 
of a highly K/R rich sequence at its N terminus (data not shown), it is possible that VPg bind and co-
purify cellular RNA along with any associated host cell factors. EFIα, that is responsible for translation 
elongation was isolated using NTAP-MNV VPg from the CdCl2 expression system. It has been implicated 
in the replication of turnip yellow mosaic virus. At the 3’UTR of this virus genome, there is a tRNA-like 
structure which can bind EFIα to repress synthesis of the minus strand RNA in vitro (Matsuda et al., 
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2004). Other study illustrates that EFIα can interacts with the tubulin beta to initiates the assembly of 
the microtubules (Gillardon, 2009). In fact, tubulin beta was also isolated using the NTAP-MNV VPg from 
the CdCl2 expression system, although whether this is a direct interaction or through EFIα remains to be 
determined. Interestingly, the PB2 subunit of influenza viral RNA polymerase has shown to bind beta-
tubulin, although its role during RNA replication is not yet identified (Fislova et al., 2010), it is believed to 
serve as an anchoring site on the cytoskeleton for the viral RNA polymerase when RNA synthesis is 
active (Klumpp et al., 1997). In addition, the peptide hit obtained from mass spectrometry was also 
relatively low (figure 5.1A). Given that tubulin is the building block of microtubules and highly abundant 
in cells, it may simply be co-purified due to the high levels of this protein expressed in cells.  
Various non-canonical translation initiation factors including DDX9, ABCE1, tubulin beta 2C, LARP and 
IGF2-BP1 were isolated with NTAP-MNV VPg from the CdCl2 expression system (table 5.1a), but none of 
them were detected from the tetracycline inducible system. Since those proteins were not nuclease 
treated during the purification, these factors could be RNA-associated and co-purified with VPg that 
processes RNA-binding property. Another reason could simply be that they were co-purified with NTAP-
MNV VPg when the CdCl2-induced cells were under stress, therefore future experiments are warranted 
to determine which identified proteins interacted with VPg by Co-IP. If the assay confirms such 
interactions exist, other functional studies such as protein knockdown using RNA interference could be 
performed to investigate the role of these interactions during norovirus reproductive cycle. According to 
the literature, these non-canonical translation initiation factors have been implicated in cellular and viral 
biological processes such as translation and replication. For instance, DDX9 is a member of the DEAD-
box ATP-dependent RNA helicases. It can shuttle between the nucleus and cytoplasm and is mRNP-
associated (Merz et al., 2007). It plays a role in the unwinding of the RNA secondary structure in 
translation and in CREB-dependent transcription (Aratani et al., 2003). DDX9 plays an important role in 
FMDV replication through interactions with viral 2C and 3A protease and PABP, in order to promote the 
assembly of the replication complexes (Lawrence and Rieder, 2009). Reduction of DDX9 resulted in an 
inhibition of FMDV replication (Lawrence and Rieder, 2009). LARP plays a stimulatory role in translation 
whereby it is bound to the PABP and eIF4E proteins at the 5’ and 3’end of mRNA (Burrows et al., 2010). 
It also binds with cytoskeletal components to regulate cell migration (Burrows et al., 2010). In addition, 
the LARP isoform, LARP7, is a poly(U)-binding protein which has been suggested to play a role in the 
transcription of cellular and viral polymerase II genes (Markert et al., 2008). Recently, ABCE1 has also 
been identified to play a role in promoting ribosomal recycling (Pisarev et al., 2010). In addition, it binds 
to eIF2α and eIF5 to form a pre-translation initiation complex, suggesting its function in cell growth and 
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development (Chen et al., 2006). Study has shown that ABCE1 associates with the HIV gag protein at 
sites of assembly and disassociation of Gag-ABCE1 appears to correlate with the event of virion 
maturation and virion production (Dooher et al., 2007). IGF2-BP1 regulates IGF2 (insulin-like growth 
factor 2) translation and it is also associated with YBX1 and DDX9 in an RNA-dependent fashion, in which 
YBX1 and DDX9 are essential to ensure the stabilisation of the c-myc mRNA (Weidensdorfer et al., 2009). 
In this study, an attempt to identify binding partners for the representative of calicivirus VPg including 
FCV, RHDV and MNV VPg was performed using TAP. Although cell line expressing NTAP-FCV VPg and 
NTAP-RHDV VPg were successfully generated, the NTAP tag on FCV VPg interfered with the binding 
ability of the VPg, while there was not any protein detected in the purification of NTAP-RHDV VPg 
except the non-specifically bound proteins. However, our proteomic analyses of MNV VPg were 
successful which provides a network of interacting proteins and these interactions might involve in 
many aspect of biological processes. In conclusion, MNV VPg was found to associate with several key 
canonical translation initiation factors (eIF3, PABP and the entire eIF4F complex) and additionally, it may 
possibly bind to some non-canonical ones. Given that the F123 residue of MNV VPg is the major site 
responsible for the translation initiation factor binding, identification of direct interaction of host and 
virus would be an effective approach to hamper norovirus translation and control virus infection (see 
chapter 6).  
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6 Introduction 
As detailed in chapter 1, many viruses alter or modify the eIF4F complex to obtain a translational 
advantage for their mRNAs. The calicivirus VPg protein acts as a ‘cap substitute’ that recruits the 
translation initiation factors to drive calicivirus translation (Burroughs and Brown, 1978; Chaudhry et al., 
2006; Daughenbaugh et al., 2003; Daughenbaugh et al., 2006; Goodfellow et al., 2005; Herbert et al., 
1997). Given that the mechanism of calicivirus translation initiation is dependent on VPg, the natural 
ligands that interact with VPg could be potential anti-viral targets against virus infection. To date, limited 
functional studies have been carried out with respect to norovirus translation. Currently, MNV 
translation is known to be eIF4A-dependent and does not require an intact eIF4G for RNA translation in 
vitro (Chaudhry et al., 2006), however previous and current studies confirmed the eIF4G proteolysis did 
not occur during MNV infection (Chaudhry et al., 2006). Despite the fact that MNV VPg can bind eIF4E 
(Chaudhry et al., 2006), a functional role for this interaction has not yet been determined. According to 
the proteomic data presented in chapter 5, the VPg-associated translation initiation complex consists of 
numerous canonical and non-canonical translation initiation components that are possibly involved in 
the initiation of viral protein synthesis. Based on staining intensity and the number of unique peptides 
identified, eIF4G appeared to be the most abundant protein associated with NTAP-MNV VPg in the 
proteomics data (table 5.1). In addition, our proteomic data also suggested that eIF4E interacts with 
MNV VPg, including mutant VPg F123A, a change conferring a lethal phenotype to MNV. A major 
question thus raised was whether the eIF4G-VPg interaction is direct and how relevant this interaction is 
for MNV life cycle. The results presented in this chapter were aimed at answering the above question as 
well as trying to determine whether the interaction between eIF4E and eIF4G was required for virus 
translation. 
 
6.1 VPg binds eIF4G 
Changing the ionic strength of a buffer during immuno-precipitation can be used to define the strength 
of protein-protein interactions. In other words, higher ionic strength conditions disrupt the protein-
protein interactions which could be used as a crude way to determine the protein that binds to the 
target with the highest affinity. To identify the component or components within the VPg-associated 
translation initiation complex that bind to VPg with the highest affinity,  the ionic strength of buffer used 
at the final washing step was titrated, ranging from a standard salt concentration (125mM NaCl) to the 
highest salt concentration (1M NaCl).  The purified proteins were then analysed by western blot to 
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probe for the presence of the canonical translation initiation factors, eIF4A, eIF4E, eIF4G and PABP as 
these represented the most abundant proteins identified in the purified complex.  
 
The data presented in figure 6.1 demonstrated that eIF4A, eIF4E and PABP were co-purified with NTAP-
MNV VPg using a standard washing buffer containing roughly physiological ionic conditions, however 
these proteins became gradually undetectable after being washed with an increasingly ionic strength 
buffer (figure 6.1).  In contrast, eIF4G remained associated with VPg under high stringency conditions 
 
Figure 6.1 Determining the canonical translation initiation factors that bound to VPg with the 
highest affinity. The HEK293 TREX cell line expressing NTAP-MNV VPg was induced and 
subjected to tandem affinity purification as previously described, except that the ionic strength 
of the washing buffer was changed during the final washing step prior to elution. The ionic 
strength of the washing buffer was changed by titrating the NaCl concentration from 125mM to 
1M. After elution, the purified protein sample was then resolved by SDS-PAGE gel and analysed 
by western blot to immuno-probe for eIF4A, eIF4E, eIF4G and PABP. The black triangle 
represents the NTAP tag protein; the asterisk represents the NTAP-MNV VPg protein; L 
represents the lysate input and P is the protein sample isolated after tandem affinity 
purification. (Note: The endogenous level of total eIF4G protein was detected by anti-eIF4G 
antiserum (NEB).) 
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(figure 6.1), suggesting its high binding affinity for VPg. Based on this data and our previous data, eIF4G 
is the most abundant protein in complexes bound to VPg (highest number of unique peptides), we 
would therefore predict that eIF4G is a direct binding partner for MNV VPg. However, based on these 
data alone, whether or not eIF4G establishes a direct physical interaction with the MNV VPg could not 
be determined and hence further experiments were performed to answer this.  
 
6.2 Identification of functional domain in eIF4G involved in VPg binding 
Having demonstrated that eIF4G is capable of binding to the NTAP-MNV VPg protein under high ionic 
conditions, I next chose to define the VPg binding site in the eIF4G protein, using nickel affinity 
chromatography (HIS-tag pull-down assay). Several eIF4G expression constructs were kindly supplied by 
Simon Morley (University of Sussex). These constructs were designed to express HIS-tag derivatives of 
various eIF4G domains including N-FAG, M- FAG, C-FAG, p100 and 4GM (figure 6.2). These truncated 
proteins represent various eIF4G cleavage products generated by viral and/or cellular proteases. N-FAG, 
M-FAG and C-FAG are distinct breakdown products of eIF4G derived from caspase-3 proteolysis where 
FAG is an abbreviation of ‘Fragment of Apoptotic cleavage of the eIF4G’ (Bushell et al., 2000; Coldwell et 
al., 2004). M- FAG is the central region of eIF4G that has three known binding sites for eIF4E, eIF4A and 
eIF3. N-FAG is the N-terminus region of eIF4G containing the PABP binding site, while the C-FAG is the C-
terminal end of eIF4G containing both the second eIF4A and Mnk-binding sites. p100 is the C-terminal 
fragment of eIF4G generated by FMDV Lb protease, which contains a binding site for eIF3, as well as the 
two eIF4A-binding sites (Glaser et al., 2001). The 4GM is a smaller fragment of p100, containing binding 
sites for eIF3 and eIF4A (Coldwell et al., 2004) (figure 6.2).  Although a construct expressing a full length 
eIF4G was not used, given that our previously published data suggested that cleavage of eIF4G by the 
FMDV Lb protease had no effect on MNV translation (Chaudhry et al., 2006), we would expect any VPg 
binding domain to be in the p100 fragment. 
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A T7 RNA polymerase based expression system was used to overexpress the eIF4G fragments and VPg in 
BSRT7 cells. Constructs encoding various fragments of eIF4G were co-transfected with either the full 
length cDNA clone of WT MNV or the VPg F123A mutant into FPV-T7 infected BSRT7 cells. The cDNA 
clone of the VPg F123A mutant was used as a negative control for the experiment since the mutant 
showed a reduced ability to bind translation initiation factors and conferred a lethal phenotype (section 
4.2 and 5.10). In addition, an empty plasmid, pcDNA3.1+ was used as an additional control. To identify 
the functional domain of eIF4G that bound to MNV VPg, cells expressing the eIF4G fragments and MNV 
proteins were lysed and subjected to a HIS-tag pull-down assay as outlined in figure 6.3A.  
Following incubation with nickel resin, the HIS-tagged eIF4G derivatives and the associated proteins, 
including VPg in some cases, were analysed by western blotting. The purified proteins were first 
analysed using an anti-HIS tag antibody to determine whether the eIF4G fragments were expressed and 
purified as expected. As observed in figure 6.3, all the eIF4G proteins were detectable and expressed at 
similar levels. All HIS-tagged proteins were purified to similar levels following the nickel resin affinity 
purification (figure 6.3).  It is worth noting that N-FAG migrated at a higher mass than its expected size 
on an SDS-PAGE gel because of the basic amino acid sequence which acts as a nuclear localisation signal 
(Coldwell et al., 2004). Western blotting for the presence of VPg indicated that WT MNV VPg was 
precipitated and enriched with eIF4G M-FAG, p100 and 4GM, but not with N-FAG or C-FAG (figure 6.3B). 
This data highlighted that the central domain of eIF4G containing the eIF4A- and eIF3-binding sites is 
responsible for MNV VPg binding. As expected, F123A mutant that reduced the ability to bind 
translation factors compared to WT in cap-sepharose pull-downs assay was defective in binding any 
eIF4G fragment. This data further verified that the amino acid F123 in MNV VPg is critical for the 
interaction with the translation initiation factor. It is worth noting that the purified F123A VPg could be 
visible after longer exposure (figure 6.3) suggesting the F123A mutation reduced the binding to eIF4G 
but does not ablate it.  
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Figure 6.3 Functional mapping of VPg binding domain using HIS-tag pull-down assay. A) An 
overview of the in vitro HIS-tag pull-down assay. Constructs encoding the truncated eIF4G 
proteins (N-FAG, C-FAG, M-FAG, p100 and 4GM) were co-transfected with either a MNV cDNA 
clone of WT or F123A mutant into the FPV-infected BSRT7 cells. The empty plasmid (EMP), 
pcDNA3.1+ was used as a negative control. At 24 hours post-transfection, the cells were lysed 
using a standard CAP buffer and the resulting lysate (L) was incubated with the prewashed nickel 
resin. After incubation, the resin was washed extensively using a higher ionic strength buffer and 
were subsequently resuspended in a reduced protein sample buffer. B) Followed by HIS-pull-
down assay, approximately 17% of the purified protein (P) was resolved in an SDS-PAGE gel and 
analysed by western blot to probe for MNV VPg and eIF4G fragments using anti-HIS and anti-VPg 
antiserum. As expected, F123A that reduced the ability to bind translation initiation factors did 
not precipitated with any truncated eIF4G. The WT VPg proteins were precipitated with the HIS 
tag derivative of the M-FAG and 4-GM and p100 only.  
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6.3 VPg interacts with the central domain of eIF4G 
The data presented above confirms that MNV VPg binds to the central domain of eIF4G, however this 
assay does not enable us to determine whether the interaction is direct. One of the simplest approaches 
typically used to test direct interaction is to express and purify recombinant forms of both proteins and 
perform a pull-down assay. However, problems arise when the overexpressed protein is toxic to the 
cells, or the newly translated protein is degraded by intracellular proteases. Large proteins are also 
problematic as they might be insoluble or form inclusion bodies. An attempt was made to express 
various fragments of eIF4G in E. coli BL21 (DE3) cells, but only the smallest eIF4G fragment, C-FAG, 
expressed to readily detectable levels (data not shown). The remaining fragments were not expressed, 
possibly due to their large protein size. Thus, a cell-free expression system was selected as an alternative 
approach for studying direct protein-protein interaction. An E. coli based cell free coupled-transcription 
and translation (TNT) system, based on the use of a bacteriophage T7 promoter to express a high yield 
of recombinant protein in vitro, was used to express the eIF4G derivatives. The expression system 
utilises an S30 extract from E. coli strain B which is deficient in the OmpT endoproteinase and ion 
protease activity, which could prevent newly translated protein being degraded by protease. Similar to 
the other TNT systems, the expression system has S30 premix containing necessary components for 
transcription and translation, such as amino acids, tRNAs, NTPs, an energy source, an energy-
regenerating system and appropriate salts for optimal protein expression. We chose an E. coli-based 
cell-free system instead of a rabbit reticulocyte lysate expression system, because rabbit reticulocyte 
lysate contains high levels of mammalian translation initiation factors that could bridge the VPg-eIF4G 
interaction, whereas the E.coli lysate contains only bacterial translation factors. 
 
Our preliminary data indicated that even in this system, only the C-FAG and 4GM derivatives of eIF4G 
expressed to appreciable levels. According to the previous HIS pull-down assay, only the central domain 
of eIF4G, which includes 4GM, M-FAG and p100, was associated with VPg. Since 4GM is the smallest 
fragment of eIF4G found to bind VPg in our previous assays, the construct encoding 4GM was chosen to 
examine if the interaction between VPg and eIF4G was indeed direct. The construct encoding C-FAG was 
a good negative control for this experiment, given that MNV VPg was not precipitated with C-FAG in the 
previous pull-down assay. To determine if the interaction between VPg and HIS-eIF4G was direct and 
not mediated by other host factors, nickel affinity chromatography was used to evaluate the binding 
ability of in vitro expressed HIS-eIF4G fragments to recombinant MNV VPg. An overview of the 
experimental procedure is illustrated in figure 6.4A.  
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Figure 6.4  Demonstration of a direct interaction of eIF4G and MNV VPg. A) Isolation of the HIS-
tagged eIF4G fragments expressed from the TNT system by nickel affinity chromatography. 
Constructs encoding the truncated eIF4G proteins (C-FAG and 4GM) were expressed in an E.coli-
based cell free protein expression system. Essentially, the construct expressing C-FAG or 4GM and 
the TNT reaction mix containing TNT extract and components were mixed and incubated at 37°C. 
Subsequently, the reaction mix was added with a standard CAP buffer prior to incubation with the 
prewashed nickel resins. Followed by incubation, the proteins-coupled resins were washed prior to 
addition of 8 μg of the untagged MNV VPg protein and were left to incubate for three hours. The 
protein-coupled resins were washed with a higher ionic strength of CAP buffer to remove any non-
specific protein associated with them. Finally, the purified proteins were subjected to SDS-PAGE. B) 
MNV VPg bound to the HIS-4GM directly. The purified samples were analysed using western blot. 
Anti-HIS antisera were used to confirm the HIS-tagged eIF4G fragments were expressed, while anti-
VPg antibodies were used to examine whether the MNV VPg would precipitate with the HIS-eIF4G. 
The top panel shows that the truncated eIF4G proteins, C-FAG and 4GM, were expressed. The 
bottom panel indicates that VPg was isolated with HIS-4GM only. The lane on the far right 
represents 50ng of the recombinant VPg.  
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Briefly, the HIS tagged eIF4G fragments (C-FAG and 4GM) were expressed in the E.coli cell-free 
expression system as described in methods and materials and purified using nickel resin. Unbound 
proteins were removed prior to addition of the recombinant untagged MNV VPg. Following the binding 
reaction, unbound proteins were removed by washing and the protein complexes on beads were 
analysed by western blot. The western blot analysis showed that C-FAG and 4GM were expressed 
successfully using the E.coli TNT system (top panel, figure 6.4B). Our data indicated that VPg was only 
isolated with HIS-4GM, but not with HIS-C-FAG (bottom panel, figure 6.4B), correlating with our previous 
HIS-tag pull-down data from the cell culture. This verified that the binding site of MNV VPg lies within 
the central domain of eIF4G between the amino acid positions of 654-1131; however, further studies to 
define the minimal region required for VPg binding were not performed due to time constraints. 
 
6.4 Functional analysis of eIF4G in MNV translation initiation 
From the mass spectrometry analysis, two eIF4G isoforms were co-purified with NTAP-MNV VPg (section 
5.6). To investigate which specific eIF4G isoform plays a functional role in MNV translation, siRNAs were 
used to down-regulate the expression of eIF4GI and eIF4GII isoforms. Considering relatively low 
transfection efficiency of mouse RAW264.7 cells, siRNAs targeting eIF4GI or eIF4GII were transfected 
into human HEK 293T cells as described in methods and materials. 48 hours after two rounds of siRNA 
transfections, the eIF4G-silenced 293T cells were transfected with infectious MNV VPg–linked RNAs. 
Samples were harvested at 11 and 16 h.p.t of VPg-linked RNA and the levels of eIF4G as well as the viral 
polymerase NS7 were examined using western blot. The western blot analysis showed that the siRNA-
targeted eIF4GI mRNA caused a 94-98% reduction in eIF4GI levels at 11 and 16 h.p.t., while the control, 
non-specific (NS) siRNA caused no detectable down-regulation (figure 6.5). This knockdown of eIF4GI 
resulted in a 74.2% and 37% reduction of NS7 level at 11 and 16h.p.t respectively, in comparison to cells 
transfected with the NS siRNA control. In contrast, eIF4GII knockdown resulted in a reduction of its 
expression level by 93-96% at 11 and 16h.p.t., and a significant reduction of NS7 expression of 
approximately 79% to 53% at 11 and 16h.p.t., respectively. The translation of NS7 from the viral mRNA 
was severely affected in response to the eIF4GI and eIF4GII knockdown, suggesting that the eIF4G plays 
a critical role in MNV translation. The western blot analysis showed that the eIF4GII knockdown had a 
more dramatic effect on MNV translation than the eIF4GI siRNA-targeted cells (figure 6.5A), which 
indicated that MNV translation heavily relies on the availability of eIF4GII. Notably however, the siRNA 
selected to target eIF4GII, also resulted in a significant reduction in eIF4GI expression; thus, the effect of 
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eIF4GII siRNA on MNV translation could be a collective knockdown effect of both eIF4G isoforms exerted 
on the translation of viral protein (i.e, the eIF4GII siRNA targeting sequence against eIF4GI and eIF4GII is 
approximately 89% and 100% respectively).  
 
 
Figure 6.5  Knockdown effect of eIF4G on the MNV lifecycle. HEK 293T cells were transfected 
with specific siRNAs for eIF4GI or eIF4GII, as well as random non-specific (NS) siRNA. The cells 
were re-transfected with the siRNA at 24h.p.t to improve the knockdown efficiency. Thereafter, 
the cells were transfected with MNV VPg-linked RNA. A) Western blot was performed on the 
lysates harvested at 11 and 16 h.p.t of RNA to examine the efficiency of eIF4GI and eIF4GII 
silencing and the translation of NS7 and GAPDH. The numbers below the figures represent the 
percentage of protein expression relative to the control, which were quantified by densitometry 
using ImageJ. B) The virus yield was determined in RAW264.7 cells from two independent 
experiments, expressed as TCID50/ml and compared to NS control. Transfections were 
performed in triplicate and error bars represent the standard error of the mean. C) The genomic 
copy of RNA was analysed by qPCR. Transfections were performed in triplicate and the error bar 
indicates the standard error of the mean. Error bars reflect the standard deviation seen between 
the replicate titrations. The statistical differences compare to the negative control is calculated 
by one-way ANOVA which are represented by the P-values P < 0.0001 (***). 
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In addition to the effect on viral protein synthesis, the virus yield and genomic RNA synthesis were 
analysed by TCID50 and qPCR respectively to examine the effect of the eIF4GI and eIF4GII knockdown 
on the MNV replication. The production of infectious virus was equally inhibited in cells transfected with 
eIF4GI and eIF4GII siRNAs. The down-regulation of eIF4GI and eIF4GII had a significant effect on virus 
yield, with up to 9 fold reduction (P < 0.0001) in virus titre at 11 and 16h.p.t (figure 6.5B). Similar to the 
level of viral protein, a reduction of the eIF4GII level had a more dramatic effect on RNA replication than 
in cells with reduced eIF4GI levels. At 11 and 16h.p.t., the genomic RNA level in cells transfected with 
eIF4GI siRNA was reduced by 4.9 and 1.4 fold respectively (P < 0.0001), while a 6.1 to 7.0-fold reduction 
of genomic RNA was detected in cells with reduced levels of eIF4GII. As shown in figure 6.5C, the eIF4GI 
knockdown significantly affected the genomic RNA synthesis at an early time point, but the level of 
genomic RNA gradually returned to levels similar to that of the control. Possibly, the detectable level of 
eIF4GI resulting from an incomplete knockdown is capable of aiding the MNV translation at a slow rate, 
and once a sufficient level of viral protein has accumulated and reached a threshold, viral replication 
remains unaffected and continues as normal. However, an alternative hypothesis could be that MNV not 
only relies on the function of eIF4GI, but is also dependent on eIF4GII during its lifecycle. For instance, 
MNV may adopt to use eIF4GII as an alternative for translation when the eIF4GI is depleted. The qPCR 
analysis showed a greater effect of eIF4GII knockdown on the genomic RNA synthesis, which might 
imply that MNV translation is more dependent on the VPg-eIF4GII interaction than on eIF4GI. However, 
since the eIF4GII siRNA also affected the level of eIF4GI isoform in this study, the effect on genomic RNA 
synthesis in the eIF4GII siRNA-targeted cells could be due to the combined knockdown of both eIF4G 
isoforms, eIF4GI and eIF4GII. Nevertheless, both eIF4G isoforms contributed to an efficient MNV 
translation in this heterologous cell based system. 
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A CAT-luciferase assay was performed to prove that eIF4G knockdown in this system had a functional 
consequence on cap-dependent translation without affecting IRES-driven translation. A bicistronic RNA 
transcript (Cap-CAT:PTV IRES-fLuc) transcribed from the pGEM:Cap-CAT:PTV IRES-fLuc plasmid was used 
(Pisarev et al., 2004). This reporter expresses a chloramphenicol acetyltransferase (CAT) driven by a 5’ 
cap structure and a firefly-luciferase (fLuc) under the control of PTV IRES (figure 6.6A). PTV IRES was 
selected as a control since the translation from PTV IRES is unaffected even in the absence of eIF4G 
(Bakhshesh et al., 2008; Pisarev et al., 2004). The bicistronic RNA reporter was transfected into the 
 
Figure 6.6 Effect of siRNA of eIF4GI and eIF4GII on bicistronic reporter gene expression. A) 
Diagram of the bicistronic reporter constructs (pGEM: Cap-CAT:PTV IRES-fLuc). The construct was 
in vitro transcribed into capped RNA and was transfected into 293T cells that had been 
previously treated with siRNAs of eIF4GI or eIF4GII or non-specific (NS) control. The expression of 
CAT and fLuc proteins was controlled by a cap structure and PTV IRES respectively. B) A western 
blot was performed on the lysates of HEK 293T cells that transfected with the bicistronic RNA 
reporter constructs and siRNAs. The numbers below the figures represent the percentage of 
protein expression relative to the control, which were quantified by densitometry using LI-COR 
imaging system.  
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eIF4G-silenced 293 cells or NS siRNA-targeted cells. A quantitative analysis of the translation efficiency 
of CAT in eIF4GI- and eIF4GII-silenced cells resulted in 11% and 19% inhibition respectively compared 
with the NS siRNA-targeted cells, although previous studies have documented a reduction of 40-50% in 
translation rate (Coldwell and Morley, 2006; Welnowska et al., 2009). Nevertheless, our results are 
consistent with findings indicating that eIF4G partially affects protein synthesis (Coldwell and Morley, 
2006; Welnowska et al., 2009). In agreement with the previous studies (Bakhshesh et al., 2008; Pisarev 
et al., 2004), the translation of fLuc under the control of the eIF4G-independent PTV IRES was not 
significantly affected, which suggests that the general translation capacity of the eIF4G-silenced cells 
was not affected (figure 6.6B). 
 
6.5 The eIF4E- eIF4G interaction is not limiting for MNV translation 
Our mass spectrometry data demonstrated that eIF4E was sequestered to a VPg-translation initiation 
complex together with eIF4G. In addition, previous data along with our ELISA assay showed that eIF4E 
binds to VPg (Chaudhry et al., 2006). The data presented above indicated that there is a direct 
interaction between VPg and eIF4G (see figure 6.4). However, the eIF4E interaction appears not to be 
essential for the formation of a functional VPg-associated translation complex in viral protein synthesis, 
since eIF4E can bind directly to the defective F123A VPg, based on the VPg mutagenesis studies. 
Furthermore, during the in vitro cleavage of eIF4G mediated by FMDV Lb protease which resulted in 
separation of the eIF4E-binding domain from the C-terminal domain, the binding site of eIF4A and eIF3 
(Belsham et al., 2000; Gradi et al., 1998b), a slight stimulation of MNV mRNA translation was observed 
in the rabbit reticulocyte lysate system (Chaudhry et al., 2006). This earlier data along with our current 
data strongly suggests that the interaction of eIF4G and eIF4E is not required and that the C-terminal 
fragment of eIF4G is sufficient for the MNV translation, similar to the case observed in PV infection 
(Lamphear and Rhoads, 1996; Willcocks et al., 2004).  
To examine the effect of eIF4E sequestration on MNV translation, the activity of eIF4E was altered by 
over-expressing either the WT or non-phosphorylatable mutant form of the 4E-BP1. 4E-BP regulates 
cap-dependent translation by competing with eIF4G for eIF4E binding, whereby the reaction is 
reversible (Gingras et al., 1999b). When 4E-BP is hypo-phosphorylated, it binds to eIF4E, therefore the 
levels of eIF4E available for the formation of eIF4G-eIF4E complex declines, and consequently, cap-
dependent translation is repressed. In contrast, hyper-phosphorylated 4E-BP does not interact with 
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eIF4E, stimulating cap-dependent translation (Gingras et al., 1999a; Mothe-Satney et al., 2000). Five 
mTOR-dependent phosphorylation sites have been identified in 4E-BP1, which are at T37, T46, S65, T70 
and S83 (Mothe-Satney et al., 2000). The first four phosphorylation sites are required for the release of 
4E-BP1 from eIF4E. A construct expressing non-phosphorylatable mutant forms of the 4E-BP1 (HA-4E-
BP1-4A) containing alanine substitutions at the first four sites was obtained (Burgui et al., 2007). This 
mutant binds to eIF4E strongly, preventing eIF4E from binding to eIF4G and hence, suppresses 
translation. To confirm overexpression of the 4E-BP1 would cause the eIF4E-eIF4G disassociation, an 
eIF4E pull-down assay was performed using cap sepharose. Essentially, the construct encoding WT 
(pcDNA3-HA-4E-BP1-WT) or mutant form (pcDNA3-HA-4E-BP1-4A) of 4E-BP1s or a pcDNA3.1+ construct 
(EMP) as a negative control of the experiment was transfected into BV2 cells using Neon-mediated 
electroporation. 6-hours post-transfection, the cells were lysed and subjected to cap-sepharose affinity 
chromatography. Since 4E-BP1 was fused with a HA tag, the expression of WT 4E-BP1 and its mutant 
could be detected by HA antisera, as shown in figure 6.7A. The pull-down assays showed that GAPDH did 
not bind to the cap-sepharose, which proves only the translation initiation factors that bound eIF4E 
could be isolated using cap-sepharose. While a similar level of eIF4E was isolated using cap-sepharose 
under different experimental setups, the amount of the purified eIF4G was significantly reduced upon 
overexpression of both HA-4E-BP1 proteins (figure 6.7A). It is worth noting that the amount of eIF4G 
expression in BV-2 cell lysate is low (figure 6.7), therefore it is not surprising that less eIF4G was retained 
after the pull-down assay, but was definitely increased in pull downs compared to input lysate. The level 
of eIF4G precipitated with eIF4E using cap-sepharose relative to the total input was quantified by 
densitometry using a LICOR imager and compared with the control. For cells overexpressing the mutant 
and the WT forms of 4E-BP1, 60% and 80% of eIF4G was isolated with eIF4E using cap-sepharose 
respectively, when compared to the control (figure 6.7B). Surprisingly, overexpression of the 4E-BP1 
mutant caused a lesser reduction in the level of retained eIF4G than that of the WT 4E-BP1 in cap 
sepharose chromatography. This observation could be due to all five phosphorylation sites in WT 4E-BP1 
being hypo-phosphorylated compared to the mutant with four non-phosphorylatable sites at the time of 
sample collection. Nevertheless, this experiment demonstrates that the overexpression of 4E-BP1 
disassociated the eIF4E- eIF4G complex, as predicted.  
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Given that the 4E-BP1 overexpression disrupted the interaction of eIF4E and eIF4G, its effect on viral 
translation was analysed during MNV infection. BV2 cells were transfected with different HA-4E-BP1 
constructs and infected with MNV at a high M.O.I three hours after transfection. The viral protein 
expression, virus titre and viral RNA copy number were analysed with western blot, TCID50 and qPCR 
respectively (figure 6.8). Overexpression of either WT 4E-BP1 or non-phosphorylatable 4E-BP1 mutant in 
MNV infected cells showed no significant change in viral RNA, virus titre or protein expression. This 
 
Figure 6.7 Overexpression of 4E-BP1 reduced the level of retained eIF4G. BV2 cells were 
transfected with construct expressing the WT or non-phosphorylatable mutant (MUT) of HA-4E-
BP1 or an empty construct, pcDNA3.1+ (EMP) as a control. At 6 h.p.t, the total extract was 
subjected to cap sepharose chromatography to examine whether the disassociation of eIF4G and 
eIF4E complex is mediated by 4E-BP1 overexpression. A) Western blot analysis was performed on 
the total lysates and samples isolated from the assay in order to access the level of HA-4E-BP1, 
eIF4G, eIF4E and GAPDH. (Note: The amount of eIF4G present in those lysate was less; therefore 
less eIF4G was recovered after the pull-down assay.) B) The level of eIF4G retained on the cap 
sepharose was quantified from the western blot analysis using LICOR imaging system.  
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result indicated that the MNV translation was not influenced by altering the availability of eIF4E, 
suggesting that the eIF4G-eIF4E interaction in VPg-translation initiation complex is not limiting for MNV 
translation. It also implies that the MNV translation could be eIF4E-independent. 
 
 
Figure 6.8 Effect of eIF4E overexpression on the MNV lifecycle. BV2 cells were transfected with 
construct expressing a WT or non-phosphorylatable mutant (MUT) of HA-4E-BP1 or an empty 
construct, pcDNA3.1+ (EMP) as a control. At 2 h.p.t, cells were infected with MNV at a high m.o.i 
of 3. A) A western blot analysis was performed on the lysates harvested at 9, 12 and 20 h.p.i, in 
order to access the translation of HA-4E-BP1, NS7 and GAPDH. The numbers below the figures 
represent the percentage of protein expression relative to the control, which were quantified by 
densitometry using LI-COR imaging system. B) The yield of total virus and virus release was 
determined in BV2 cells and expressed as TCID50/ml and compared to EMP control. The 
genomic copy of RNA was analysed by qPCR. Transfections were performed in triplicate and 
error bars represent the standard error of the mean. 
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To evaluate whether or not the overexpression of 4E-BP1 could impair a viral eIF4E-dependent 
translation, an in vitro transcribed RNA construct (Cap-CAT: PTV IRES-fLuc) was used (figure 6.6A) and 
was transfected into BV2 cells expressing WT 4E-BP1 or 4E-BP1 mutant. Since the translation of fLuc 
controlled by PTV IRES was eIF4G-independent (Pisarev et al., 2004), the fLuc expression from 4E-BP1-
overexpressed cells should be of similar levels when compared to cells transfected with empty plasmid 
(a control). As predicted, there was no significant difference in the expression level of fLuc in cells 
transfected with various constructs expressing 4E-BP1 compared with the control (figure 6.9). The 
translation of CAT was driven by the cap structure at the 5’ end of in vitro transcribed RNA construct 
(Cap-CAT: PTV IRES-fLuc). Overexpression of 4E-BP1 has been associated with cell cycle arrest and 
impaired cap-dependent translation in vitro. As predicted, when compared to control, a reduced level of 
 
Figure 6.9 Effect of the 4E-BP1 overexpression on bicistronic reporter gene expression. A capped 
bicistronic RNA reporter (Cap-CAT:PTV IRES-fLuc) was transfected into BV2 cells that overexpressed 
the wild type (WT) or non-phosphorylatable mutant (MUT) of HA-4E-BP1 or an empty construct, 
pcDNA3.1+ (EMP), as a control. B) A western blot analysis was performed on the lysates of BV2 cells 
transfected with the bicistronic capped RNA reporter constructs and different pcDNA3 constructs to 
evaluate the translation of CAT, fLuc and GAPDH. The numbers below the figures represent the 
percentage of protein expression relative to the control, which were quantified in triplicate by 
densitometry using ImageJ.  
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CAT was expressed when the cells had overexpressed with the WT or non-phosphorylatable 4E-BP1 
(59% and 67% respectively) (figure 6.9). This observation is consistent with the effect of 4E-BP1 on the 
eIF4G and eIF4E association in the cap-sepharose pull-down assay 
 
6.6 Discussion 
6.6.1 A direct interaction between eIF4G and MNV VPg required in MNV translation 
As a multifunctional protein, eIF4G has a key role in recruitment of 43S preinitiation complex to the 5’ 
end of the mRNA. Since it serves as a docking site for many other translation initiation factors including 
eIF4F complex, PABP and eIF3 (Borman et al., 2002; Imataka et al., 1998; LeFebvre et al., 2006; 
Marcotrigiano et al., 2001), viruses modulate the activity of eIF4G to ensure preferential translation over 
host mRNAs. Early studies have demonstrated rotaviruses sequester eIF4G from its utilisation by host 
machinery to promote viral protein synthesis. Rotavirus NSP3 protein binds to the N-terminus of eIF4G 
and interacts tightly with the 3’ end of the viral mRNA, which consequently prevents PABP from binding 
to the eIF4F complex in order to inhibit host translation (Groft and Burley, 2002; Piron et al., 1998). 
Alternatively, some viruses (i.e. enteroviruses) mediate eIF4G cleavage resulting in profound reduction 
in cellular mRNA cap-dependent translation, hence facilitating IRES-dependent viral protein production 
(Kerekatte et al., 1999; Lamphear et al., 1995; Roberts et al., 2000). 
During the course of MNV infection, proteolysis of eIF4G did not occur and hence did not correlate to 
host shutoff. Instead, MNV VPg established a direct interaction with the central domain of eIF4G (region 
within 654-1131) in the HIS-tag pull-down assay. Our mutagenesis study suggested that the F123A 
mutation in VPg conferring lethal phenotype showed a reduction in its ability to bind eIF4G, while down-
regulation of the eIF4G expression by siRNA abrogated the translation of genomic MNV RNA, which 
resulted in a delay in virus production and genomic RNA synthesis. Our in vitro functional data indicated 
that translation of MNV mRNA relied on both eIF4G isoforms with different degree of dependence, 
where eIF4GII exert a greater effect on viral protein synthesis. However the effect of eIF4GII siRNA on 
the MNV translation could be a collective knockdown effect of both eIF4G isoforms exerted on the 
translation of viral protein, and therefore a specific siRNA that targets only eIF4GII mRNA expression 
should be used to address which eIF4G isoform is mostly essential to the MNV translation. Whilst our 
study was based on an infectious MNV VPg-linked RNA to study the effect of eIF4G knockdown on a 
human cell line, studies using mouse cell lines such as RAW and BV2 cells will provide more valuable 
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information on the eIF4G-depleted cells during an authentic MNV infection. Furthermore, the collective 
data from VPg mutagenesis and the mapping study suggested that the amino acid position at F123 is 
critical for binding to translation initiation factors other than eIF4E. It is possible that F123 residue is 
responsible for binding to the strongest affinity binder, eIF4G through its central region that lies 
between 654-1131 amino acids to initiate protein synthesis. Hence, it would be of considerable interest 
to determine the minimum VPg- binding region in eIF4G, to allow drug development studies targeting 
the specific binding site. For instance, designing a drug targeting at the VPg-binding region in eIF4G may 
be a good anti-viral approach to abolish the MNV lifecycle, while leaving host protein synthesis 
unaffected.  
Sequestration of eIF4G to the translational apparatus mediated by VPg is not exclusive to calicivirus. The 
VPg protein from yellow rice mottle virus (YRMV) mediates a direct interaction with eIF4G via its central 
domain. It has been demonstrated that a point mutation in eIF4G could disrupt the interaction with 
YRMV VPg, which confers the virus resistance, and this suggests that the interaction of VPg and the 
central domain of eIF4G contributes to the virulence of YRMV (Hebrard et al., 2010). As detailed in 
chapter 4 and 5, V115A, D116A and F123A mutations in MNV VPg reduced its ability to bind translation 
initiation factors; thereby F123A conferred lethal phenotype, while V115A and D116A showed a 
reduction in virus yield from the reverse genetics system. The data suggested that F123A is a major 
residue responsible for the translation initiation factors binding, whilst V115 and D116 residues on MNV 
VPg reinforced the interaction with the translation initiation factors. Given that VPg bound to eIF4G with 
the highest affinity among the key canonical factors (PABP and the components of the eIF4F complex), 
we can hypothesise that these residues are responsible for eIF4G binding. In addition, VPg mutation (i.e 
double mutation of V115 and D116) could potentially have detrimental bystander effect on virus 
resulting from viral translation inhibition, therefore, it would be interesting to study the effect of 
mutation on MNV virulence in the animal models available. When disruption of the MNV and eIF4G 
interaction would be proved to confer virus resistance, such mutated virus would be potentially a good 
vaccine, since those mutated residues are conserved among caliciviruses.  
In addition, it would be particularly interesting to perform a similar comparative mutagenesis and 
proteomic studies of the homology position in NV VPg, i.e. F137, an equivalent reside to F123 residues in 
MNV VPg. In fact, a NTAP-NV VPg F137A expressing construct was made and would be interesting to 
examine whether it is unable to bind eIF4A, eIF4G and PABP, except eIF4E, similar to that finding from 
MNV VPg NTAP-F123A. Hence, employing similar studies on NV VPg as MNV VPg will provide further 
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insights on the interaction between human noroviruses and the host cell, which reveals potential targets 
for drug or vaccine designing. 
6.6.2 Effect of the eIF4E sequestration to MNV translation 
The activity of eIF4E is regulated through direct interaction with the 4E-BP proteins that are themselves 
regulated by phosphorylation (Gingras et al., 1999a; Gingras et al., 1999b). Interaction of eIF4E with 4E-
BP affects formation of the eIF4E- eIF4G complex assembly thereby preventing formation of an active 
eIF4F complex, which results in suppression of cellular protein synthesis. When 4E-BP is phosphorylated, 
the eIF4E- 4E-BP inhibitory complex dissociates leading to stimulation of cellular mRNA translation 
(Gingras et al., 1999a). Our current proteomic data demonstrated that 4E-BP was not purified from 
NTAP-MNV VPg, which suggest eIF4E isolated with NTAP-MNV VPg was not associated with 4E-BP1 and 
in fact, it is likely to be associated with eIF4G within the VPg-associated initiation complex. However, the 
F123A mutation in VPg was found to bind eIF4E, similar to the WT VPg, implying eIF4E is not involved in 
MNV translation despite being bound to VPg. Previous in vitro translation data has demonstrated that 
MNV translation can occur even if eIF4G is cleaved by recombinant FMDV Lb protease, suggesting that 
either the interaction of eIF4G-eIF4E is not essential for virus translation or the C-terminus of eIF4G is 
not needed. A functional analysis of eIF4E on MNV life cycle was carried out to evaluate the effect of the 
eIF4G- eIF4E interaction on MNV translation. Constitutive overexpression of the hypo-phosphorylated 
4E-BP1 had no effect on MNV translation and replication. This means that dephosphorylation of 4E-BP1, 
which typically resulted in the sequestration of eIF4E away from eIF4G, in fact, did not affect the MNV 
lifecycle, suggesting that the MNV translation could be eIF4E-independent. Other viruses, such as 
influenza viruses and bunyavirus bypass the requirement of eIF4E to promote viral protein production 
(Burgui et al., 2007; Mir and Panganiban, 2008; Yanguez et al., 2012). Based on our data, eIF4E could be 
dispensable for MNV translation and might contribute to the host-shutoff in MNV-infected cells, 
therefore future studies on the functional role of eIF4E are required to confirm this hypothesis. Our 
work has highlighted that eIF4G contributes to efficient MNV translation in vitro, while the interaction of 
eIF4G and eIF4E is not limiting to viral translation. Finally, our current data support the theory that MNV 
translation is likely to be eIF4E-independent. 
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7 Conclusion and future perspective 
 
For positive-strand RNA viruses, the first event after the virions have entered and uncoated within the 
cells is viral RNA translation. Viruses do not encode their own translational machinery, therefore they 
have evolved ways to hijack the cellular pathways or adopt novel mechanisms of translation initiation 
(Belsham and Jackson, 2000; Chaudhry et al., 2006; Cuesta et al., 2004; Jang, 2006). They regulate and 
supersede cellular translation by recruiting and modifying translation factors to gain translational 
advantages for their own mRNAs (Belsham et al., 2000; Gradi et al., 1998b; Ohlmann et al., 1996; Svitkin 
et al., 2005). Consequently, translation factor modification results in altering cap-dependent translation 
efficiency, and often eliciting a host shutoff effect that can affect the efficacy of the host’s antiviral 
response. Given that the initiation step of translation is a rate-limiting process, viruses often target the 
translation factors involved in the regulation of translation initiation in order to subvert the cellular 
translation machinery, such as eIF4G, eIF4E and PABP. Investigating the molecular interaction of these 
proteins with viral proteins can shed light on how these regulatory changes impact the virus lifecycle 
and the host. The study of the molecular biology of the norovirus has been hampered due to the lack of 
a suitable cell culture system to support human norovirus infection. Though a new report suggests that a 
3D cell culture system mimicking the small intestinal epithelium could support norovirus replication, 
these cells required at least a month to prepare for every infectivity assay and as yet, this experimental 
system has not been reproduced by other laboratories (Straub et al., 2007). As a cell culture compatible 
surrogate for the human norovirus, MNV remains the best available model for expediting the knowledge 
of non-cultivatable human norovirus biology. 
Translation of MNV RNA mediated by VPg involves complex protein-protein and RNA-protein 
interactions. Disruption of these interactions could lead to the development of an antiviral therapeutic 
agent. To identify peptides that could potentially inhibit MNV or FCV VPg activity, screen of a phage 
display peptide library was performed using two approaches. Although several peptides with binding 
activity towards the recombinant HIS- tagged VPg were successfully identified, the subsequent 
specificity binding assays indicated that those phages did not specifically bind to the respective VPg. In 
fact, those phages appeared to have binding specificity for histidine. If time permitted, a revised panning 
protocol that used untagged proteins could enhance the chance of selecting VPg-binding phage. Given 
that the general elution buffer, glycine was used in the panning procedure, a specific ligand against 
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target protein as a specific elution buffer could be used to increase the stringency of isolating phage 
with desirable binding properties.  
 
Understanding the lifecycle of viruses makes a fundamental contribution to the facilitation of anti-viral 
drugs and vaccine development to combat virus infection. As a ‘cap substitute’ mimicking the 5’ end of a 
cellular RNA, calicivirus VPg has previously been shown to bind various translation initiation factors, 
such as eIF4GI, eIF4E and some eIF3 components (Daughenbaugh et al., 2003; Daughenbaugh et al., 
2006). Consistent with this, our full scale proteomic analysis of MNV VPg has not only identified the 
previously identified canonical translation initiation factors, but also numerous other factors that 
constitute VPg-mediated translation complexes. These include eIF4GII, eIF4A (isoform 1 and 2), 
components of the eIF3 complex, PABP (isoform 1 and 4) and possibly some non-canonical factors (table 
5.1). Among the canonical factors, eIF4G was found to establish a direct interaction with MNV VPg 
through its central domain, the region containing eIF4A- and eIF3-recognition sites (figure 6.4). Although 
the minimum requirement of establishing the eIF4G-VPg interaction remains to be determined, it is 
believed that the eIF4G interaction with eIF4A and eIF3 is critical for unwinding the viral RNA and 
ribosome recruitment during viral translation (Chaudhry et al., 2006) (figure 7.1). The siRNA-mediated 
knockdown of the eIF4G appeared to show that MNV mRNA translation is more reliant on eIF4GII than 
Figure 7.1 Cartoon model of calicivirus VPg-associated translation initiation complex. The above 
is a predicted model of the A) FCV VPg- or B) MNV VPg-associated translation initiation complex 
based on the published and current data. VPg attached at the 5’ end of viral RNA is highlighted in 
blue. The translation initiation factor that binds directly to VPg and plays a functional role in virus 
translation is indicated by a solid red line, while the factor that binds directly to VPg, the function 
of which remains to be elucidated, is indicated by a dashed solid line. The factor that has not yet 
been identified to bind directly to VPg, but is indispensable for calicivirus translation initiation, is 
shaded in black. The factor highlighted in green is likely to be responsible for the host shutoff.  
A. Model of FCV VPg-associated 
translation initiation complex
VPg AUG4E
4G
4A
PABP
3
(n)AAA
B. Model of MNV VPg-associated 
translation initiation complex
VPg AUG4E
4G
4A
3
PABP
(n)AAA
                                                             P a g e  | 176 
 
eIF4GI when the infectious VPg-linked RNA was transfected into human 293 cells (figure 6.5). However, 
the dependence of eIF4GII in the MNV translation could be due to the combined knockdown effect of 
both eIF4G isoforms as the eIF4GII siRNA targets the central domain of eIF4GII that is highly similar to 
the eIF4GI isoform (i.e. the eIF4GII siRNA targeting sequence against eIF4GI and eIF4GII is approximately 
89% and 100% respectively). The silencing experiment also indicated that the viral titre was reduced 
suggesting eIF4G plays an important role in MNV mRNA translation, although further experiments are 
required to determine which isoform is essential for norovirus translation. 
Our proteomic analysis of NTAP-MNV VPg did not isolate 4E-BPs (table 5.2). The 4E-BP proteins interact 
with eIF4E at the same site as eIF4G. The inability to isolate the 4E-BP proteins in the VPg containing 
translation initiation factor complex would suggest that the eIF4E in this complex is associated with only 
eIF4G. The F123A mutation in VPg that was not able to recover any virus (table 4.1), substantially 
reduced the ability of VPg being purified by cap-sepharose (figure 4.2), indicating the F123 residue is 
important for the translation initiation factors binding. A comparative proteomic analysis between 
NTAP-MNV VPg derivatives of WT and F123A mutant indicated eIF4A, eIF4G and PABP were co-purified 
with the WT form, but not with the F123A mutant (figure5.9). Interestingly, eIF4E was isolated with 
NTAP-MNV VPg as well as mutant F123A. Consistent with this data, the recombinant F123A protein 
could bind directly to eIF4E, similar to the WT MNV VPg (figure 5.9). These experiments have highlighted 
that eIF4E may not be crucial for the formation of a VPg-mediated translation initiation complex to 
facilitate the synthesis of MNV proteins. A previous in vitro translation study has also suggested that 
MNV mRNA translation is not sensitive to eIF4E depletion or the impairment of the eIF4E-eIF4G 
interaction by the addition of recombinant 4E-BP1 (Chaudhry et al., 2006). In contrast FCV mRNA 
translation is clearly reliant on eIF4E and requires the presence of eIF4E (Chaudhry et al., 2006) (figure 
7.1). Furthermore, the current study has demonstrated that the 4E-BP1 overexpression had no effect on 
the MNV translation and viral titre, suggesting that the eIF4G-eIF4E interaction may not be essential for 
MNV translation (figure 6.8). Taken together, the collective data supports the hypothesis that eIF4E may 
not form part of the VPg-associated complex to play an active role in MNV translation. Instead we would 
hypothesise that eIF4E is sequestered to the VPg-translation factor complex as part of a control 
mechanism to regulate cellular translation. It has been suggested that reducing the steady state level of 
eIF4E impairs cellular cap-dependent translation, which results in host shutoff during PV and EMCV 
infection (Gingras et al., 1996). Therefore, based on our data we would suggest a model whereby MNV 
VPg recruits eIF4E to block the eIF4E-eIF4G interaction, thus preventing the eIF4F complex formation 
and ultimately leading to cap-dependent translation inhibition (figure 7.2B). Decreasing the eIF4E level 
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by siRNA in infected cells will confirm whether eIF4E is indispensable for MNV mRNA translation, 
however due to time constraints I was unable to undertake this work. 
Based on an observation of the expression levels of several canonical factors during MNV infection, 
PABP was cleaved at 9 hours post-infection, whereas the protein expression level of other canonical 
factors remained unaffected during MNV infection (figure 5.8). Similar to MNV infection, PABP cleavage 
has also been observed when permissive cells were infected with FCV (figure 7.2A) and when treated 
with recombinant NV protease, which was shown to correlate to the host shutoff (Kuyumcu-Martinez et 
al., 2004a). Although it is not known if PABP together with the poly(A) tail at the 3’ end of the calicivirus 
genome stimulates VPg-dependent translation, its cleavage would inhibit the poly(A)-dependent 
translation, potentially affecting the translation of cellular mRNAs (as depicted in figure 7.2). In the case 
of PV and DV infection, it has been proposed that PABP cleavage may serve as part of a regulatory 
system to switch translation to replication when sufficient viral proteins are made (Joachims et al., 1999; 
Kuyumcu-Martinez et al., 2004b). This enables viruses to preferentially inhibit cellular translation at the 
late stage of infection without extensively affecting the production of viral proteins at the early stage, 
however, this hypothesis has not yet been fully tested. Of interest, the phenomenon of genome 
circularization appears to be a common theme in RNA viruses, such as in PV and DV (Filomatori et al., 
2006; Friebe and Harris; Kuyumcu-Martinez et al., 2004b). Previous study has shown that PCBP binds to 
the 5’ and 3’ ends of MNV genomic RNA. Although whether or not this circularisation is required for 
calicivirus replication is not yet been determined, it presumably promotes viral RNA replication (Bailey 
et al., 2010a). One might predict that PCBP secures a linkage between two ends of the viral RNA for 
replication (Edgil et al., 2006).  
During FCV infection, eIF4G cleavage correlated with the cellular shutoff (Willcocks et al., 2004), which 
highlighted that the cleavage of key canonical factors serves as part of the regulatory system to 
manipulate the protein synthesis in the host (as illustrated in figure 7.2A). Given that an intact eIF4G is 
required for FCV mRNA translation in the rabbit reticulocyte cell-free system (Chaudhry et al., 2006), it is 
hypothesised that eIF4G is cleaved to terminate translation on genomic RNA, when replication is 
favoured over translation in the latter stages of the FCV replication cycle, similar to the functional role of 
PABP cleavage. In contrast, my data and that previously published by our lab would suggest that eIF4G 
cleavage does not occur during MNV infection. Clearly then, consistent with previous published data 
(Chaudhry et al., 2006), MNV and FCV differ in their requirement of the component of eIF4F complex, 
suggesting they have different translational control mechanisms to regulate their gene expression 
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(figure 7.1A) and cellular protein synthesis (figure 7.2). Nevertheless, my data would indicate that MNV 
and FCV may share a similar strategy to subvert cellular translation, such as PABP cleavage, which may 
also be involved in switching translation to replication when sufficient viral proteins have been 
produced. Importantly however, the fundamental role of PABP and its action during viral replication 
remains to be fully determined and future studies are clearly warranted. 
Since MNV and NV share significant sequence similarity and their VPg exhibits a 54% amino acid identity 
(Daughenbaugh et al., 2006), they are thought to share relatively similar mechanisms to regulate their 
gene expression. During this study, a genetically-modified MNV cDNA clone expressing NV VPg was 
created to evaluate whether or not NV has the same translation mechanism as MNV. For instance, the 
functional role of the residues in the NV VPg required for viral translation could be determined by 
performing a mutagenesis study, once the MNV:NV chimera was made successfully. In spite of the 
considerable effort in rescuing the virus from the genetically-modified MNV chimera, no viable virus was 
recovered. Since VPg can bind to cellular translation factors as well as viral proteins, NS7 and VP1, the 
lack of recovery could be due to some type of species specific interaction between VPg and its 
interacting protein partners. This has been subsequently supported by published work indicating MNV 
VPg cannot bind to human norovirus GII.4 NS7 (Subba-Reddy et al., 2011). Nonetheless, the 
development of an NV replicon system enables us to expedite the understanding of human norovirus 
translation (Chang et al., 2006) and the NV VPg could be isolated using cap-sepharose via interacting 
with canonical translation factors (figure 4.4). Consistent with the analysis of cap-sepharose 
chromatography, the TAP derivatives of NV VPg were able to isolate the entire eIF4F complex, together 
with PABP (figure 5.10), which verifies NV VPg can bind to the translation initiation factors. Furthermore, 
the NTAP-derivative of NV VPg F137A mutant (i.e. equivalent to MNV VPg F123A) was generated. Given 
that F123A mutation in MNV VPg showed a reduction in its ability to bind PABP and eIF4F complex 
except eIF4E, the F137A residue in NV VPg is presumably defective in the translation initiation factor 
binding, however a more detailed proteomic analysis was not possible due to time constraints. Although 
the translation factors required for human norovirus translation have not as yet been identified, a study 
of the NV replicon system could potentially elucidate the functional roles of the individual translation 
factors required for NV translation and could be used to examine the effect of NV VPg mutation on their 
generation of replicon containing cell line. Nonetheless, this work provides the first evidence for an 
interaction between the human norovirus VPg protein and translation initiation factors during virus 
replication although using an artificial replicon system. Ultimately, the mutagenesis study, together with 
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the functional studies could lead to unravelling the translation mechanism mediated by NV VPg 
compared with MNV VPg.   
 
 
 
Figure 7.2  Cartoon model of inhibition of cellular cap-dependent translation. A) Model of 
inhibition of cellular cap-dependent translation mediated by FCV protease. FCV protease cleaves 
PABP and eIF4G to mediate cellular inhibition. PABP cleavage is also thought to serve as a 
mechanism to terminate translation in order to switch on replication mode for the viral RNA 
synthesis. The dashed green line indicates the site where the viral protease mediates the cleavage. 
B) Model of inhibition of cellular cap-dependent translation mediated by MNV protease and VPg. 
MNV protease cleaves PABP which may contribute to the host shutoff and is a mechanism for 
switching translation to replication. MNV VPg sequesters eIF4E into its translational complex, 
thereby preventing eIF4E from interacting with eIF4G to form an intact eIF4F complex, thus 
inhibiting cap-dependent translation. The dashed green line indicates the cleavage mediated by 
MNV protease during infection.  
4E
4G
4A
PABP
3
(n)AAA
m7
A. Model of the cellular inhibition 
mediated by FCV protease
4G
3
VPg AUG4E
4G
4A
3
PABP
(n)AAA
4A
PABP
(n)AAA
Reduce eIF4E availability 
due to VPg recruitment 
m7
B. Model of the cellular inhibition 
mediated by MNV protease and VPg
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The discovery of drugs or vaccines relies heavily on identifying the basic aspects of the cellular 
regulatory system and its manipulation by viruses at different levels, which impacts virus replication and 
translation, together with the hosts.  Since viral translation is the first intracellular step of the viral life 
cycle, targeting this step would provide a way of controlling virus infection before it starts. Creating 
attenuated VPg mutant viruses that affects translation factor binding may provide a good candidate for 
live-attenuated vaccine and promote vaccine development. Given that the transformed nature of cell 
lines causes overexpression of many translation factors and allows cells to grow rapidly, therefore the 
introduction of mutation into VPg that reduces the binding ability of VPg may result in producing 
attenuated but cultivatable virus. Finally, our work has provided new insights into how norovirus VPg 
interacts with the cellular factors necessary for an efficient translation, which is an important step to 
fully elucidate the mechanism of translational control adapted by caliciviruses. In this way, identification 
of the translation initiation factors involved in VPg-mediated translation would reveal antiviral targets 
and potentially open new avenues to combat the highly transmissible norovirus infections worldwide. 
 
Summary of the main conclusions 
 
 Our full scale proteomic analysis of MNV VPg has demonstrated that VPg associates with 
numerous canonical initiation factors and possibly non-canonical initiation factors. The 
canonical translation initiation factors include eIF4G (i.e. eIF4GI and eIF4GII), eIF4A (i.e. eIF4AI 
and eIF4AII), components of the eIF3 complex, PABP (i.e. PABP1 and PABP4).  
 Our proteomic analysis of NTAP-MNV VPg did not isolate 4E-BPs. Given that the 4E-BP proteins 
interact with eIF4E at the same site as eIF4G, therefore the inability to isolate the 4E-BP proteins 
in the VPg containing translation initiation factor complex would suggest that the eIF4E in this 
complex is associated with only eIF4G.  
 Among the canonical factors, eIF4G was found to establish a direct interaction with MNV VPg 
through its central domain, the region containing eIF4A- and eIF3-recognition sites.  
 eIF4G plays an important role in MNV mRNA translation. The siRNA-mediated knockdown of 
either eIF4G isoform resulted in a 9 fold reduction in virus titre, as well as reduction of viral RNA 
and protein synthesis, confirming that eIF4G has a functional role in norovirus life cycle.  
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 Overexpression of either the wild type 4E-BP1 or the non-phosphorylatable 4E-BP1 mutant in 
MNV infected cells showed no significant change in viral RNA, virus titre or protein expression 
suggesting that the eIF4G-eIF4E interaction in a VPg-translation initiation complex is not limiting 
for MNV translation. 
 The mutational analysis of MNV VPg indicated the C-terminus of VPg is essential for the 
association of VPg with the components of eIF4F complex and virus viability. The F123A 
mutation in VPg that was not able to recover any virus, substantially reduced the ability of VPg 
being purified by cap-sepharose, indicating the F123 residue is important for the translation 
initiation factors binding.  
 A comparative proteomic analysis between NTAP-MNV VPg derivatives of WT and F123A mutant 
indicated eIF4A, eIF4G and PABP were co-purified with the WT form, but not with the F123A 
mutant. Interestingly, eIF4E was isolated with NTAP-MNV VPg as well as mutant F123A. 
Consistent with this data, the recombinant F123A protein could bind directly to eIF4E, similar to 
the WT MNV VPg. These experiments have highlighted that eIF4E may not be crucial for the 
formation of a VPg-mediated translation initiation complex to facilitate the synthesis of MNV 
proteins. A previous in vitro translation study has also suggested that MNV mRNA translation is 
not sensitive to eIF4E depletion or the impairment of the eIF4E-eIF4G interaction by the 
addition of recombinant 4E-BP1 (Chaudhry et al., 2006). Taken together, the collective data 
supports the hypothesis that eIF4E may not form part of the VPg-associated complex to play an 
active role in MNV translation. Therefore, we would hypothesise that eIF4E is sequestered to 
the VPg-translation factor complex as part of a control mechanism to regulate cellular 
translation. It has been suggested that reducing the steady state level of eIF4E impairs cellular 
cap-dependent translation, which results in host shutoff during PV and EMCV infection (Gingras 
et al., 1996). Therefore, based on our data we would suggest a model whereby MNV VPg 
recruits eIF4E to block the eIF4E-eIF4G interaction, thus preventing the eIF4F complex formation 
and ultimately leading to cap-dependent translation inhibition.  
 MNV and FCV differ in their requirement of the component of eIF4F complex, suggesting they 
have different translational control mechanisms to regulate their gene expression. During FCV 
infection, eIF4G cleavage correlated with the cellular shutoff (Willcocks et al., 2004), which 
highlighted that the cleavage of key canonical factors serves as part of the regulatory system to 
manipulate the protein synthesis in the host. In contrast, eIF4G cleavage does not occur during 
MNV infection.  
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 MNV and FCV may share a similar strategy to subvert cellular translation, such as PABP cleavage, 
which may also be involved in switching translation to replication when sufficient viral proteins 
have been produced.  
 Similar to MNV VPg, NV VPg can bind to the translation initiation factors, including the entire 
eIF4F complex and PABP. This provides the first evidence for an interaction between the human 
norovirus VPg protein and translation initiation factors during virus replication although using an 
artificial replicon system. 
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